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Summary 1 
Summary 
The correct regulation of cell growth and proliferation is essential during normal animal 
development. Myc proteins function as transcription factors, being involved in the con-
trol of many growth- and proliferation-associated genes and deregulation of Myc is one 
of the main driving factors of human malignancies.  
The first part of this thesis focuses on the identification of directly regulated Myc target 
genes in Drosophila melanogaster, by combining ChIPseq and RNAseq approaches. 
The analysis results in a core set of Myc target genes of less than 300 genes which are 
mainly involved in ribosome biogenesis. Among these genes we identify a novel class 
of Myc targets, the non-coding small nucleolar RNAs (snoRNAs). In vivo studies show 
that loss of snoRNAs not only impairs growth during normal development, but that 
overexpression of several snoRNAs can also enhance tumor development in a neu-
ronal tumor model. Together the data show that Myc acts as a master regulator of ribo-
some biogenesis and that Myc’s transforming effects in tumor development are at least 
partially mediated by the snoRNAs. 
In the second part of the thesis, the interaction of Myc and the Zf-protein Chinmo is 
described. Co-immunoprecipitations of the two proteins performed under endogenous 
and exogenous conditions show that they interact physically and that neither the two 
Zf-domains nor the BTB/POZ-domain of Chinmo are important for this interaction. Fur-
thermore ChIP experiments and Myc dependent luciferase assays show that Chinmo 
and Myc share common target genes, and that Chinmo is presumably also involved in 
their regulation. While the exact way of how Myc and Chinmo genetically interact with 
each other still has to be investigated, we show that their interaction is important in a 
tumor model. Overexpression of the tumor-suppressors Ras and Chinmo leads to tu-
mor formation in Drosophila larvae, which is drastically impaired upon loss of Myc. 
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Zusammenfassung 
Die korrekte Regulation von Zellwachstum und Proliferation ist von entscheidender 
Bedeutung für die Entwicklung von Tieren. Myc-Proteine fungieren als Transkriptions-
faktoren, die in die Funktionskontrolle vieler Gene eingebunden sind die eine Rolle bei 
Zellwachstum und Proliferation spielen. Fehlregulierung von Myc ist ein Hauptfaktor 
menschlicher Tumorbildung. 
Der erste Teil dieser Dissertation beschäftigt sich mit der Identifizierung direkt regulier-
ter Myc Zielgene in Drosophila melanogaster durch Kombination von ChIPseq und 
RNAseq Analysen. Insgesamt wurde eine Hauptgruppe von weniger als 300 Myc Ziel-
genen identifiziert, von denen der Großteil eine Funktion in der Ribosomen Biogenese 
hat. Unter diesen Genen haben wir eine neue Klasse an Myc Zielgenen identifiziert, die 
nicht-codierenden „small nucleolar RNAs“ (snoRNAs). In vivo Experimente zeigen, 
dass der Verlust der snoRNAs nicht nur das Wachstum während der natürlichen Ent-
wicklung beeinträchtigt, sondern auch, dass Überexpression verschiedener snoRNAs 
die Tumorbildung in einem neuronalen Tumormodel begünstigt. Zusammenfassend 
zeigen die Daten, dass Myc maßgeblich Ribosomen Biogenese steuert und dass der 
transformierende Effekt, den Myc in der Tumorentwicklung inne hat, zumindest teilwei-
se durch die snoRNAs gesteuert wird. 
Im zweiten Teil der Arbeit wird die Interaktion von Myc und dem Zink-Finger Protein 
Chinmo beschrieben. Co-Immunoprezipitationen der zwei Proteine die unter endoge-
nen und exogenen Bedingungen durchgeführt wurden zeigen, dass sie physisch mitei-
nander interagieren und dass weder Chinmos Zf-Domänen noch seine BTB/POZ-
Domäne für diese Interaktion verantwortlich sind. ChIP-Versuche und Myc abhängige 
Luciferase-Assays zeigen weiterhin, dass Chinmo und Myc gemeinsame Zielgene be-
sitzen und dass Chinmo darüber hinaus wahrscheinlich auch an ihrer Regulation betei-
ligt ist. Während der genaue Zusammenhang der genetischen Interaktionen von Myc 
und Chinmo noch ungewiss ist und weiterer Untersuchungen bedarf, kann gezeigt 
werden, dass die Interaktion der beiden Proteine in einem Tumormodel eine Rolle 
spielt. Die Tumorbildung die durch Überexpression des Tumorsuppressors Ras zu-
sammen mit Chinmo hervorgerufen wird, wird durch den Verlust von Myc stark redu-
ziert.  
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1 Introduction 
1.1 Transcription factor Myc 
The transcription factor Myc is one of the best characterized genes in the field of bio-
medical research. Nearly 40 years ago, the first Myc gene was identified as a trans-
forming oncogene in retroviruses leading to myelocytomatosis in birds (Sheiness et al., 
1978). Since then, more than 26,000 primary and review articles have been published, 
dealing with Myc (Pubmed, June 2015). In the following years, the cellular homologs in 
vertebrates, c-, N- and L-Myc, were identified (Vennstrom et al., 1982; Kohl et al., 
1983; Nau et al., 1985). Two additional Myc variants, B-Myc and s-Myc, were de-
scribed in rodents (Ingvarsson et al., 1988; Sugiyama et al., 1989). The different Myc 
genes encode transcription factors that play essential roles in cell growth, proliferation, 
apoptosis, cell cycle progression and differentiation (Dang et al., 2006; Vita and 
Henriksson, 2006). The deregulation of Myc contributes to genomic instability, uncon-
trolled cell proliferation, immortalization and escape from immune surveillance, leading 
to the formation of tumors. In the following sections, the vertebrate system is referred 
to, where not otherwise stated.   
1.1.1 Functional domains of Myc 
The Myc protein contains several domains with various functions that are highly con-
served between c-, N- and L-Myc (Meyer and Penn, 2008), and show a moderate to 
high conservation between different vertebrate species (Atchley and Fitch, 1995; Tan-
sey, 2014). The Myc boxes I and II are located at the N-terminus, whereas Myc box IV 
is located centrally; the DNA binding domain (basic region) and the dimerization do-
main (helix-loop-helix and leucine-zipper (bHLH-LZ)) are located at the C-terminus. 
Myc box III is located centrally (Figure 1-1 A). The Myc boxes I-IV mediate important 
functions such as Myc-induced apoptosis (Evan et al., 1992), transformation (Stone et 
al., 1987) and inhibition of differentiation (Freytag et al., 1990). More precisely, Myc box 
I is essential for Myc’s destabilization as it contains two phosphorylation sites, threo-
nine 58 and serine 62 that control ubiquitination (Sears et al., 2000). Myc box II medi-
ates the interaction with partners such as Trrap (McMahon et al., 2000) and TIP48/49 
(Wood et al., 2000), and is needed for transformation as well as for transcriptional acti-
vation and repression by Myc. The Myc boxes III and IV are essential in modulating 
Myc-induced apoptosis and transformation (Cowling et al., 2006; Herbst et al., 2005). 
The basic region (BR) mediates sequence specific binding to DNA (Prendergast et al., 
1991), while the HLH-LZ-domain is responsible for interaction between Myc and co-
factors such as Max (Myc associated factor X) (Blackwood and Eisenman, 1991). In 
addition, Myc contains a nuclear localization sequence (NLS) which is important for the 
subcellular localization (Dang and Lee, 1988).  
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Figure 1-1: Schematic diagram of the Myc protein 
 
A. Myc protein contains several conserved regions, the Myc boxes I, II, III and IV (MB I, II, III, 
IV), a nuclear localization sequence (NLS), a basic region (BR), a helix-loop-helix motif (HLH) 
and a leucine zipper (LZ). The human c-Myc consists of 439 amino. 
 
1.1.2 Transcriptional regulation by Myc 
Several ChIPseq analysis performed in various cell lines (Zeller et al., 2006; Raha et 
al., 2010; Seitz et al., 2011) revealed that the human genome contains thousands of 
Myc binding sites and it is assumed that around 15% of all human genes are regulated 
by Myc (Dang et al., 2006; Li et al., 2003). As described earlier (1.1.1), Myc contains a 
basic region in the C-terminus which mediates interactions between protein and DNA. 
This interaction is mainly achieved via a palindromic DNA-sequence (CACGTG) called 
canonical E-box (enhancer-box) (Blackwell et al., 1990) but Myc can also bind to non-
canonical (CANNTG) E-boxes with a lower affinity (Blackwell et al., 1993). In order to 
bind E-box sequences, Myc needs to heterodimerize with Max via its bHLH-LZ domain. 
The heterodimer binds to DNA and recruits different co-activator complexes, such as, 
histone acetyltransferases or ATPases, which can directly bind to Myc via the adaptor 
protein Trrap (Adhikary and Eilers, 2005). Acetylation of the nucleosomes results in an 
open chromatin structure and therefore enables the transcription of target genes (Lee 
and Workman, 2007). Another Myc-dependent mechanism of transcriptional activation 
works via binding of Myc to the mediator complex and to the transcription elongation 
factor P-TEFb (positive transcription elongation factor b) which enables recruitment of 
RNA Pol II to the promoter and elongation of the nascent mRNA, respectively (Bou-
chard et al., 2004; Eberhardy and Farnham, 2001; Rahl et al., 2010). 
The process of transcriptional repression by Myc has been less well studied than the 
process of activation. Myc represses genes by getting recruited to the promoters via 
further transcription factors such as Sp-1 (specificity protein-1) (Gartel et al., 2001) and 
Miz1 (Wanzel et al., 2003). The best described mechanism involves Miz1 (Peukert et 
al., 1997). Miz1 activates negative cell cycle regulators such as CDKN2B, CDKN1A 
and CDKN1B by binding to their core-promoters (Herold et al., 2002; Staller et al., 
2001; Seoane et al., 2002). The expression of these Cdk-inhibitors (cyclin dependent 
kinase) is repressed by binding of Myc-Max complexes to Miz1, leading to the recruit-
ment of repressing co-factors and the displacement of activating co-factors (Lüscher 
and Vervoorts, 2012). 
In recent years, microarrays and next generation sequencing technologies were used 
to identify Myc regulated genes. It was shown that Myc, when expressed at high levels, 
sits at nearly all promoters with open chromatin and also binds to many enhancers, 
independent of E-boxes (Chen et al., 2008; Lin et al., 2012). This is consistent with 
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earlier studies where it was shown that promoters targeted by Myc are associated with 
an active chromatin profile, including methylation marks at H3K4 (Guccione et al., 
2006). In agreement with these data, Nie et al. (2012) and Lin et al. (2012) suggested a 
model where Myc functions as an amplifier of active transcription rather than as a regu-
lator of specific sets of genes. In this model, the transcriptional repression by Myc 
would be indirect via activation of repressors which are recruited to Myc target genes 
(Nie et al., 2012). However, Sabo et al. (2014) and Walz et al. (2014) were able to 
show that induction of Myc resulted in changes of promoter binding, which correlated 
with changes of gene expression. Furthermore, stoichiometric binding of Myc and Miz1 
(Myc interacting zinc-finger-protein 1, see below) at the same promoter suppresses 
target gene expression (Walz et al. 2014), and consequently, transcriptional repression 
by Myc is not an indirect process. Consistent with earlier publications (van Riggelen et 
al., 2010; Lee et al., 2012), it was shown that a large fraction of genes regulated by 
Myc play a role in ribosome biogenesis, RNA-processing and translation while the 
regulation of other gene sets (e.g. involved in cell adhesion, apoptosis or angiogenesis) 
depends on Myc levels and promoter affinity (Walz et al., 2014; F. Lorenzin, pers. 
com.).  
1.1.3 Myc-Max network 
The dimerization between Myc and Max is essential for different biological functions of 
Myc, such as transcriptional activation and repression of genes. As well as binding to 
all Myc family members, Max can also homodimerize and interact with proteins of the 
Mxd-family (Maxd 1-4; Ayer et al., 1993; Hurlin et al., 1995; Zervos et al., 1993), Mnt 
(Hurlin et al., 1997), and Mga (Hurlin et al., 1999). All of these proteins contain a bHLH-
LZ domain and form heterodimers with Max which recognize the same E-box sequenc-
es as Myc-Max heterodimers. In contrast to Myc-Max, Max-Mxd and Max-Mnt do not 
activate but repress the corresponding target genes and they effectively compete with 
Myc for interactions with Max. 
In Drosophila melanogaster Myc is represented by a single protein. Drosophila Myc 
(dMyc) is equally similar to all vertebrate Myc paralogs with an overall sequence identi-
ty of 26%. In fact, the first Myc mutant was described in the 1930's by Calvin Bridges 
who isolated the mutant and called it diminutive (dm) for its smaller body size (Bridges 
1953). In 1996, dm was shown to correspond to a hypomorphic mutation of Drosophila 
Myc (Gallant et al., 1996). Even when dMyc shows only a moderate sequence identity 
to the vertebrate Myc family, all the domains characterized, including the C-terminal 
bHLH-LZ-domain, Myc box II and Myc box III (Figure 1-2 B), are highly conserved. The 
N-terminus of dMyc is considerably longer than that of c-MYC and, like Myc box I, 
shows poor sequence conservation (Gallant et al., 1996). Not only the domains of Myc 
are conserved from insects to vertebrates but c-MYC and dMyc proteins can partially 
substitute each other. Drosophila Myc can rescue proliferation defects in murine em-
bryonic fibroblasts that lack endogenous c-MYC (Trumpp et al., 2001); it can cooperate 
with human RasV12 in transforming rat fibroblasts (Schreiber-Agus et al., 1997) and 
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substitute for c-MYC in transactivation assays in human cell culture (Gallant et al., 
1996). Alternatively, a human c-MYC variant can rescue a lethal dMyc mutant allele 
(Benassayag et al., 2005). 
 
Figure 1-2: Schematic diagram of the vertebrate and the Drosophila Myc protein 
 
A/B. Myc proteins contain several conserved regions, the Myc boxes I, II and III (MB I, II, III), a 
nuclear localization sequence (NLS), a basic region (BR), a helix-loop-helix motif (HLH) and a 
leucine zipper (LZ).  
A. Human c-Myc consists of 439 amino acids and contains additionally Myc box IV (MB IV). 
B. Drosophila Myc consists of 717 amino acids. 
 
In Drosophila only one homolog for Max (dMax; Gallant et al., 1996; Schreiber-Agus et 
al., 1997) and one homolog for Mnt (dMnt; Loo et al., 2005) exist. Like dMyc, they show 
sequence similarity to their vertebrate homologs. dMnt shares the same domains with 
vertebrate Mnt and Mxd proteins with a higher sequence similarity towards Mnt. These 
domains are the bHLH-LZ and an N-terminally located Sin3- Interaction domain (SID) 
(Gallant, 2009). With an overall amino acid sequence identity of 52% and the identical 
genomic organization, dMax shares the highest conservation with its human counter-
part (Gallant et al., 1996; Gallant, 2006). 
1.1.4 Growth control in Drosophila 
One of the most prominent functions of Myc in Drosophila is the regulation of growth. 
Flies carrying the Myc null allele dm4 show severe growth defects. The mutant larvae 
hatch at the same time as wildtype animals but fail to undergo normal growth and die 
early in development (Figure 1-3 B; Pierce et al., 2004). Hypomorphic mutant animals 
(dm1, dmP0) undergo normal development, but the resulting normally proportioned adult 
flies are smaller and carry thin and short bristles (Figure 1-3 A; Johnston et al., 1999). 
The size reduction in Myc-mutants is based on smaller but not fewer cells (Johnston et 
al., 1999; Steiger et al., 2008). This stands in contrast to vertebrates, where Trumpp et 
al. (2001) incrementally reduced the c-myc expression in mice to zero and observed a 
reduced body mass due to mulitorgan hypoplasia. Elevated Myc levels on the other 
hand lead to an increase in cell size by accelerating cellular growth (Johnston et al., 
1999). This is accompanied with an increase of nucleoli size and therefore an increase 
in ribosomal RNA levels (Grewal et al., 2005). Furthermore, overexpression of Myc 
leads to an augmented adult body size of almost 30% (de la Cova et al., 2004). Myc, 
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therefore, promotes cell-autonomous growth in part by modulating ribosome biogenesis 
(0). Another observation which suggests a link between dMyc activity, cell growth and 
ribosomal proteins are the so-called Minute mutations. These ribosomal gene muta-
tions also lead to a smaller body size due to smaller cells and exhibit a thin bristle phe-
notype comparable to dmyc mutants (Marygold et al., 2007). 
 
Figure 1-3: Myc controls growth in Drosophila 
 
A. Differences in whole body size (left column) and bristle size and structure of an adult wildtype 
male (upper row) and a hypomorphic Myc mutant male (lower row). Wildtype animals are bigger 
and their bristles thicker and longer compared to mutant animals (modified from Johnston et al., 
1999). 
B. Comparison of a wildtype male larva (upper row) with a Myc null mutant larva (lower row) 
(modified from Pierce et al., 2004). 
 
Myc interacts with other pathways known to control growth, like the TOR and the insu-
lin signaling pathways. The insulin receptor (Inr) and the target of rapamycin (TOR) 
signaling pathway have been shown to mediate nutrient dependent growth and both 
pathways have been shown to influence Myc levels in the cell (Parisi et al., 2011; Li et 
al., 2010). In contrast to vertebrates, Drosophila has a single insulin receptor (InR), 
which is bound by a group of Drosophila insulin-like peptides (DILPs) in response to 
dietary proteins. These DILPs trigger growth by recruitment of Chico, the Drosophila 
insulin receptor substrate (IRS) protein, and initiate a conserved phosphorylation cas-
cade that activates the phosphatidylinositol 3-kinase (PI3K) and Akt kinase signaling 
pathway (Böhni et al., 1999; Brogiolo et al., 2001; Edgar, 2006). One downstream ef-
fector is dFOXO (forkhead transcription factors of the O class), which is active under 
starvation conditions (Puig and Tjian 2006) and represses Myc mRNA expression in 
muscle cells, whereas it is required in the fat body to maintain constant myc levels 
(Teleman et al., 2008). The target genes of FOXO are involved in various processes 
such as cell cycle arrest, DNA repair, cellular differentiation and apoptosis (Salih and 
Brunet, 2008). Mutations in components of the InR pathway lead to a change in cell 
size and number (Brogiolo et al., 2001). 
The TOR signaling pathway acts in parallel with the PI3K/Akt signaling pathway (Jacin-
to and Hall, 2003) and is activated in a cell autonomous manner in response to extra-
cellular nutrients and amino acids. Additionally, TOR can be activated as a downstream 
target of the PI3K/Akt pathway. Akt activates TOR by phosphorylating the tumor sup-
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pressor genes TSC1 and TSC2 which inhibit the TOR activator Rheb (de Virgilio and 
Loewith, 2006). TOR regulates growth through downstream effectors including the ri-
bosomal protein kinase S6K (p-70-S6 ribosomal protein kinase) and the eIF4E (eukar-
yotic initiation factor-4E) inhibitor 4E-BP (initiation factor 4E binding protein) which is a 
common target of the PI3K/Akt signaling pathway (Jünger et al., 2003). S6K balances 
Insulin and TOR activities by a negative feedback mechanism which is activated when 
TSC1 is highly activated (Kockel et al., 2010). The TOR pathway regulates TIF-IA 
(transcription initiation factor-1A) recruitment to ribosomal DNA (rDNA) (Grewal et al., 
2007) and induces the activation of several Myc targets which are involved in ribosome 
biogenesis (Li et al., 2010). Furthermore, TOR stabilizes Myc, probably through inhibi-
tion of GSK3β (Glycogen synthase kinase 3 beta) via S6K and the same was found for 
the InR/PI3K pathway (Parisi et al., 2011). Additionally a strong correlation between 
TOR pathway and Myc target genes exist (Parisi et al., 2011), suggesting that Myc acts 
downstream of InR/PI3K and TOR signaling. Loss of TOR or S6K leads to a reduction 
in body size which is based primarily on the reduction in cell size and impairment in cell 
proliferation (Oldham et al., 2000; Zhang et al., 2000). Figure 1-4 shows a schematic 
overview of the insulin/TOR signaling pathway in Drosophila.  
 
 
Figure 1-4: Schematic diagram of insulin/TOR signaling in Drosophila and the proposed 
relationship to Myc 
 
The insulin/TOR signaling pathway controls growth via transcriptional effects through the nucle-
ar factors Myc, FOXO and TIF-IA, which together regulate the expression of ribosome biogene-
sis and protein synthesis genes. Arrows and bars indicate positive and negative regulation, 
respectively. DILPs: Drosophila insulin-like peptides; InR: insulin receptor; IRS: insulin-receptor 
substrate; PI3K: phosphatidylinositol-3 kinase; TSC1/2: tuberous sclerosis 1/2; Rheb: Ras hom-
olog enriched in brain; S6K: p-70-S6 ribosomal protein kinase; TOR: target of rapamycin; 
GSK3β: Glycogen synthase kinase 3 beta; FOXO: forkhead transcription factors of the O class 
*tissue specific activation/repression 
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1.2 Ribosome biogenesis 
The cellular processes of growth and cell division are tightly linked to ribosome biogen-
esis as the ribosomes provide the basis for protein production (Lempiäinen and Shore, 
2009). The process of ribosome synthesis requires a lot of energy and the coordinated 
regulation of all three RNA polymerases. Ribosomes consist of four structural RNA 
components, 5S, 5.8S, 18S and 28S rRNAs which are associated with more than 70 
ribosomal proteins (Tschochner and Hurt, 2003). The 5.8S, 18S and 28S rRNAs are 
encoded by ribosomal DNA (rDNA) in the nucleolus (Roeder and Rutter, 1970) and are 
transcribed by RNA polymerase I (Pol I), while the 5S rRNA is encoded outside the 
nucleolus by RNA polymerase III (Pol III) (Weinmann and Roeder, 1974). Together with 
approximately 80 different ribosomal proteins and over 200 additional proteins and 
non-coding RNAs (ribosome biogenesis, or RiBi factors) (Lempiäinen and Shore, 2009) 
which are transcribed by RNA polymerase II (Pol II), a pre-mature small (40S) and a 
pre-mature large (60S) ribosomal subunit are assembled in the nucleus and transport-
ed into the cytoplasm. After dissociation of the non-ribosomal factors, the mature 40S 
and 60S subunits form the 80S ribosome together with mRNA (Tschochner and Hurt, 
2003). The RiBi factors are important for processing, assembly, modification and nu-
clear import-export reactions and can consist of simple proteins, heteromers or large 
complexes of molecules like the snoRNPs (Loewith, 2010).  
1.2.1 Function of snoRNPs 
Before the pre-rRNAs are further processed to mature rRNA, and undergo a complex 
pattern of nucleoside modifications, the 3’-end is cleaved by endo- and exonucleases 
allowing the addition of the poly(A) tail. The two main types of modifications are meth-
ylation of the 2’-O-ribose and pseudouridylation (Figure 1-5 A). In humans, there are 
around 100 pseudouridines and 100 2’-O-methyl groups in 5.8S, 18S and 28S rRNAs 
together (Kiss, 2001).These modifications are directed by two major classes of small 
nucleolar ribonucleoprotein particles (snoRNPs). Each snoRNP consists of a set of 
proteins, common to each class of family, and a small nucleolar RNA (snoRNA). The 
snoRNPs are divided into so-called box C/D and box H/ACA snoRNPs. Box C/D 
snoRNPs guide methylation of the 2’-O-ribose, whereas box H/ACA snoRNPs are re-
sponsible for pseudouridylation. Fibrillarin, Nop56p, Nop58p and 15.5 kDA are essen-
tial partner proteins for box C/D snoRNPs (Kiss, 2001) with Fibrillarin being the 
methyltransferase enzyme that is responsible for the addition of a methyl group to the 
2'-O-ribose of the target nucleotide. Dyskerin, Gar1p, Nhp2p and Nop10p are common 
to box H/ACA snoRNPs (Henras et al., 1998; Watkins et al., 1998). The pseudouridine 
synthase Dyskerin catalyzes the conversion of uridine to pseudouridine. The associat-
ed snoRNAs, which range from 60 to 300 nucleotides in length, guide the modification 
of one or a maximum of two sites, and therefore one rRNA is predicted to associate 
with approximately 150-200 snoRNAs (Kiss, 2001; Bachellerie et al., 2002). As stated 
above, snoRNAs are divided into two classes, box C/D (SNORA) and box H/ACA 
(SNORD) snoRNAs, which specify the modified sites. Box C/D snoRNAs are responsi-
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ble for directing 2’-O-ribose-methylation and contain two conserved sequences, box C 
(RUGAUGA, R stands for any purine) and box D (CUGA), which are located close to 
the 5’ and 3’ ends, respectively (Figure 1-5 B). Additionally the box C/D snoRNAs con-
tain less conserved copies of both boxes, box C’ and box D’ which are located centrally 
(Kiss-László et al., 1998). The box C/D snoRNAs contain one or sometimes two ele-
ments of 10-21 nucleotides which are complementary to a site of rRNA 2’-O-ribose-
methylation (Bachellerie et al., 1995). The group of box H/ACA snoRNAs is required for 
pseudouridylation of target RNAs. They consist of two hairpins and two short single-
stranded regions (Figure 1-5 B) which contain the conserved box H (ANANNA, N indi-
cates any nucleotide) and box ACA (a trinucleotide, located always three nucleotides 
away from the 3’ end) (Ganot et al., 1997b). The guide sequences are located in one or 
both of the hairpin loop domains and by forming two helix structures with the target 
rRNA, the snoRNA guides the conversion from an unpaired uridine residue of the rRNA 
sequence to pseudouridine (Ganot et al., 1997a). The distance between the target 
uridine and the location of the H or ACA box of the snoRNA (14-16 nucleotides) is im-
portant in determining the correct pseudouridylation site (Bortolin et al., 1999). 
Besides their function in rRNA modification, snoRNAs have been found to modify seg-
ments in small nuclear RNAs (snRNAs) involved in intermolecular RNA-RNA as well as 
RNA-Protein interactions. This suggests that the snoRNAs play an important role in 
splicing control (Bachellerie et al., 2002). Additionally, snoRNAs modify and process 
tRNAs (Zemann et al., 2006; Clouet d’Orval et al., 2001) and probably even mRNAs 
(Cavaillé et al., 2000). Bioinformatic approaches identify a growing number of so-called 
“orphan” snoRNAs which lack complementarities to rRNAs, snRNAs, tRNAs or any 
other known stable RNAs (Hüttenhofer et al., 2001). This might indicate that novel roles 
for nucleotide modifications mediated by snoRNAs have yet to be discovered. Further-
more individual snoRNAs were described as having a function in mRNA editing 
(Bachellerie et al., 2002) and miRNA production (Ender et al., 2008; Taft et al., 2009). 
The mode of expression of the snoRNAs is uniquel. In yeast and plants, most 
snoRNAs are cleaved from mono-, di- or polycistronic RNA transcripts which are pro-
cessed by exo- and endonucleases. In metazoans No polycistronic transcripts have 
been detected (Tollervey and Kiss, 1997) and independently transcribed snoRNAs are 
rare. The vast majority is encoded within introns and processed from pre-mRNA introns 
by exonucleolytic digestion of the debranched lariat. Many snoRNAs are embedded 
within introns of genes that encode for proteins which themselves are involved in ribo-
some biogenesis (Tollervey and Kiss, 1997). Some snoRNA host genes contain multi-
ple snoRNAs in their intronic sequences but do not code for proteins (Tycowski et al., 
1996). In Drosophila seven of those non-protein coding host genes exist, numbered 1-
5, 7, and 8, the so-called Uhgs (from the originally identified U22 host genes) 
(Tycowski et al., 1996; Tycowski and Steitz, 2001; Huang et al., 2005). The gene for-
merly called Uhg6 is now known as Nop60B. Up to 16 snoRNAs can be encoded in 
one Uhg, resulting in a total number of 48 snoRNAs for the previously described Uhg 
genes. 
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Figure 1-5: Structure and function of box C/D and box H/ACA snoRNAs 
 
A. 2’-O-ribose-methylation: a methyl group is added to the 2’ hydroxyl group of the ribose moiety 
of a nucleoside. Pseudouridylation: pseudouridine is synthesized from uridine via tha action of 
pseudouridine synthases. 
B. Schematic secondary structures of the C/D and H/ACA classes of eukaryotic snoRNAs. The 
conserved motifs of boxes C, D, C’, D’, H and ACA are indicated (in green and orange boxes, 
respectively). The sequence tracts complementary to the specific RNA target (thick blue lines) 
are shown. R is a purine and N stands for any nucleotide (adapted from Bachellerie et al., 
2002). 
1.2.2 The role of snoRNAs in cancer 
For many years snoRNPs have been considered to be important elements in the pro-
tein synthesis machinery fulfilling exclusively housekeeping functions. Recent publica-
tions, however, point to a possible role for snoRNAs in controlling cell behavior, and 
argue that snoRNA dysfunction might contribute to oncogenesis (Williams and 
Farzaneh, 2012; Martens-Uzunova et al., 2013). The box H/ACA snoRNA h5sn2, which 
is significantly downregulated in human meningiomas compared to normal brain tissue, 
was the first snoRNA that was linked to cancer (Chang et al., 2002). Some years later, 
the box C/D snoRNA U50 was found to be transcriptionally downregulated in prostate 
cancer (Dong et al., 2008) and breast cancer cells (Dong et al., 2009). On the other 
hand, certain snoRNAs were shown to be elevated in tumor tissue compared with their 
normal counterparts. SNORA 42, a box H/ACA snoRNA, for example, is frequently 
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overexpressed in non-small-cell lung cancer (NSCLC) and SNORA 42 expression lev-
els are inversely correlated with survival (Liao et al., 2010; Mei et al., 20012). In other 
studies, several snoRNAs (e.g. SNORA 17C and SNORD 116) were found to be over-
expressed in neuroblastomas with N-Myc amplification (Schramm et al., 2013), in acute 
leukemias (Valleron et al., 2012), and metastatic prostate cancer (Martens-Uzunova et 
al., 2012). Together, these studies show that snoRNAs might be of functional im-
portance in cancer since they could either promote tumor development or act as tumor 
suppressors. 
1.2.3 Control of protein production by Myc 
One of the most important evolutionarily well-conserved functions of Myc is the process 
of cellular growth (0). Myc affects cell growth, but also other processes like cell cycle 
progression and differentiation, partially by increasing protein synthesis. Therefore, 
Myc stimulates a number of genes essential for ribosomal biogenesis and protein 
translation, including ribosomal proteins. In vertebrates, heterodimers of c-Myc and 
Max are associated with E-box binding sites in the ribosomal DNA (rDNA) promoter 
and terminator regions. Myc recruits the cofactor Trrap, which leads to an increase in 
histone acetylation (Arabi et al., 2005) and might, therefore, activate the transcription of 
rRNA. Additionally, Myc recruits the RNA Pol I cofactors upstream binding transcription 
factor (UBF) and selectivity factor 1 (SL1) which are both essential for enhancement of 
rDNA transcription (Poortinga et al., 2004; Grandori et al., 2005). While UBF stimulates 
the transition from transcriptional initiation to elongation and thus activates RNA Pol I 
transcription (Panov et al., 2006), SL1 stabilizes UBF binding and directs RNA Pol I 
pre-initiation complex formation on the rDNA (Friedrich et al., 2005). UBF itself is a Myc 
target gene and is regulated in a RNA Pol II dependent manner (Poortinga et al., 
2004). In contrast to vertebrates, the Drosophila rDNA locus contains no canonical E-
boxes, but dMyc is an important regulator of rRNA synthesis as well. However, the 
Myc-dependent regulation of rRNA synthesis by RNA Pol I is most probably indirect 
since dMyc induces an increase in levels of the RNA Pol I transcriptional machinery, for 
example of TIF-1A and RpL135 (Grewal et al., 2005; Grewal et al., 2007). 
Apart from the regulation of RNA Pol I, Myc activates transcription of ribosomal protein 
genes as well as of non-ribosomal protein genes involved in ribosome biogenesis via 
RNA Pol II (Coller et al., 2000). These include small ribosomal subunit (RPS) and large 
ribosomal subunit (RPL) proteins, as well as proteins required for ribosome assembly 
and processing, like nucleolin (NCL1) and nucleophosmin (NPM1). Also proteins that 
modify ribosome activity like the upstream growth signaling factor S6 kinase (S6K) or 
proteins involved in nucleolar functions such as fibrillarin (fib) (van Riggelen et al., 
2010) are among Myc's target genes. The transcription of ribosome components by 
RNA Pol II is stimulated by Myc-Max heterodimers (van Riggelen et al., 2010).  
In addition to RNA Pol I and Pol II, Myc enhances transcription of 5S rRNA, transfer 
RNA (tRNA) and other small RNA genes via the RNA Pol III transcription apparatus 
(Gomez-Roman et al., 2003). In Drosophila it was shown that RNA Pol III transcribed 
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target genes, such as 5S rRNA, snoRNA U3 and tRNALeu, are activated by dMyc and 
that this regulation is Max-independent (Steiger et al., 2008). Activation of Pol III is 
achieved through binding of Myc to the transcription factor IIIB- (TFIIIB) component Brf, 
which is responsible for recruiting Pol III to its target promoters (Gomez-Roman et al., 
2003; Steiger et al., 2008). Besides Myc’s function in the regulation of ribosomal pro-
teins, RNA and cofactors Myc influences mRNA translation by regulating the transcrip-
tion of elongation and translation initiation factors (Boon et al., 2001). The translation 
initiation factors eIF4E and eIF4A are required for CAP-dependent translation 
(Schmidt, 2004), whereas eIF5A was shown to act as a translation elongation factor 
(Gregio et al., 2009; Saini et al., 2009). By regulating translation and ribosome biogen-
esis, Myc controls protein production. Figure 1-6 summarizes Myc’s control of ribosome 
biogenesis commonly accepted in 2010 when I commenced this work. It remains to be 
discussed if the regulation of the previously specified factors involved in ribosomal bio-




Figure 1-6: Myc controls several components of ribosome biogenesis 
 
In vertebrates, Myc enables the transcription of rDNA via RNA Pol I, by recruiting cofactors such 
as UBF (upstream binding transcription factor) and SL1 (selectivity factor). The Myc-Max heter-
odimer stimulates transcription of ribosomal protein genes and other genes essential for rRNA 
processing and export via RNA Pol II, such as nucleolin (NCL1), nucleophosmin (NPM1) or 
UBF. Independently of Max, Myc activates transcription of 5S rRNA and tRNAs through RNA 
Pol III by recruiting TFIIIB (transcription factor IIIB) (modified from van Riggelen et al., 2010). 
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1.3 Myc-interactors: The BTB-Zf protein Chinmo  
One objective of this work was to understand how Myc fulfills its functions and what 
other factors are involved in these mechanisms. This was attempted by characterizing 
a previously identified Myc-interacting protein, Chinmo (chronologically inappropriate 
morphogenesis). The BTB-zinc finger (Broad complex, Tramtrack, Bric à Brac) protein 
Chinmo was described for the first time by Zhu et al. (2006) who found it in a screen for 
genes required for temporal identity of mushroom body neurons in Drosophila. It was 
also found to be an effector of the JAK/STAT pathway and involved in the proliferation 
of mature hemocytes (Flaherty et al., 2010). Additionally, it was shown to regulate neo-
plastic tumors in Drosophila together with RasV12 (Doggett et al., 2010). Furthermore it 
was characterized in two independent screens performed in the Hafen and the Gallant 
laboratories (Sulzer, 2003; Schwinkendorf, 2008) aimed to identify genes involved in 
growth control and novel Myc interacting proteins, respectively. 
The Chinmo gene spans a total length of 45,368 base pairs. Four transcripts (RH; RD; 
RG; RA) code for a protein of 604 amino acids, while two other transcripts (RE; RF) 
give rise to a protein of 840 amino acids (flybase.org, FB release 2015_03; Figure 1-7). 
A BTB/POZ- (Broad complex, Tramtrack, Bric à Brac / poxvirus and zinc finger) domain 
is located at the N-terminus and at the C-terminus, two C2H2 zinc-fingers (Zf) are pre-
sent. BTB-domains mediate protein-protein interactions, including dimerization, re-
cruitment of transcriptional repressors to DNA and protein degradation (Bardwell and 
Treismann, 1994; Stogios et al., 2005). Zinc fingers are involved in DNA binding but 
can also bind to RNA and proteins (Razin et al., 2012). Classical zinc-fingers contain 
an α-helix where a single zinc atom is hold in complex by two cysteines and histidines 
(C2H2). Based on the presence of BTB-Zf domains and the nuclear localization (Zhu et 
al., 2006) Chinmo is likely to be a transcriptional regulator.  
 
Figure 1-7: Schematic overview of the different chinmo transcripts1
 
 
The transcripts RD, RG, RH and RA contain the same ORF, coding for a protein of 604 amino 
acids. The transcripts RE and RF contain an ORF, which codes for a protein of 840 amino ac-
ids. Numbers indicate nucleotides (nt) and amino acids (aa). Purple boxes show the open read-
ing frame (ORF) and black boxes the untranslated region (UTR). The black line represents in-
trons. 
                                                 
1 flybase.org; FB release 2015_03 
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1.3.1 The role of Chinmo in brain development 
As mentioned above, Chinmo was first described to play a role in brain development 
(Zhu et al., 2006). In the EMS (ethyl methanesulfonate) screen which was performed to 
identify genes that alter temporal identity in mushroom body neurons, a mutant was 
found which was called chronologically inappropriate morphogenesis (chinmo) due to 
the observed phenotype. Wildtype neuroblasts of the fly brain mushroom body produce 
four different types of neurons: γ, α’β’, late-born pioneer-αβ (pαβ) and αβ neurons (Lee 
et al., 1999). Mosaic animals, whose mushroom bodies are mutant of Chinmo have 
fewer early-born γ and α’β’ neurons and more late-born pαβ and αβ neurons, which fits 
the expression profile of Chinmo in neurons. While Chinmo is strongly expressed in 
early-born γ neurons, the expression level dwindles along the lineage and is undetect-
able in the latest-born pαβ− and αβ− neurons (Doe, 2006). 
Chinmo was shown to be a functional effector of the JAK/STAT pathway in eye devel-
opment and stem cell self-renewal. In a genome-wide expression study on eye discs 
with elevated Stat92E levels, chinmo was identified as a new Stat92E target gene (Fla-
herty et al., 2009). Additionally, it was found in a micro-array screen for JAK/STAT tar-
get genes in adult testis (CG31666; Terry et al., 2006). Further studies confirmed that 
chinmo is a cell-autonomous downstream mediator of Stat92E. Loss of either Stat92E 
or Chinmo in the eye-imaginal disc, combining ey-FLP and Minute techniques (Morata 
and Ripoll, 1975) leads to defects in eye progenitor cells, which results in malformed 
head capsules and eyes, whereas overexpression of either of them in eye-imaginal 
discs (ey-FLP) results in blood cell tumors (Flaherty et al., 2010). Chinmo as well as 
Stat92E are expressed in GSCs (germline stem-cells) and in CySCs (cyst stem-cells) 
in gonads and Chinmo is required for the self-renewal of CySCs, but not of GSCs. Fur-
thermore, it plays an important role in the inhibition of CySC differentiation and in the 
signal transduction form CySCs to GSCs. This process requires the BTB and the Zf 
domains of Chinmo, suggesting that Chinmo’s main functions in this process are tran-
scriptional repression and protein degradation (Flaherty et al., 2010). Recent publica-
tions additionally stated that transformation of testis somatic stem cells into their ovari-
an counterparts is prevented by Chinmo (Ma et al., 2014). 
1.3.2 Chinmo regulates growth 
Chinmo was already identified in a screen for growth-defective mutants (Sulzer, 2003). 
Stocks of flies with bigger (bigheads) or smaller (pinheads) heads were established 
and mapped. One complementation group with three alleles was shown to affect the 
CG31666/ chinmo gene, resulting in pinheads. The three alleles have either a mutation 
in the zinc finger domain (chinmo110) or lack it completely (chinmo108, chinmo134). The 
mutation 110 is a base substitution from cytosine to thymine leading to an amino acid 
alteration from histidine (CAT) to tyrosine (TAT) at the first histidine of the first zinc fin-
ger domain. The chinmo108 allele has a deletion of 11bp which leads to a frame shift 
and a stop after 247 amino acids. Chinmo134 has again a base substitution from cyto-
sine to thymine leading to an alteration from glutamine (CAG) to a stop codon (TAG), 
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resulting in a protein of only 126 amino acids (Figure 1-8). Sections of adult heads, 
being homozygous mutant for one of the alleles, using ey-FLP, showed that the reduc-
tion in head size is based on a cell number reduction and not on cell size reduction. In 
another screen Chinmo was found to interact with Myc. This screen was performed to 
search for novel components of the “Myc pathway” and was based on the dominant 
genetic interaction between the hypomorphic allele dmP0 and the transcription cofactor 
Tip49/Pontin (Bellosta et al., 2005). Animals carrying dmP0 are normally patterned and 
display only moderate growth defects, whereas heterozygosity for the Myc cofactor 
Pontin shows no effect in a wildtype background. Flies being heterozygous mutant for 
Pontin in a dmP0 background are characterized by delayed  development, poor survival 
and, in particular, reduced size and irregular shape of the eye. In total, 605 deficiency 
lines were tested in the dmP0 background (w dmP0 tub-FRT-dMyc-FRT-GAL4 ey-FLP) 
and the deficiency [Df(2L)Exel6005] was found to cause the characteristic eye defects 
(Schwinkendorf, 2008). Further investigations revealed chinmo as the responsible 
gene. The effects on developmental timing and eye size were also observed with the 
three different Chinmo alleles and were even more dramatic in a Myc null-mutant 
background (dm4). 
 
Figure 1-8: Schematic diagram of the different chinmo alleles referring to Figure 1-7  
 
The diagram refers to the Chinmo ORF containing 604aa (RD, RG, RH, RA). Chinmo110 has a 
C-T transition in the first zinc finger that changes the first conserved histidine to a tyrosine. 
Chinmo108 carries a deletion after the BTB/POZ domain, followed by a frame-shift and a prema-
ture stop codon and the allele chinmo134 contains a C-T transition, which leads to a premature 
STOP. The BTB/POZ domain is shown in green and the two zinc finger domains in grey. The 
numbers indicate the amino acid coordinates of the mutant codons (modified from 
Schwinkendorf, 2008). 
 
Developmental delay and eye size reduction are even enhanced when both Myc and 
Chinmo are completely eliminated. While loss of either Myc or Chinmo protein in the 
eye discs allows normal development that results in normal shaped eyes, the double 
mutants are fully lethal and generate only rudimentary heads (Figure 1-9 A; 
Schwinkendorf, 2008). Ubiquitous expression of Chinmo by armadillo or tubulin pro-
moters, or overexpression in specific tissues under the control of GMR or apterous 
(eye and dorsal compartment of the wing disc), results in the death of the fly. Most an-
imals died at early pupal stages (Schwinkendorf, 2008). Overexpression of Chinmo in 
the head using ey-FLP in a dm4 or dmP0 background, however, leads to an increase in 
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survival rate, indicating that Chinmo requires Myc to be fully active. The harmful effect 
of Chinmo overexpression can also be seen on the cellular level, where overexpression 
of Chinmo reduces clone area which is presumably a consequence of apoptosis. 
Therefore, it seems that Chinmo’s ability to induce apoptosis is dependent upon Myc 
on the cellular as well as the organismal level.  Chinmo is not only dependent on Myc 
for its full activity. Overexpression of Myc in cells normally leads to an increase in cell 
size, however, Myc cannot induce growth in clones mutant for Chinmo (Figure 1-9 B, 
B’). Since part of Myc’s activity requires the association with Chinmo, and vice versa, it 
is very likely that Myc and Chinmo fulfill partially redundant functions in growth and 
development of the head. In summary, the genetic data by D. Schwinkendorf indicate a 
close functional interaction between Chinmo and Myc, indicating that both proteins 
might be transcription factors and might share common target genes. 
 
Figure 1-9: Chinmo and Myc interact in growth control  
 
A. Phenotypes of homozygous chinmo mutant eyes in dm+ (A-A’’’), dmP0 (B-B’’’) or dm4 back-
ground (C-C’’’). The corresponding genotypes are depicted on the right.  
B. Size of clones overexpressing dMyc relative to control clones. Clonal size is increased upon 
overexpression of dMyc (2nd bar) in chinmowt clones; however dMyc cannot induce growth in a 
Chinmo mutant background. 
B’. Clones homozygous mutant for the different chinmo alleles (shown in green) in a Myc wt (B, 
C, D), and in a Myc overexpression background (F, G, H). Size of clones was measured and the 
ratio to control clones is shown in B.  
Modified from Schwinkendorf, 2008 
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1.4 Objectives of the thesis 
Growth control is one of the most essential processes in animal development. It is de-
pendent on the correct regulation of the transcription factor Myc. Similarly, enhanced 
activation of Myc is one of the main driving factors in human tumors. To understand 
how Myc regulates growth in normal and pathological situations, it is essential to know 
Myc’s target genes and partner proteins. While three different proteins of the Myc fami-
ly of proto-oncogenes, c-, N- and L-MYC, exist in vertebrates, only a single Myc protein 
exists in insects, qualifying Drosophila as an easier model organism to study Myc’s 
function. 
(1) Several publications have shown that Myc is capable of controlling a large number 
of genes in vertebrates, but the number of Myc targets in Drosophila is still unclear. 
Myc regulated genes in Drosophila have been described in the past, but these studies 
do not include non-protein coding genes or address which genes are regulated by di-
rect Myc binding. The first aim of this thesis was to establish ChIPseq analysis for Dro-
sophila cells to get a comprehensive list of direct Myc targets. To investigate, which of 
the Myc bound genes are also regulated by Myc, the results of the ChIPseq analysis 
will be combined with data sets obtained from RNAseq analysis. RNAseq was per-
formed by M. Stauch and will be briefly addressed in this thesis for completeness of 
content. After validating direct Myc regulated genes, the role of interesting new candi-
dates should be studied in growth control in vivo. 
(2) The transcriptional regulation by Myc involves the interaction with different co-
activators and co-repressors. D. Schwinkendorf found a new potential co-activator of 
Myc in a genetic screen searching for Myc interacting proteins. Chinmo was shown to 
be involved in growth control and is likely to act with Myc in partially redundant path-
ways. To study whether Chinmo and Myc physically interact, co-immunoprecipitations 
are performed, including Chinmo mutants lacking its interaction domains, the zinc-
finger and the BTB/POZ domains. Furthermore, it will be investigated if Chinmo and 
Myc share common target genes and if Chinmo and Myc also interact in tumor devel-
opment. 
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2 Materials 
2.1 Strains and cell lines 
2.1.1 Bacterial strains 
DH5α Escherichia coli; chromosomal Genotype: F-, 
φ80dlacZΔM15, Δ(lacZYAargF) U169, deoR, recA1, 
endA1, hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, 
gyrA96, relA1; for generation of plasmids 
XL1 blue Escherichia coli; recA1, endA1, gyrA96, thi-1, hsdR17, 
supE44, relA1, lac [F' proAB lacIqZΔM15 Tn10(Tetr)]; 
for generation and amplification of plasmids 
BL21 Escherichia coli; chromosomal Genotype: B, F-, dcm, 
ompT, hsdS (rB-mB-) gal [malB+] K-12 (λS) ; for expression 
of GST fusion proteins 
2.1.2 Drosophila melanogaster cell lines 
Drosophila Schneider 2 
cells 
S2 cells (Schneider, 1972)  
Kc167  Kc cells (Echalier and Ohanessian, 1969) 
Kindly provided by Aurelio Teleman 
S2pmt Myc S2 cells, containing a metallothionein promoter and a 
HA-Myc construct; inducible upon CuSO4 addition 
Kindly provided by Laura Johnston 
2.2 Cultivation media and supplements 
2.2.1 Media and antibiotics for bacterial cell culture 
 
LB-medium 10% (w/v) bacto trypton 
0.5% (w/v) yeast extract 
1% (w/v) NaCl 
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LB-agar LB-medium  
1.2% (w/v) Bacto-Agar 
autoclaved, cooled down to 50°C, 20 ml poured into 10 
cm dishes 
The following antibiotics were added to the LB-medium or the LB-agar depending on 
the resistance gene of the used DNA-plasmid 
Ampicillin     100 μg/ml 
2.2.2 Media for cell culture 
The basal Schneider’s insect medium was purchased from Sigma.  
Fetal bovine serum (fetal bovine serum, FBS; PAN Biotech) was heat inactivated for 30 
min at 56°C before use. 
 
Schneider’s insect medium 10% (v/v) FBS 
1% (v/v) Penicillin/Streptomycin (100.000 U/ml, PAN 
Biotech) 
Freezing medium 45% (v/v) full medium 
45% (v/v) conditioned medium 
10% (v/v) DMSO 
2.2.3 Further supplements  
Blasticidin S (InvivoGen) 5-10 µg/ml 
Selection of stably transfected cell lines 
CuSO4 1 mM 
Induce expression of the stable transfected plasmids 
2.3 Nucleic acids 
2.3.1 Oligonucleotides 
DNA-oligonucleotides were synthesized by Sigma (for = forward; rev = reverse). Oligo-
nucleotides for ChIP and quantitative RT-PCR were designed with the help of the Pri-
mer3 (http://bioinfo.ut.ee/primer3-0.4.0/). Quantitative RT-oligonucleotides are all in-
tron-spanning to avoid amplification of genomic DNA. 
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Table 2-1: List of oligonucleotides 
Name Application 5‘ to 3‘ 
Myc_qPCR-2 for qRT PCR CAACGATATGGTGGACGATG 
Myc_qPCR-2 rev qRT PCR CACGAGGGATTTGTGGGTAG 
Uhg1_qPCR for qRT PCR AGAAATGCGGTCAAGTTTGG 
Uhg1_qPCR rev qRT PCR CCTGCGTTCCCGTTTAACTA 
Uhg2-2_qPCR for qRT PCR GTTGAGACACCTTGGGCACT 
Uhg2-2_qPCR rev qRT PCR TGCAGCTGGACCCATACATA 
Uhg3_qPCR for qRT PCR GGGACCAACCAGCATGGGAA 
Uhg3_qPCR rev qRT PCR ACCATTCTTTCGTCGGTTTTC 
Uhg4_qPCR for qRT PCR ACCGCATTGGAAACGATTAA 
Uhg4_qPCR rev qRT PCR ACAAATGCCAGCGCTTTAAC 
Uhg5-2_qPCR for qRT PCR ATCAATCTCATGCAACTGCA 
Uhg5-2_qPCR rev qRT PCR CATCGCGTGCAATGCCGGCT 
Uhg7_qPCR for qRT PCR CTTTCAGATTGGATACTTCA 
Uhg7_qPCR rev qRT PCR AAGCTTCCCATTTAAAGACA 
Uhg8_qPCR for qRT PCR CGTATGGGCTCGTCTCCTTT 
Uhg8_qPCR rev qRT PCR CGTTCTGGTGCGGTATGTGT 
Me28S-A3407a for qRT PCR TGAAACATTTACCCAGCTCGC 
Me28S-A3407a rev qRT PCR TGCGTTGGATATGGAACAGT 
Me18S-A1576 for qRT PCR AATTCTCGACTTGGCGCTGT 
Me18S-A1576 rev qRT PCR CATCAGATCGCCGAATCATCT 
U14_30Ea for qRT PCR CCTTTTGCGGTTTCCACCAG 
U14_30Ea rev qRT PCR GTCAGACGCCTTAGACCATCA 
Me28S_C2645a for qRT PCR TGAAATCGTTAGATGGGGACA 
Me28S_C2645a rev qRT PCR ATCGAGATGAATCAGTCACAGTAATC 
Psi28S_2949 for qRT PCR TTGTGATGCGCAGGGAAATG 
Psi28S_2949 rev qRT PCR TGGAATCTCGACCACGTGAC 
Or_CD2 for qRT PCR GTCAAGCGCTGGCAATCTTC 
Or_CD2 rev qRT PCR CAGGGCCCATAACCAGTCAA 
Me28S_G2703 for qRT PCR CCGTGGTTTTACACTGAGACAA 
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Me28S_G2703 rev qRT PCR TGTATCAGTTGGGGAAAAATGA 
Me18S_U1356a for qRT PCR TGACAACTTCATACCCAAATCAG 
Me18S_U1356a rev qRT PCR TTCAGATGGTGATGCATGTT 
Or_CD11 for qRT PCR TGTGAAGAGCATTCCACGTAA 
Or_CD11 rev qRT PCR ATACGGAATAGTCAAGCACACTT 
αTub84B for qRT PCR GCCAGATGCCGTCTGACAA 
αTub84B rev qRT PCR AGTCTCGCTGAAGAAGGTGTTGA 
rab6 for qRT PCR TGCACGTGGCCAAGTCCTA 
rab6 rev qRT PCR CAGCGAACGCGACTGCTA 
snm158 for qRT PCR CACTCTACCCAAGGCCAAGA 
snm158 rev qRT PCR CACTGGCTGCTATCCCATCT 
Fibrillarin for qRT PCR ACGACAGTCTCGCATGTGTC 
Fibrillarin rev qRT PCR ATGCGGTACTTGTGTGGATG 
Nop60B for qRT PCR CCGGCAAGCTAGACAAGTTC 
Nop60B rev qRT PCR ACATAACCGGTCAGCCACTC 
Chinmo RNAi for dsRNA 
TAATACGACTCACTATAGGGAGACGGATCTAC
TGGCCGATGTC 
Chinmo RNAi rev dsRNA 
TAATACGACTCACTATAGGGAGACAAGATGCC
AGTGGATCCGC 
Myc RNAi for dsRNA 
TAATACGACTCACTATAGGGAGACCACCCGGC
TCTGATAGTGACTCC 
Myc RNAi rev dsRNA 
TAATACGACTCACTATAGGGAGACCACCCGGC
TCTGATAGTGACTCC 
GFP RNAi for dsRNA 
TAATACGACTCACTATAGGGAGAAGTGGAGAG
GGTGAAGGTGA 
GFP RNAi rev dsRNA 
TAATACGACTCACTATAGGGAGAAAAGGGCAG
ATTGTGTGGAC 
Max T7 for dsRNA 
TAATACGACTCACTATAGGGAGATTTGCGCGC
AATCCGTG 
Max T7 rev dsRNA 
TAATACGACTCACTATAGGGAGATAAGG 
TCGATTGGGTGGG 
Uhg1-E2 for ChIP CGATTCTTGGAACTACCCTCT 
Uhg1-E2 rev ChIP GTGACCGCACTACGATTCTG 
Uhg2-ES1 for ChIP CCGCCATCTTTTCACAGAAT 
2 Materials 23 
Uhg2-ES1 rev ChIP CGAAGAGCACACAACTTACCA 
Uhg4 for ChIP TGGCTTGTTTGCAGAACTCA 
Uhg4 rev ChIP TTTGAATTGCAATCGGTGAA 
Uhg5 for ChIP AAAATGCAATTGTGGGAAGC 
Uhg5 rev ChIP GCTGTCCCTCTCTTTTCACC 
Cluster2R for ChIP CGGTTTATTGCTCGTGGAGA 
Cluster2R rev ChIP AGCACTCTGCTACCCTGGAA 
Hoip for ChIP TTTAAGCTAGGGCTGCAGAG 
Hoip rev ChIP CGCAGGTGGTTCGGAAATAC 
Nop5 for ChIP CAGCCAGCAGCAACTTAACC 
Nop5 rev ChIP TGTTATGCGCGAACCAAGTG 
Pka-C1-cod for ChIP CATGACACGGCCAAAGGAGC 
Pka-C1-cod rev ChIP GGACAAGTGGCGACGCAATC 
Fibrillarin for ChIP GCAACCAAAACGCTTGAAAA 
Fibrillarin rev ChIP TCTTGGTATTTTCGCCTTTG 
Nop60B ChIP TCACGATGACATATCGCAAGA 
Nop60B ChIP GGACGAAAAACACGTGGAGT 
Y1476 for ChIP TCCAAAAGGTTCGTGTCCAT 
Y1476 rev ChIP CTTGGGTCTGGGTTCGTCT 
Y1421 for ChIP ATTTAGTTGGACCGCACGAC 
Y1421 rev ChIP CTGATTCGAAGAGAGGACAGC 
Y724 for ChIP CATTCGGGGTTTATTGCTGT 
Y724 rev ChIP CTCCGGATTTACAGCTCAGG 
Y683 for ChIP GCCCTCAAGTCCACTCGTC 
Y683 rev ChIP CGGGTCTGTTGTTCTTCCAT 
Y1601 for ChIP ACCGTTTCACTGCTTCAACC 
Y1601 rev ChIP GCGCCCTGATTTGAAATACT 
Y2679 for ChIP GCTACCAACACCACCCCTTA 
Y2679 rev ChIP AATGGAATCAGTGTGCGTGA 
Y3421 for ChIP CGTATGGGAGTTTCGCTCTC 
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Y3421 rev ChIP CGCAGTTCAACAGCATTGAT 
Y3304 for ChIP TCGATTGTGGCGAACATTTA 
Y3304 rev ChIP ATTGCGAAAGCATCGAAAAA 
Y505 for ChIP CCTTATCGCCGCAGAAGTAA 
Y505 rev ChIP CATCACCACTCATCGTCCAG 
Y2248 for ChIP ACACTCCGCCCCATTTTTAT 
Y2248 rev ChIP TCTTAGCCACCTCCTTTTGG 
Y1503 for ChIP GAAGAGTGGCAAAGGAATGG 
Y1503 rev ChIP GCCATTTGATTGACTGACGTT 
Y193 for ChIP ATGTAGAATTCTCCTAGTCGTGCT 
Y193 rev ChIP ACAGTGACATCAAGGATCCATCT 
Y340 for ChIP CCGCATTAGTTTTCCGATTC 
Y340 rev ChIP ATGGCGAGCAGAGTGAGC 
Y2613 for ChIP CGAATGGCTCGCATTAAAGT 
Y2613 rev ChIP TTTTGTTGTTCGTTCGTTCG 
Y429 for ChIP CAGAGGCAACCGACTCTTTC 
Y429 rev ChIP TCTTCCGCGATTCGATATTC 
Y1764 for ChIP GTTAGGCGTTGCCAGACAAG 
Y1764 rev ChIP GCAGTGTGACCGTAATCGAG 
Y1234 for ChIP GCAGTGTGACCAAGTGTACCA 
Y1234 rev ChIP GGTTTCGGTCACCGCTAATA 
A1666 Methylation GCCTTGAACTTAGGACCGACT 
G3081 Methylation ACACCGAGATCAAGTCAGCA 










GFP for2 Cloning 
GATCGAATTCCAAAATGAGTAAAGGAGAAGAA
C 






2.3.2.1 Empty vectors 
pGEX 4T1 Bacterial expression vector with tac-promoter expres-
sion of GST-tagged proteins (GE Healthcare) 
pUAST Drosophila expression vector, P element-based vector 
for Gal4-regulated expression of genes in Drosophila 
 
2.3.2.2 Expression vectors 
GFP rev Cloning 
GATCGGTACCTTACTCGAGACGCGTTTTGTAT
AGTTCATCCATGCC 
Chinmo for Cloning GTACCTCGAGATGGATCCGCAGCAGCAGTTC 
Chinmo rev Cloning GTACCTCGAGATGGATCCGCAGCAGCAGTTC 
Chinmo-Zf rev Cloning GTACCTCGAGATGGATCCGCAGCAGCAGTTC 
GST-Chinmo for2 Cloning GCCACAGATCTCTCGAGCAACAACACATGGG 
GST-Chinmo rev2 Cloning 
CCAGTGAATTCCTCGAGCTACTTCTTACCGTC
GG 
2R-Cluster_for ≙      
Cluster2R for (ChIP) 
Cloning CGGTTTATTGCTCGTGGAGA 
2R-Cluster_rev1 Cloning AATGGGTTAAGCACGTTCCA 
2R-Cluster_rev2 Cloning CCTCAAAACGCAAAGCTTCTT 
UAS-Uhg1 for Cloning GAGGGCGGCCGCCACTTCTTTTTTTCGTTCAA
A 
UAS-Uhg1 rev Cloning ACGTGGTCTAGAGAAATGGCGTTGTTCGATCT 
UAS-Uhg4 for Cloning GAGGAGATCTTTAAAGAACGTGGAGCGAAC 
UAS-Uhg4 rev Cloning 
CCTCGCGGCCGCAAGAACACATATGAATTTTA
TTTATTCGTGA 
UAS-Uhg5 for Cloning 
GAGGGCGGCCGCTTCTTGGCGAGCTGTGGTG
T 
UAS-Uhg5 rev Cloning CTTCGGTACCTTTTAGTTTTAGTACTTGAA 
pGEX-Chinmo pGEX 4T1 expression vector with CDS of Chinmo 
pUAS- GFP pUAST expression vector with CDS of GFP 
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2.4 Antibodies 
WB = Western-Blot; ChIP = Chromatin-Immunoprecipitation 
m = mouse; r = rabbit; mono = monoclonal; poly = polyclonal 
2.4.1 Primary antibodies 
Table 2-2: List of primary antibodies 
Protein Application Type Company 
AU1 WB r, poly Biomol (A190-125A) 
Chinmo IP, ChIP, WB r, poly 
Group Gallant Production 
ImmunoGlobe 
GFP WB m, mono Santa Cruz (sc-9996) 
Crude GST- 
Chinmo 
IP, WB r, poly 
Group Gallant Production 
ImmunoGlobe 
HA ChIP, WB m, mono Sigma (H3663) 
IgG ChIP m, poly Sigma (I5381-10MG) 
IgG ChIP r, poly Sigma (I5006-10MG) 
Myc ChIP, WB r, poly 
Group Morata Production, 
provided by G. Morata; 
Martín et al., 2009 
Myc ChIP, WB m, mono 
 Group Gallant Production 
Prober and Edgar, 2000 
Myc-N ChIP, WB r, poly Santa Cruz (sc-28208) 
α-Tubulin WB m, mono Sigma (T-5168) 
pUAS-GFP-Chinmo-wt pUAST expression vector with CDS of GFP and 
Chinmo-wt 
pUAS-GFP-Chinmo-∆BTB pUAS-GFP with CDS of Chinmo lacking BTB/-POZ-
domain 
pUAS-GFP-Chinmo ∆Zf pUAS-GFP with CDS of Chinmo lacking Zf- domain 
pRL-CG5033-wt CG5033wt-Renilla-luciferase 
pGL-CG5033-∆Ebox CG5033∆EBox-Firefly-luciferase 
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2.4.2 Secondary antibodies 
α-rabbit-HRP donkey-anti-rabbit- immunoglobulin, coupled with horserad-
ish peroxidase (GE Healthcare) 
α-mouse-HRP goat-anti-mouse- immunoglobulin, coupled with horseradish 
peroxidase (Jackson) 
2.5 Chemicals 
All chemicals were purchased from the companies Sigma, Merck, Roth, Invitrogen and 
AppliChem and used without further purification. Radioactively marked products were 
purchased from Hartmann Analytics. 
2.6 Enzymes, standards and kits 
2.6.1 Enzymes 
Absolute qPCR SYBR Green Mix Thermo Scientific 
AMV reverse transcriptase Promega 
Antarctic phosphatase New England biolabs 
Mini Protease inhibitor cocktail tablets Roche 
Omniscript reverse transcriptase Qiagen 
Proteinase K Roth 
Q5-polymerase New England biolabs 
Rnase A Roth 
Rnase free Dnase I Qiagen 
Rnasin® Ribonuclease inhibitor Promega 
Taq-polymerase New England biolabs 
T4-polynucleotide kinase New England biolabs 
Turbo Dnase Life technologies 
2.6.2 Standards 
GeneRuler 1 kb DNA Ladder Thermo Scientific 
GeneRuler 100 bp DNA Ladder Thermo Scientific 
GeneRuler 50 bp DNA Ladder Thermo Scientific 
PageRuler Prestained Protein Ladder Thermo Scientific 
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2.6.3 Kits 
Cellfectin II Reagent Life technologies 
dNTPs Roche 
ddNTPs Roche 
Effectene® Transfection Reagent Qiagen 
GenElute Plasmid MiniPrep Kit Sigma Aldrich 
GeneJET Gel Extraction Kit Thermo Scientific 
MEGAscript® T7 Transcription Kit life technologies 
miRNeasy Mini-Kit Qiagen 
Omniscript RT Kit Qiagen 
Plasmid Midi Kit Qiagen 
Quant-iT PicoGreen dsDNA Assay Kit Invitrogen 
Random Hexamers Roche 
Rnase-Free Dnase Set Qiagen 
Absolute qPCR SYBR Green Mix Thermo Scientifc 
Qiaquick PCR Purification Kit   Qiagen 
2.7 Buffer and solutions 
 
Annealing buffer (2x) 500mM KCl  
50mM Tris pH 8.3  
aliquot and store at -20°C 
Blocking solution 5% (w/v) skim milk powder in TBS-T 
Bradford solution 8.5% (v/v) phosphoric acid solution 
4.75% (v/v) ethanol 
0.01% (w/v) Coomassie G250 stain 
stir overnight, filter with filter paper 
keep away from light 
BSA-PBS 0.5% (v/v) BSA in PBS 
Blue DNA loading Dye (6x) 0.2% (v/v) Bromphenol blue 
60% (v/v) Glycerin 
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60 mM EDTA 
Coomassie destaining solution 10% (v/v) Acetic acid 
20% (v/v) Methanol 
Coomassie staining solution 25% (v/v) Isopropanol 
10% (v/v) Acetic acid 
0.05% (w/v) Coomassie G250 stain 
ChIP Lysis buffer I  5 mM PIPES, pH 8 
85 mM KCl 
0.5% (v/v) NP-40 
ChIP Lysis buffer II 10 mM Tris-HCl, pH 7,5 
150 mM NaCl 
1% (v/v) NP-40 
1% (w/v) DOC 
0.1% (w/v) SDS 
1 mM EDTA 
ChIP Wash buffer I 20 mM Tris pH 8,1 
150 mM NaCl 
2 mM EDTA 
0.1% (w/v) SDS 
1% (v/v) Triton X-100 
ChIP Wash buffer II 20 mM Tris pH 8,1 
500 mM NaCl 
2 mM EDTA 
0.1% (w/v) SDS 
1% (v/v) Triton X-100 
ChIP Wash buffer III 10 mM Tris pH 8,1 
250 mM LiCl 
1% (v/v) NP-40 
1% (w/v) SDS 
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1 mM EDTA 
ChIP Elution buffer 1% (w/v) SDS 
100mM NaHCO3 
Church Buffer 1 mM EDTA pH 8.0 
0.17% (v/v) Phosphoric acid 
7% (v/v) SDS 
0.5 M Na2HPO4 x 2 H20 
Denaturing Lysis buffer 2% (v/v) SDS 
20 mM EDTA 
50 mM Tris, pH 8 
DEPC water 0.1% (v/v) DEPC in aqua bidest. 
Overnight at 37°C, autoclaved 
Drosophila Ringer’s solution 3 mM CaCl2* 2H2O 
182 mM KCl 
46 mM NaCl 
10 mM Tris base 
Adjust to pH 7.2 
Extraction buffer A 0.1 M Tris/HCl, pH 9.0 
0.1 M EDTA 
1% (v/v) SDS 
Formamide loading dye 95% (v/v) formamide 
18 mM EDTA 
0.025% (v/v) SDS 
0.025% (v/v) xylene cyanol 
0.025% (v/v) bromophenol blue 
GST Lysis buffer 50 mM NaCl 
50 mM Tris base 
5 mM EDTA 
1:1000 Protease Inhibitor 
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GST Elution buffer 50 mM Tris-HCl 
10 mM reduced Glutathion 
pH 8.0 
Laemmli-buffer (2x) 3% (v/v) SDS 
10% (v/v) Glycerol 
62.5 mM Tris, pH 6.8 
0.001% (v/v) bromphenol blue 
5% (v/v) β-mercaptoethanol 
NP-40 Lysis buffer 150 mM NaCl 
50 mM Tris/ HCl, pH 8 
5 mM EDTA, pH 8 
0.1% (v/v) NP-40 
Orange DNA Loading Dye (6x) 0.4% (w/v) Saccharose  
10 mM EDTA, pH 8.0 
10 µl (v/v) Orange G 
PBS 137 mM NaCl 
2.7 mM KCl 
10.1 mM Na2HPO4 
1.76 mM KH2PO4 
SDS-Running buffer 25 mM Tris base 
250 mM Glycin 
0.1% (v/v) SDS 
Separating gel 10-15% 10-15% (v/v) acrylamide/bisacrylamide 
375 mM Tris-HCl (pH 8.8) 
0.1% (v/v) SDS 
0.1% (v/v) APS 
0.1% (v/v) TEMED 
SSC (20x) 3 M Na3C6H5O7 * 2H2O 
0.3 M NaCl 
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Stacking gel 4% 4% acrylamide/bisacrylamide 
125 mM Tris-HCl (pH 6.8) 
0.1% (v/v) SDS 
0.1% (v/v) APS 
0.1% (v/v) TEMED 
Stripping buffer 62.5 mM Tris-HCl, pH 6.8 
2% (v/v) SDS 
0.1 M β-mercaptoethanol 
TAE (50x) 40 mM Tris 
0.114% (v/v) acetic acid 
1 mM EDTA 
adjusted to pH 8.0 
TBE (2.5x) 10 mM Tris base 
50 mM Boric acid 
30 mM EDTA 
TBS (10x) 250 mM Tris base 
1.4 M NaCl 
pH 7.4 
TBS-T 140 mM NaCl 
25 mM Tris-HCl, pH 7.4 
0.2% (v/v) Tween 
TE 10 mM Tris-HCl, pH 8.0 
1 mM EDTA 
Transfer Buffer 48 mM Tris base 
390 mM Glycine 
3.5 mM SDS 
20% (v/v) Methanol 
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2.8 Consumables and equipment 
Consumables such as reaction tubes, cell culture and other plastic products were pur-
chased from Applied Biosystems, Eppendorf, Greiner, Kimberley-Clark, Nunc, 
Sarstedt, B. Braun, Schleicher und Schüll, Millipore and VWR international. 
2.8.1 Equipment 
Binocular Olympus SZ61 
Chemiluminescence imaging LAS-4000 mini (Fujifilm) 
Cell culture incubator Incu-Line (VWR) 
Centrifuges Eppendorf 5415 R (Eppendorf) 
Biofuge 15 (Heraeus) 
Avanti J-26 XP (Beckman Coulter) 
Heating block Thermomixer comfort (Eppendorf) 
Heat Sealing ALPSTM 50V (Thermo) 
Luminometer Glomax 96 Microplate Luminometer 
(Promega) 
Magnetic Stirrer Combimag RCH (IKA) 
Microplate Reader Infinite M200 PRO (Tecan) 
Microscope for immunofluorescence 
 
DMI 6000 B (Leica) 
SP5 (Leica)  
Discovery V8 (Zeiss) 
Microscope for cell culture Axiovert 40CFL (Zeiss) 
PCR thermal cycler Vapo protect (Eppendorf) 
C1000 Thermal Cycler (Biorad) 
Phosphorimager Typhoon 9200 (GE healthcare) 
Photometer UltrospecTM 3100 pro UV/Visible (Amer-
sham Biosciences) 
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Power supply PowerPac 300 (Bio-Rad) 
Quantitation of RNA and DNA Experion Automated Electrophoresis Sys-
tem (Bio-Rad)  
NanoDrop 3000 (Thermo Scientifc) 
Quantitative real-time PCR machine MXp3000P qPCR system (Stratagene) 
SDS-PAGE system Mini Trans-Blot (Bio-Rad) 
Sterile bench Lamin Air (Heraeus) 
Ultrasonifer W-250 D (Heinemann) 
UV fluorescent table maxi UV fluorescent table (PEQLAB) 
Universal shaker SM-30 (Edmund Bühler GmbH) 
Titramax 101(Heidolph) 
Vortex mixer Vortex-Genie 2 (Scientifc Industries) 
Waterbath ED-5M heating bath (Julabo) 
Western blot transfer chamber Mini-PROTEAN Tetra Cell (Bio-Rad) 
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2.9 Fly lines 
Table 2-3: Fly strains 
Name Genotype Figure 
Uhg1rev yw; Uhg1_4 Figure 4-9, Figure 
4-10 
Uhg11 yw; Uhg1_18/CyO,y+ Figure 4-9, Figure 
4-10 
Myc OE/ Uhg11 y w actin-FRT-CD2-FRT-GAL4 hs-FLP/y w; 
Uhg1_18; UAS-vito:GFP/UAS-Myc, GFP 
Figure 4-11 
Myc OE y w actin-FRT-CD2-FRT-GAL4 hs-FLP/w; (Sp or 
CyO,y+)/+; UAS-vito:GFP/UAS-Myc, GFP 
Figure 4-11 
Brat-kd w; wor-Gal4 ase-Gal80; UAS-brat-IR UAS-Fluc/ 
TM3, Sb tub-Gal80 
Figure 4-11 
Brat-wt w; (wor-Gal4 ase-Gal80; UAS-Rluc QUAS-Fluc)/ 
(SM5; TM6B) 
Figure 4-11 
ctr y w Figure 4-11 
Uhg4/1 y w; UAS-Uhg4 [F1b] Figure 4-11 
Uhg4/2 y w; UAS-Uhg4 [F12A] Figure 4-11 
Uhg5/1 y w; UAS-Uhg5 [F9D] Figure 4-11 
Uhg5/2 y w; UAS-Uhg4 [M3A] Figure 4-11 
Myc-kd w; UAS-Myc-IR Figure 4-11 
RasV12 + Chinmo yw tub-FRT-Myc-FRT-GAL4 ey-FLP/Y; UAS-
RasV12/+; UAS-Chinmo/UAS-GFP 
Figure 4-11 
RasV12 + Chinmo, 
Uhg11/+ 
yw tub-FRT-Myc-FRT-GAL4 ey-FLP/Y; UAS-
RasV12/Uhg11; UAS-Chinmo/UAS-GFP 
Figure 4-11 
RasV12 + Chinmo, 
Uhg11 
yw tub-FRT-Myc-FRT-GAL4 ey-FLP/Y; Uhg11 UAS-
RasV12/ Uhg11; UAS-Chinmo/UAS-GFP 
Figure 4-11 
yw ey-FLP y w tub-FRT-Myc-FRT-GAL4 ey-FLP/Y; FRT-40 
chinmoX/CyO, y+ 
Figure 4-12 
yw eyFLP; FRT40 
cl w+ 
y w tub-FRT-Myc-FRT-GAL4 ey-FLP; FRT-40 
chinmoX/FRT-40 cl w+ 
Figure 4-12 
w dmP0 ey-FLP w dmP0 tub-FRT-Myc-FRT-GAL4 ey-FLP/Y; FRT-40 
chinmoX/CyO, y+ 
Figure 4-12 
w dm4 ey-FLP w dm4 tub-FRT-Myc-FRT-GAL4 ey-FLP/Y; FRT-40 
chinmoX/CyO, y+ 
Figure 4-12 
2 Materials 36 
GFP y w tub-FRT-Myc-FRT-GAL4, ey-FLP; UAS-GFP/+; Figure 4-15 
Chinmo y w tub-FRT-Myc-FRT-GAL4, ey-FLP; UAS-GFP/+; 
UAS-Chinmo/+ 
Figure 4-15 
RasV12 y w tub-FRT-Myc-FRT-GAL4, ey- FLP; UAS-GFP/ 
UAS- RasV12; 
Figure 4-15 
RasV12 + Chinmo y w tub-FRT-Myc-FRT-GAL4, ey- FLP; UAS-GFP/ 
UAS-RasV12; UAS-Chinmo/+ 
Figure 4-15 
Myc y w tub-FRT-Myc-FRT-GAL4, ey- FLP; UAS-GFP/+; 
UAS-Myc/+ 
Figure 4-15 
Myc + Chinmo y w tub-FRT-Myc-FRT-GAL4, ey- FLP; UAS-
GFP/UAS-Chinmo; UAS-Myc/+ 
Figure 4-15 
RasV12 + Myc y w tub-FRT-Myc-FRT-GAL4, ey- FLP; UAS-
GFP/UAS- RasV12; UAS-Myc/+ 
Figure 4-15 
RasV12 + Chinmo 
miRNA 
y w tub-FRT-Myc-FRT-GAL4, ey- FLP; UAS-GFP/ 
UAS- RasV12; UAS-Chinmo-miRNA/+ 
Figure 4-15 
dm4 ey-FLP, 
RasV12 + Chinmo 
w dm[4] tub-FRT-Myc-FRT-GAL4 ey-FLP; UAS-
RasV12/ +; UAS-Chinmo/ UAS-GFP 
Figure 4-15 
dmP0 ey-FLP, 
RasV12 + Chinmo 
w dm[P0] tub-FRT-Myc-FRT-GAL4 ey-FLP; UAS-
RasV12 / +; UAS-Chinmo/ UAS-GFP 
Figure 4-15 
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3 Methods 
3.1 Molecular biology methods 
3.1.1 Transfection of bacteria with plasmid DNA and plasmid 
amplification 
To amplify a plasmid circular DNA can be transformed into bacteria. Competent bacte-
ria were thawed on ice and mixed with 0.5-1 µg Plasmid DNA or the whole ligation mix 
(3.1.9). After 30 µl incubation on ice followed by a two minutes heat shock at 42°C, LB 
media without antibiotics was added and incubated for 45 minutes on 37°C. The bacte-
ria suspension was then centrifuged resolved in 100 µl media and plated out on an LB 
agar plate containing antibiotics. 
3.1.2 Isolation of plasmid DNA from bacteria 
For large scale purification of plasmid DNA (midi prep), 100 ml of cultivated bacteria 
were used to isolate the plasmid with the Plasmid Midi Kit (Qiagen) according to the 
manufacturer's instructions until the isopropanol precipitation step. After removal of the 
isopropanol, the air dried pellet was resuspended in 400 µl aqua bidest and ethanol 
precipitated (3.1.3). After 30-60 µl at -20°C, the DNA was pelleted through centrifuga-
tion (13000 rpm, 30 µl, 4°C). The DNA was washed once with 70% Ethanol, then dried 
and resuspended in 50 µl aqua bidest or TE and stored at -20°C. 
For the isolation of small amounts of plasmid DNA, 5 ml of cultivated bacteria were 
treated with the GenElute Plasmid MiniPrep Kit (Sigma Aldrich) according to the manu-
facturer's instructions. The DNA was resuspended in 50-75 µl of the included elution 
buffer or aqua bidest. 
3.1.3 Ethanol precipitation of nucleic acids 
Nucleic acids can be precipitated from aqueous solutions by addition of ethanol. There-
for 2.5 volumes of ethanol (100%) and 0.1 volumes of sodium acetate (3 M, pH 5.2) 
were added, vortexed and incubated for at least 30 µl at -20°C. After centrifugation 
(13000 rpm, 30 µl, 4°C), the precipitated nucleic acids were washed once with 1.0 vol-
ume of ice cold ethanol (70%). The nucleic acid sediment was air dried and resolved 
with ddH2O in the initial volume. 
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3.1.4 Nucleic acid quantitation 
The concentration of DNA and RNA in solution was measured with Peqlab’s NanoDrop 
1000. The purity of the nucleic acids was determined by assessing the ratio of absorb-
ance at 260 nm and 280 nm. For pure DNA the ratio is ~1.8, for RNA ~2. 
3.1.5 Separation of proteins from aqueous nucleic acid solutions 
To remove proteins from aqueous protein-nucleic acid solutions, 1 volume of Phenol / 
Chloroform / Isoamylalcohol (25:24:1) was added and mixed properly. After centrifuga-
tion (13000 rpm, 5 min, RT) the upper aqueous phase containing the nucleic acids, 
was transferred into a new reaction tube. The remaining phenol-phase was washed 
once with 1 volume ddH2O and pooled with the first aqueous phase. Afterwards the 
aqueous phases were extracted once with chloroform and the nucleic acids were pre-
cipitated with ethanol (3.1.3) or 2-Propanol. 
For 2-Propanol precipitation an equal volume of 2-Propanol was added to the sample, 
put on -20°C for at least 15min and pelleted (13000 rpm, 15 min, 4°C). The nucleic 
acid sediment was air dried and resolved with ddH2O in the initial volume. 
3.1.6 Sequence specific hydrolysis of DNA (restriction digest) 
DNA was hydrolyzed in a sequence-specific manner with restriction endonucleases 
from New England Biolabs (NEB) and Roche using the recommended reaction buffers. 
The digestions were set up according to the table below and incubated at 37°C for one 
hour to overnight. 
Table 3-1: Restriction digest mix 
DNA 1-2 µg  
restriction endonuclease 1 0.5 µl 
restriction endonuclease 2 (if applicable) 0.5 µl 
10 x reaction buffer 2.0 µl 
ddH2O ad 20 µl 
 
3.1.7 Separation of DNA and RNA fragments via gel electrophoresis 
DNA and RNA fragments of different sizes were separated by agarose gel electropho-
resis. A solution of 0.8-2% agarose was boiled in 1xTAE buffer depending on expected 
fragment size. 
Agarose gel 
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0.3 µg/ml ethidium bromide was added to the solution and poured into a gel chamber 
with combs to form sample wells in the gel. Loading buffer was then added to the sam-
ples which were pipetted into the wells of the polymerized gel. Different standards were 
separated next to the samples depending on the expected fragment size. The gel was 
run at 120 V for one to three hours and bands were visualized using a UV 
transilluminator which detects the intercalator ethidium bromide.  
Small DNA and RNA fragments (< 100 nt) were separated on Acrylamide/ Urea gels. 
Depending on their size the gel consisted of 8% to 12% Acrylamide and 7 M to 8 M 
Urea. Samples were mixed with 2x formamide loading dye (
Acrylamide/ Urea gel 
2.7) and boiled for 2 min at 
95°C prior to loading. 
3.1.8 DNA extraction and purification from agarose gels 
After separation the DNA fragment of interest was cut out from the agarose gel with a 
scalpel and purified with the help of GeneJET Gel Extraction Kit (Thermo Scientific) 
following the manufacturer's protocol. 
3.1.9 Ligation of DNA fragments 
Double stranded DNA fragments were attached to one another covalently by means of 
ligation. Insert and plasmid were incubated in a molar ration of 3:1 in the ligation mix 
according to the table below and incubated for one to three hours at RT or overnight at 
16°C. To calculate the optimal amounts of backbone and plasmid the Insilico ligation 
calculator was used (http://www.insilico.uni-duesseldorf.de/Lig_Input.ht ml). 
Table 3-2: Ligation mix 
linearized plasmid ~ 100 ng 
DNA fragment (insert) X ng 
T4 DNA ligase buffer (NEB) 1 µl 
T4 DNA ligase (NEB) 1 µl 
aqua bidest ad 10 µl 
 
Linearized plasmids were dephosphorylated with Antarctic Phosphatase (New England 
Biolabs) prior to ligation to prevent self-ligation following manufacturer’s instructions. 
3.1.10 Isolation of total RNA from larvae or tissue culture 
For isolating RNA from up to 10 larvae, 100 µl of Trizol (Life Technologies) were added 
to the larvae and homogenized with a micro pistil. After complete homogenization an-
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other 600 µl Trizol were added and either frozen at -80°C or directly further processed 
with the miRNeasy Kit (Qiagen) according manufacturer’s instructions. 
Cells were harvested and pelleted by centrifugation (1200 rpm, 5 min, RT) before 700 
µl Trizol were added, homogenized by vortexing for 1 min and either frozen at -80°C or 
directly further processed with the miRNeasy Kit (Qiagen) according manufacturer’s 
instructions. 
For isolating RNA from larvae and cells an on-column DNase digestion was performed 
with DNase I (Qiagen) following the instructions in Appendix B of the miRNeasy Kit 
(Qiagen) protocol. The RNA concentration was determined by NanoDrop measure-
ment. The RNA was used for cDNA synthesis and stored at -80°C. 
3.1.11 cDNA synthesis 
To quantify specific mRNAs, the RNA was then transcribed into complementary DNA 
(cDNA) by reverse transcription, using the miScript II RT Kit (Qiagen) (Table 3-3) which 
allows the conversion of all RNA species or the Omniscript RT Kit (Qiagen) (Table 3-4) 
which converts mRNA. The cDNA synthesis mix were incubated for one hour at 37°C 
and stored at -20°C. 
Table 3-3: miScript II RT Kit 
total RNA 1 µg 
5x miScript HiFlex Buffer 4 µl 
10x miScript Nucleics Mix 2 µl 
miScript Reverse Transcriptase 2 µl 
RNase free water ad 20 µl 
Table 3-4: Omniscript RT Kit 
total RNA 1 µg 
10x Reverse Transcription buffer 2 µl 
dNTP mix 2 µl 
random hexamers (final conc: 10 µM) 0.2 µl 
RNase inhibitor 10u 
Reverse Transcriptase  1 µl 
RNase free water ad 20 µl 
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3.1.12 Polymerase chain reaction (PCR) 
To amplify specific regions of nucleic acids for different purposes polymerase chain 
reaction (Mullis et al., 1986) was used. 
 
PCR to amplify cDNA for cloning or dsRNA synthesis 
To generate new expression vectors, the gene of interest was amplified based on exist-
ing expression vectors. This also allowed the addition of new tags or new restriction 
sites. Furthermore the newly synthesized cDNA was used for dsRNA synthesis 
(3.1.16). 
Table 3-5: Standard PCR setup 
cDNA 100-500 ng  
primer 30 pmol each 
dNTP mix (10mM each) 2 µl 
Phusion 5 u 
RNase free water ad 100 µl 
Table 3-6: Standard PCR thermal cycle profile 
1 cycle 94°C 120 s 
25-30 cycles 
94°C 15 s 
Tm-(2-4°C) 30 s 
72°C 1 kb/min 
1 cycle 
72°C 420 s 
4°C Hold 
 
Quantitative reverse transcriptase PCR (qRT-PCR) 
To quantify specific mRNA levels the cDNA synthesized by reverse transcription was 
amplified by real time PCR. The qPCR SYBR Green Mix from Thermo Scientific was 
used to set up a reaction mix as described in the table below, and pipetted into the 
wells of a 96-well qPCR plate. Finally, 200 ng of cDNA in 10 µl was added to each well. 
The measurement was carried out with the Mx3000P qPCR system (Stratagene). 
The quantification of the amplified transcripts can be determined by fluorescent moni-
toring in every cycle after the end of the elongation step. 
The basis of real time PCR is fluorescent monitoring of DNA amplification, from which 
target DNA concentration can be determined from the fractional cycle at which a 
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threshold amount of amplicon DNA is produced. For normalization the housekeeping 
genes α-tubulin, rab6 and snm158 were used, the calculation was performed using the 
∆∆−CT method (Applied Biosystems User Bulletin 2). Every qRT-PCR was performed 
in triplicates for at least two biological independent samples. 
 
Quantitative real-time PCR (qPCR) 
For analyzing the expression of specific genes and the enrichment of ChIP DNA, quan-
titative PCR was used. Therefore, the synthesized cDNA was diluted 10 times and 
added to 10 µl of the qPCR setup. The measurement was carried out as described for 
quantitative reverse transcriptase PCR (see above).  
Table 3-7: qRT-PCR/qPCR setup 
SYBR Green Mix (Thermo Scientific) 5 µl 
forward primer (10 pmol/ml) 0.5 µl 
reverse primer (10 pmol/ml) 0.5 µl 
RNase free water 4 µl 
Table 3-8: qRT-PCR/qPCR thermal cycling profile 
1 cycle 95°C 15 min 
38 cycles 
95°C 30 sec 
60°C 20 sec 
72°C 15 sec 
1 cycle 
95°C 1 min 
60°C 30 sec 
95°C 30 sec 
3.1.13 Chromatin immunoprecipitation (ChIP) 
To investigate the interaction between proteins and DNA chromatin 
immunoprecipitation (ChIP) were performed. Therefore, 40x106-120x106 cells (200x106 
cells for ChIPseq) were cross-linked with 1% formaldehyde at 37°C for 10 µl and the 
reaction was stopped with 50 mM glycine for 5 min. After washing the cells 3 times in 
ice-cold PBS, cells were swelled for 20 µl in 3 ml Lysis buffer I (containing protease 
inhibitor) and nuclei were lysed in 2 ml Lysis buffer II (containing protease inhibitor) for 
10 µl or longer. Afterwards sonication with a Branson sonifier was carried out (15 min in 
total, amplitude 15%) until the majority of fragments showed nucleosomal size.  
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Protein A/G-dynabeads (30 µl (100 µl for ChIPseq), Invitrogen) were coupled to anti-
bodies (3 µg (10 µg for ChIPseq)) of interest and their corresponding IgGs overnight. 
The beads were washed three times in PBS/BSA before the cross-linked chromatin 
was added for at least 6 hours. Before the chromatin was eluted (150 µl, 15min, RT, 
two combined eluates) from the dynabeads they were washed three times with Wash 
buffer I-III, containing increasing salt concentration to get rid of background signal due 
to unspecific binding. The same amount of elution buffer was added to the 1% input 
samples and the crosslink was reverted overnight. 
To revert the crosslink, 14 µl 1 M Tris pH 6.8, 1.2 µl 5 M NaCl and 1 µl RNase A (10 
mg/ml) were added and the samples were incubated for one hour at 37°C and after-
wards at 65°C for six hours to overnight. Finally, 3.5 µl 0.5 M EDTA and 7 µl proteinase 
K (10 mg/ml) were added and incubated for another two hours at 45°C before the DNA 
was purified with Phenol-Chloroform followed by ethanol precipitation, diluted 1:15 in 
RNase free water and analyzed by quantitative real-time PCR (3.1.12). 
3.1.14 ChIP seq 
For ChIPseq experiments, ChIP DNA was end repaired and A-tailed. After ligating 
Illumina adaptors to the ChIP DNA fragments they were loaded on a 2% agarose gel 
and fractions of 175-225 bp size were cut out. After they were extracted from the gel 
with the Qiagen gel extraction kit they were enriched by 18 cycles of PCR amplification. 
The library was quantified using a picogreen assay (Invitrogen) and the library size was 
controlled with the Experion-system (BioRad). The library was sequenced on an 
Illumina GAIIx sequencer. 
The resulting library DNA was analyzed by quantitative real-time PCR (3.1.12) under 
predetermined conditions for all oligonucleotide sets in a MX3000P (Stratagene). 
3.1.15 Bioinformatical analysis 
ChIP seq analysis 
The resulting sequence data were processed with OLB_v1.9 and mapped to the Dro-
sophila genome release 5 with bowtie-0.12.7. Peaks were identified with MACS14, 
using the same number of reads with single alignment for all conditions (6’874’000) and 
the default settings (with the switch “-g dm”). Only peaks called by the software as “sig-
nificant” were considered, i.e. with an FDR (false discovery rate) of <10%. Subsequent-
ly, all unmapped peaks (mostly mapping to chromosome “Uextra”; 3-17 peaks per con-
dition) and all peaks that were called in any of the ChIPs with non-immune IgGs or in 
Myc-ChIPs from Myc-depleted S2 cells were eliminated from the Myc-ChIP lists.  
 
Selection of Yang peaks for ChIP 
For the analysis of peaks from Yang et al. (2013) the data published by these authors 
were used. To determine the ratio of mouse α-Myc ChIPseq reads from naïve S2 cells 
versus Myc-depleted S2 cells for each of the 3993 peaks the program intersectBed 
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(bedtools v.2.17.0.) was used. 1936 regions with a ratio “naïve/Myc-depleted” ≤1.2 that 
did not overlap any of our peaks were retained and sorted by the number of reads that 
were recorded by Yang et al. From this sorted list, every 50th peak (for a total of 20 
peaks) was selected, starting with the region with the highest number of reads in the 
Yang analysis. Primers were designed to cover the summit coordinate indicated by 
Yang et al., resulting in 17 functioning primers (one region was omitted since no ac-
ceptable primers could be generated, and two primer pairs did not function, i.e. did not 
produce the expected product). 
3.1.16 dsRNA synthesis 
To generate specific dsRNA, linearized DNA (amplified by PCR (3.1.12)), was in vitro 
transcribed into RNA using the Megascript T7 kit (Ambion).  
Table 3-9: Megascript T7 kit 
Linear template DNA 2 µg 
10x Reaction Buffer 4 µl 
rNTPs 4 µl each 
Enzyme Mix 4 µl 
RNase free water ad 40 µl 
After an incubation time of 2-4 hours at 37°C, 1 µl TURBO DNase was added, mixed 
well and incubated for additional 15 min. DsRNA was purified with phenol/ chloroform 
(3.1.5) followed by isopropanol precipitation and resuspended in 50 µl RNase free wa-
ter. Afterwards dsRNA was once heated up to 65°C and was then slowly cooled down 
to RT, before it was frozen at –80°C.  
3.1.17 Northern blot 
Total RNA was extracted from Drosophila S2 cells as described before (3.1.10). 20 µg 
were loaded per lane on a 10% Acrylamide 8 M Urea gel (3.1.7) and then transferred to 
a nylon membrane (Hybond N+, GE Healthcare). After UV cross-linking at 254 nm the 
membrane was pre-hybridized in 10 ml Church buffer for 1 hour at 62°C. As probes, 
DNA oligonucleotides were used, which were 5’ end-labeled with γ-P32-ATP using T4 
polynucleotide kinase (NEB). Therefore, a 15 µl reaction was set up according to Table 
3-10 and incubated for 1 hour at 37°. To stop the reaction 30 µl of 30 mM EDTA were 
added to the reaction. 
 
Table 3-10: Oligo labeling 
Oligo 100 µM 1 µl 
10* PNK buffer 1.5 μl 
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PNK 1 μl 
γ-32P-ATP (10 µCi/µl) 2 μl 
H2O 9.5 μl 
Unincorporated γ-P32-ATP was removed with illustra MicroSpin G-25 Columns (GE 
Healthcare), following manufacturer’s protocol. Hybridization of the probe was per-
formed overnight in 10 ml Church buffer at 62°C. The blot was washed for 30 µl in 2x 
SSC and 0.2x SSC at 62°C, dried and exposed on a Storage Phosphor Screen. 24-96 
h later it was developed on the Typhoon 9200 (GE healthcare). Quantification was per-
formed using ImageJ2
3.2 Cell biology methods  
 software. 
All cell culture work was performed at a sterile workbench. Cells were cultivated at 
25°C. 
3.2.1 Passaging of cells 
Semi adherent cells were passaged after they completely covered the surface of the 
flask and started to distribute in several layers. Depending on the dilution factor, cells 
were taken out of the flask and transferred to one or more fresh ones. Afterwards full 
media was added to the maximum capacity of the flasks, 15 ml for 125 cm2 flasks and 
25 ml for 175 cm2 flasks.  
3.2.2 Freezing and thawing cells 
For long term storage cells were harvested, counted and pelleted (800 rpm, 5 min, RT). 
The cells were resuspended in freezing medium (45% complete medium, 45% condi-
tioned medium, 10% DMSO) to a final concentration of 2 x 107 cells/ml. 1 ml of cell 
suspension was always transferred to one cryo vial and slowly frozen at -80°C using 
MrFROSTY freezing container. After 24 hours the cells were stored in liquid nitrogen 
storage tank. 
Cells were thawed by quickly heating them up in a 37° waterbath, washed once in full 
medium and resuspended in 5 ml full medium before they were plated in a 75 cm2 fal-
con. 
3.2.3 Transfection of plasmid DNA 
To transfect Drosophila cells, one of the following transfection methods was used. An 
expression of the transiently transfected DNA was observed mostly 40 hours after 
transfection. 
                                                 
2 http://imagej.nih.gov/ij/ 
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Cells were split 24 hours before transfection. For 6-well plates 5 x106 cells were plated 
and let adhere for 2 to 3 hours. 100 µl transfection mix was prepared according to the 
table below, for dishes with a lower or higher surface area the total volume of cells and 
transfection agent was scaled appropriately. The transfection mix was incubated for 
5min at RT, then 10 µl of Effectene Reagent was added to the DNA-enhancer mixture 
and incubated for 5-10 µl at RT to enable transfection complex formation. 
Effectene Transfection 
In the meantime the cells were washed once with PBS and 1.6 ml of complete medium 
was added. The transfection mixture was mixed with 600 µl of complete medium and 
dropwise added to the cells. 16h later the medium with the remaining DNA precipitates 
was removed and 3 ml of fresh medium was added to the cells. Cells were harvested 
24-48 h later. 
Table 3-11: Effectene transfection mix 
plasmid DNA 0.4 µg 
tub-Gal4 0.1 µg 
Enhancer 3.2 µl   
EC-buffer ad 100 µl 
 
Cellfectin transfection was only used for luciferase assays. Cells were split 24 hours 
before transfection. For 24-well plates 1.3 x106 cells were plated and let adhere for 2 to 
3 hours. 42 µl transfection mix was prepared according to the table below, for dishes 
with a lower or higher surface area the total volume of cells and transfection agent was 
scaled appropriately. The transfection mix was incubated for 15min at RT to generate 
transfection complex formation then 178 µl of serum free medium were added to the 
mix and directly added to the cells which were washed once with PBS during the incu-
bation period. 
Cellfectin Transfection 
30 µl later 200 µl of full medium was added to the cells. 16 hours later the medium with 
the remaining DNA precipitates was removed and 650 µl of fresh medium was added 
to the cells. Cells were harvested 24-48 h later. 
Table 3-12: Cellfectin transfection mix 
plasmid DNA 0.4 µg 
tub-Gal4 0.1 µg 
Cellfectin 21 µl  
Serum free-medium ad 42 µl 
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3.2.4 Transfection of dsRNA 
Cells were split 24 hours before transfection. For 6-well plates 5 x106 cells were plated 
and let adhere for 2 to 3 hours. 1 ml of serum free medium was added to the cells, 
which were washed with serum free medium before. 10 µg of dsRNA were added and 
the plates were shaken smoothly. After an incubation of 30 µl at 25°C, 2 ml of full me-
dium was added to the cells. Cells were harvested for further processing after 24-96h 
depending on the used dsRNA.  
3.2.5 Induction of inducible fly cells 
Cells which were stable transfected with constructs under the control of a 
metallothionein promotor were induced with CuSO4 in a final concentration of 125 µM. 
Cells were harvested 6-8 h later and processed for RNA isolation used for qRT-PCR 
(3.1.10) or Western Blot (3.3.1). 
3.2.6 Luciferase reporter gene assay 
1.3x 106 cells in 24-well plates were transfected with “CG5033wt-Renilla-luciferase” and 
“CG5033∆EBox-firefly-luciferase” reporter constructs and additional expression plasmids 
with the Cellfectin method (3.2.3). 24 hours later, the cells were washed with PBS and 
disrupted in 100 µl passive lysis buffer (1x) (Promega) for 15 min at RT while shaking. 
The lysate was transferred into a reaction tube and cleared of the cell debris by centrif-
ugation (1 min, 800 rpm, 4°C). To determine the luciferase activity, 10 µl of lysate was 
pipetted into a 96-well plate and placed into the Glomax 96 Microplate Luminometer. 
The device automatically added 50 µl of freshly prepared luciferase substrate solution 
and measured light emission at 562 nm two seconds later for an interval of ten seconds 
(in relative light units, RLU). To normalize the results the ratio of Firefly to Renilla was 
calculated. 
3.3 Protein biochemistry methods 
3.3.1 Generation of protein lysates for Western blot 
To isolate total protein cells were harvested by rinsing out the dish with the actual me-
dium, washed once in PBS and pelleted (800 rpm, 5 min, 4°C). The cell pellet was di-
rectly subjected to lysis by resuspending cells in NP 40 buffer with freshly added pro-
teinase inhibitors (1:100). 5x106 cells were lysed in 50 µl lysis buffer respectively. The 
cells were incubated for 30 minutes on ice, then the cell debris was pelleted (13000 
rpm, 15 min, 4°C) and the supernatant transferred to a fresh tube. The lysates were 
mixed with Laemmli Buffer in an equal volume and were directly used for Western blot 
analysis or stored at -20°C. 25 µl (1.25x106 cells) were loaded per lane on a SDS-Gel 
(3.3.2). 
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3.3.2 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
Discontinuous SDS-PAGE (Sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
was used to separate proteins according to size (Laemmli et al., 1970). Protein lysates 
as described in 3.3.1 were incubated 5 minutes at 95°C and spun down afterwards. 
The protein samples were then transferred into the wells of an SDS polyacrylamide gel 
consisting of a 10% stacking gel and a 5% resolving gel. The PageRuler Pre-Stained 
Protein Ladder (Fermentas) was used as a size marker. The electrophoresis was car-
ried out using the Bio-Rad SDS-PAGE chamber with SDS running buffer, first at 80 V 
for 30 minutes, then at 120 V for 90-120 minutes. 
3.3.3 Staining Protein gels with Coomassie Blue 
The quality and quantity of GST fusion proteins (3.3.7) after bacterial expression was 
checked by separating the samples on a SDS-PAGE followed by coomassie staining 
for at least 1 hour. To remove excess dye the gel was incubated several times with 
fresh destaining solution until a clear background was obtained.  
3.3.4 Western blot 
Proteins were separated by SDS-PAGE (3.3.2), followed by blotting onto a nitrocellu-
lose membrane using a tank blot system. A nitrocellulose membrane of the size of the 
SDS gel was incubated first in water for 30 sec and then equilibrated in tank blot buffer 
for another 30 sec. Gel and membrane were neatly layered on top of each other and 
fixed between Whatman filter papers in a Western blot transfer chamber (BioRad). The 
electrophoretic protein transfer was carried out at 215 mA for 2 hours. All following in-
cubation steps were performed with gentle shaking. The membrane with immobilized 
proteins was blocked in blocking solution for at least 30 µl, and then cut into pieces if 
several proteins from the same membrane were visualized. The membrane pieces 
were incubated o./n. with a dilution of primary antibody in blocking solution (see Table 
3-13), then washed (3 x 10 min in TBS-T), incubated with secondary antibody (coupled 
to horseradish peroxidase; dilution 1:10,000) in blocking solution for 3-4 hours at RT, 
and then washed again (3 x 10 µl in TBS-T). To visualize the proteins of interest a spe-
cific chemiluminescent signal was triggered by the Immobilon Western 
Chemiluminescent HRP Substrate from Millipore, which was used according to the 
manufacturer's instructions. The signal was detected with the ImageQuant LAS 400 
imager (Fujifilm Global). 
 
Table 3-13: Amount of antibodies used for western blot  
Antibody concentration Western blot 
α-AU1 1.0 mg/ml 1.0 µg/ml 
α-HA 1.0 mg/ml 1.0 µg/ml 
mouse α-Myc 0.015 mg/ml 0.3 µg/ml 
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rabbit α-Myc (SC) 0.2 mg/ml 0.4 µg/ml 
α-GST-Chinmo not known dilution: 1:500 
α-Chinmo 1.21 mg/ml 6.05 µg/ml 
α-GFP 0.2 mg/ml 0.2 µg/ml 
α-Tub not known dilution: 1:100,000 
3.3.5 Stripping antibodies from nitrocellulose membranes 
To release antibodies from a nitrocellulose membrane covered with immobilized pro-
teins the membrane was incubated at 60°C in a water bath in freshly prepared stripping 
buffer for 30 µl. Afterwards the membrane was washed with TBS-T (3 x 10 µl), blocked 
and incubated with primary and secondary antibodies as described in 3.3.4. 
3.3.6 Immunoprecipitation 
Immunoprecipitations (IPs) were performed to detect protein-protein interactions. Cells 
were collected as described in 3.3.1 and lysed in 300 µl ice cold NP-40 lysis buffer with 
fresh proteinase inhibitors (1:100). All quantities refer to one single well from a 6-well 
plate, containing approximately 5x106 cells. After vortexing 3 x 15 sec at full speed, 
samples were put on ice and shook for 30 µl.  
In the meantime Protein A-Sepharose 4B (Invitrogen) and Protein G-Sepharose 
4FastFlow (GE Healthcare) beads (each 150 µl) were mixed and washed 5 times with 
lysis buffer and finally resuspended in an equal volume of lysis buffer. For pre-clearing, 
40 µl of the 50% protein A/G beads/ lysis buffer suspension was added to each sample 
and incubated on a rotating wheel for 45 min at 4°C. The beads were spun down and 
the supernatant was transferred into a new tube. A 6% input of each lysate was col-
lected and mixed with Laemmli buffer prior to freezing. 
To each IP sample 1 µg specific antibody and 40 µl of the 50% protein A/G beads/ lysis 
buffer suspension were added and rotated for 4 hours at 4°C. The beads loaded with 
protein-bound antibodies were washed three times with lysis buffer, then 40 µl of 
Laemmli buffer were added and the samples were frozen at -20°C until they were fur-
ther processed by SDS-PAGE and Western Blot, using the input as a reference for IP 
efficiency. 
Endogenous Immunoprecipitation 
For endogenous IPs of Chinmo and Myc 260*106 naïve cells were harvested and pre-
cipitated with 9.6 µg of rabbit α-Chinmo antibody or rabbit-IgG and 100 µl of a 50% 
suspension of protein A/G beads. 
In contrast to exogenous IPs, samples were sonicated (5 sec, 59 sec pause; in total 1 
min, amplitude 15%) directly after lysis and ethidium bromide was added after 
sonification (20 µg/ml; incubate 30 µl before pre-clearing). 
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3.3.7 Bacterial expression and purification of GST fusion proteins 
The gene of interest was cloned into the pGEX 4-T1 vector, which enables expression 
of GST fusion proteins in E.coli B21 cells upon induction with Isopropyl--D-
thiogalactopyranosid (IPTG). A clonal overnight culture of 5 ml was diluted 1:50 and 
incubated shaking at 37°C until it reached an optical density of A600 nm = 0.6. IPTG 
was added to a final concentration of 1 mM and the culture was grown for another 3 
hours at 37°C. The bacteria were pelleted (460 rpm, 10 µl, 4°C) and either stored at -
80°C or directly lysed in 7.5 ml lysis buffer containing fresh proteinase inhibitors. The 
lysate was sonicated (10 x 10 sec, pausing 1 min in between, 20% amplitude) and cen-
trifuged (4600 rpm, 30 µl, 4°C) to pellet bacterial cell debris and insoluble proteins. The 
pellet was solubilized in 7.5 ml lysis buffer and a fraction of the solubilized pellet and 
the supernatant was mixed with Laemmli buffer and analyzed on a coomassie gel to 
verify the expression of the GST fusion protein and to determine its solubility. 
For the purification of the GST fusion protein, 0.67 ml Glutathione Sepharose 4B beads 
(GE Healthcare) were used. After washing the beads three times with cold PBS (1000 
rpm, 5 min, 4°C) 0.5 ml PBS was added to the beads, resulting in a 50% suspension. 
0.3 ml of the suspension was added to the supernatant and incubated shaking for 30 µl 
at RT. The beads were sedimented (800 rpm, 5 min, 4°C) and washed three times with 
cold PBS. The GST fusion proteins were eluted in elution buffer (10 µl, shaking, RT) 
centrifuged (800 rpm, 5 min, RT) and the supernatant was transferred into a new tube. 
This step was repeated twice and the eluates were pooled. 
3.3.8 Protein determination by the Bradford method 
Protein concentrations were determined according to Bradford (1976). Bradford dye 
reagent was mixed in a ratio of 1:1 with H2O and pipetted into 1 ml cuvettes. 1 µl of the 
protein sample solution was added and mixed. After incubation of 5 min at RT the ab-
sorption was measured at a wavelength of 595 nm using an appropriate reference. The 
measured values were compared to a previously obtained standard curve to calculate 
the protein concentration of the sample solution. 
3.4 Fly specific methods 
3.4.1 Fly culturing 
Flies were kept on standard Drosophila medium. If not indicated otherwise crosses 
were performed in climate chambers at 25°C. 
3.4.2 Heat shock conditions for overexpression experiments 
Fly vials were incubated in a water bath for 1 hour at 37°C the evening before the ex-
periment. Afterwards the flies were transferred back to 25°C. 
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3.4.3 Images of fluorescent tissue 
Larvae which expressed GFP plus another transgene ubiquitously or in a tissue of in-
terest were immobilized on ice and placed on a cover lid of a 24-well plate. The size 
and shape of the fluorescent tissue was observed and documented using the binocular 
microscope (Discovery V8, Zeiss) with the GFP filter (475 nm). 
3.4.4 Extraction of genomic DNA 
To extract genomic DNA from adult flies or larvae, 1-5 flies were collected in a tube and 
homogenized with 100 µl extraction buffer A using a pestle to crash the carcasses. For 
higher number of flies 200 µl of buffer were used. After incubating the flies for 30 µl 
(70°C, shaking 350 rpm) 14 µl 8 M Sodium acetate was added and put on ice for 30 µl. 
To pellet fly debris samples were centrifuged twice (1300 rpm, 15 min, 4°C) and the 
supernatant was transferred to a new tube. To precipitate the nucleic acids, ½ volume 
isopropyl alcohol was added to the tube, inverted and centrifuged (13000 rpm, 5 min, 
RT). The pellet was washed once with cold Ethanol (100%) centrifuged as before and 
the pellet was eluted in 40 µl TE.  
To remove genomic RNA, RNase digest was performed. Therefore 1 µl RNase A was 
added and incubated for 15 min at 37°C. 
3.4.5 Methylation Assay with larvae 
For measuring methylation activity, total RNA was isolated from larvae being mutant or 
wildtype for Uhg1. 2’-O-ribose-methylation was determined by reverse transcription 
under limited nucleotide concentrations as previously described (van Nues, 2011).  
First of all, primers specific for the methylated region of interest were labeled with γ-32P-
ATP. Therefore, a 15 µl reaction was set up according to Table 3-10 (3.1.17) and incu-
bated for 1 hour at 37°C before the labelled oligos were purified through a G50 column 
(GE Healthcare) and diluted twofold. 
In the following hybridization reaction 8 µg of total RNA were annealed to 10 ng 
kinased oligo in a 30 µl reaction with 2x Annealing buffer, incubated for 2min at 95°C 
and for 10 µl 65°C before it was put on ice until the reverse transcription mix was pre-
pared. 
Reverse transcription was performed under three different dNTP concentrations, 10 
mM, 1 mM and 0.5 mM or 0.1 mM. Table 3-14 shows the ingredients of the reverse 
transcription mix, of which 4 µl were mixed with 6 µl of the hybridization reaction and 
incubated for 45 min at 42°C. Each sample was mixed with formamide loading dye and 
separated on a 10% acrylamide/ 7 M urea gel and then visualized using a 
phosphorimager. 
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Table 3-14: Reverse transcription mix 
AMV reverse transcriptase (10 u, Promega) 0.1 µl 
10x RT buffer 1 µl 
RNasin 0.5 µl 
dNTPs (10 mM, 1 mM or 0.5 mM) 1 µl 
RNase free H2O ad 4 µl 
 
The RNA sequencing ladder was carried out as previously described (Nilsen, 2013), 
using 0.167 µg RNA for each reverse transcriptase reaction. 
3.4.6 Translation Assay with larvae 
750 µl Ringer’s solution containing 15 µCi/ml 3H-Amino-Acid mix were added to 10 fully 
inverted larvae (in 100 µl Ringer’s solution) and placed on a wheel for 1 hour at room 
temperature for peptide incorporation. Subsequently, the supernatant was decanted 
and the carcasses were washed twice with cold Ringer’s solution before they were 
lysed in 350 µl Cell Lysis Buffer (100 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.5% Triton 
X-100) using a pestle to crush the carcasses. For full lysis, samples were periodically 
vortexed during a 10 µl sit on ice. To pellet larval debris samples were spun down for 2 
min (1000 rpm, RT). 
250 µl of the aqueous lysate were mixed with 15 µl suspended Strataclean Resin 
(Stratagene) and allowed to rest for 5 min. After removing the supernatant resins were 
washed with Ringer’s solution and transferred to 3 ml scintillation buffer. Following a 30 
min rest, 1 minute counts per vial were obtained. 
With the remaining aqueous lysate protein quantification was performed (3.3.8). 
3.4.7 Neuroblast type II tumors  
Type II neuroblast tumors (NBII) were induced by knocking down the tumor suppressor 
brat specifically in these cells with the driver system “worniu-GAL4 asense-GAL80”. 
Co-expression of firefly luciferase allowed the quantitative determination of tumor 
mass. Appropriate male adults were collected 12 hours after eclosion and frozen at -
80° until use. Upon thawing, 100 µl 1x Passive Lysis Buffer (Dual Luciferase Reporter 
Assay System; Promega) was added to individual flies as well as some steel beads 
(SSB14B, Next Advance). The carcasses were crushed using a Bullet Blender homog-
enizer (Next Advance) before another 100 µl of buffer were added and the lysates were 
incubated for 10 µl at RT. Fly debris was pelleted (4 min, 1200 rpm, RT) and 10 µl of 
supernatant were processed for luminometry in a Glomax luminometer (3.2.6).  
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4 Results 
4.1 Myc binds and regulates genes involved in ribosome 
biogenesis 
4.1.1 DNA-library preparation for ChIPseq  
The transcription factor Myc promotes cell growth, proliferation and other processes in 
part by stimulating transcription of a number of genes essential for ribosome biogene-
sis and protein translation including ribosomal protein genes. Furthermore it stimulates 
the expression of r- and tRNAs and therefore controls multiple components of ribosome 
biogenesis (van Riggelen et al., 2010). 
However, most studies were performed in vertebrates and a comprehensive list of Myc 
target genes in Drosophila melanogaster, including non-polyadenylated transcripts, is 
still missing. To investigate which Myc regulated genes are controlled by direct Myc 
binding, ChIPseq experiments were performed in Drosophila S2 cells. The combination 
of Chromatin immunoprecipitation (ChIP) followed by massively parallel DNA sequenc-
ing is used to map global binding sites for any protein of interest. Since all experiments 
were performed in a Drosophila background, Myc refers to Drosophila Myc if not oth-
erwise stated. 
For ChIPseq in naïve and Myc depleted cells, cells were either transfected with dsRNA 
against Myc or left untreated and further processed for Western blot (3.3.4) or ChIP 
(3.1.13). The knockdown samples were included to distinguish between specific and 
unspecific Myc binding sites and the efficiency of the depletion was verified via West-
ern blot, using α-tubulin as loading control. The knockdown was highly efficient, show-
ing a depletion by almost 100% (Figure 4-1 A). For ChIP, protein was cross-linked to 
DNA, and the chromatin was lysed and sheared to nucleosomal size before it was 
immunoprecipitated using equal amounts of mouse α-Myc antibody or non-immune 
mouse IgGs (2.4.1). Like the knockdown samples, the non-immune IgGs were used to 
check for background signals. Binding sites present in either of the controls can be 
considered Myc non-specific. The input control is necessary to identify significant en-
richment for a ChIP-Seq signal and to control for biases in the experimental methods. 
After reversion of the crosslink and digestion of the protein the efficiency of the 
immunoprecipitation was tested. Therefore qPCR (3.1.12) was performed for one posi-
tive (Nop5) and one negative (Pka-C1) Myc target gene (Figure 4-1 B) using the 
immunoprecipitated DNA. Myc was already shown to bind to Nop5 in ChIP experiments 
whereas Pka-C1 was chosen for comparison, as it shows associated Myc-binding but 
does not change expression upon depletion of Myc (Furrer et al., 2010).  
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The qPCR revealed an enrichment (22 fold) for Nop5 in the Myc ChIP over IgG control 
(0.03% ± 0.02% of input vs. 0.0008% ± 0.0004% of input) whereas the enrichment for 
Nop5 in the Myc depleted cells is reduced by almost 7 fold compared to non-treated 
cells (0.004% ± 0.001% of input vs. 0.001% ± 0.0003% of input; Figure 4-1 B). The 
negative control Pka-C1 shows only slight differences between enrichment over IgG in 
naïve (7 fold) versus depleted cells (4 fold). Since the enrichment over IgG was high for 
the positive controls in naïve cells and the α-Myc antibody did not display strong back-




Figure 4-1: Process of DNA-library preparation for ChIPseq3
 
 
A. The Western blot illustrates the efficiency of Myc depletion; the asterisk points to the Myc 
band at ca.107 kDa, the arrow to a band presumably arising from post-translational modification 
of Myc. Western blot was performed with mouse α-Myc (upper panel) and mouse anti-α-Tubulin 
antibodies (lower panel) as loading control. 
B. ChIP-qPCR of control regions. Chromatin was isolated from naïve S2 cells or from S2 cells 
depleted of Myc, precipitated with mouse α-Myc or control IgG antibodies and assayed by 
qPCR for enrichment of the indicated loci. Error bars indicate SD of technical triplicates. 
C. Gel picture of a DNA 1K chip. The lanes 1-6 show size, quality and quantity of the DNA li-
brary (d) from the depicted samples plus additional gel peaks (a, e), unbound primers (b) and 
adaptor dimers (c) ; lane 7 contains only H2O as negative control.  
C’. Electropherogram of the DNA library of the naïve Myc ChIP (lane 5, Figure 4-1 C). The 
peaks, numbered a-e correspond to the bands shown in C. 
The concentration of the recovered DNA was measured using a fluorescent probe 
(picogreen) that binds dsDNA and forms a highly luminescent complex when compared 
                                                 
3 Parts of this figure were published in similar form in Herter et al., 2015 (see also following 
pages) 
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to free dye in solution and can be measured with a fluorescent reader. Equal amounts 
of DNA were further processed for the DNA-library preparation (3.1.14). The pro-
cessing of the library included end-repair of the DNA fragments to ensure that each 
molecule is free of overhangs and contains 5’ phosphate and 3’ hydroxyl groups. Fur-
thermore, a non-templated deoxyadenosine 5’-monophosphate (dAMP) was incorpo-
rated onto the 3’ end of the blunted DNA fragments to prevent concatamer formation 
during ligation steps. This process, also called dA-tailing, enables DNA fragments to be 
ligated to adaptors with complementary dT-overhangs. After ligation of the adaptors 
containing indexed sequences which allow discriminating between different samples, 
the ligation products were size selected via an agarose gel at 175-225 bp, purified and 
PCR-amplified to enrich for fragments containing adaptors on both ends. Quality and 
quantity of the resulting DNA-library were measured with an automated electrophoresis 
station (Bio-Rad, DNA 1K chip). Figure 4-1 C shows the gel picture of the DNA 1K chip. 
As expected, the lanes 1-6 show a band around 200 bp (d), which represents the DNA 
library. The size of the band is based on the shearing of the chromatin and addition of 
the adaptors and fits to the size obtained from the size selection. On the corresponding 
electropherogram (Figure 4-1 C’) for the DNA library of the naïve Myc ChIP (Figure 4-1 
C; Lane 5) a single peak is depicted for the library (d), displaying a good quality of the 
library. This was the case for all samples. The first and the last band/peak (a and e) 
correspond to the internal Experion lower 15 bp and higher 1500 bp marker. The addi-
tional bands/peaks correspond to unbound primers (b) and adaptor dimers (c) of the 
library processing. H2O was loaded as a negative control (lane 7). To map the distribu-
tion of the sequences enriched by ChIP in a genome wide manner, Next Generation 
Sequencing was performed. Therefore, equal amounts of the different DNA-libraries 
were denatured and immobilized on a glass carrier plate. Individual DNA molecules 
were amplified using “Bridge-PCR” resulting in identical DNA-clusters, and sequenced 
by “Sequence by Synthesis” (SBS, Illumina) procedure. Table 4-1 summarizes the 
number of individual sequences (total reads), number of single aligned reads (single 
alignment), number of reads which were not aligned (no alignment) and called peaks 
(binding sites) obtained for each sample. 
For each condition between 12,569,801 and 29,940,708 reads were obtained of which 
54% to 70% mapped to a single position in the Drosophila genome. The number of 
total and single mapped genes fit to ChIPseq data obtained from vertebrates (Walz et 
al., 2014). However, the number of binding sites is much lower in Drosophila. This was 
shown before by Orian et al. (2003). The reads with multiple or no alignment were not 
further considered. To identify the number of binding sites specific to Myc, the called 
peaks identified by MACS14 (binding sites, Table 4-1), were assigned to genes with 
the help of intersectBed and further processed by eliminating all peaks that were called 
in IgG control or after Myc depletion. This resulted in a final number of 240 Myc binding 
sites. The quality of the ChIP was very good, indicated by a high ratio of binding sites 
obtained for naïve Myc ChIP versus IgG and knockdown control (90%) and loss of very 
few binding sites (7%) after filtering for FDR 0.1. 
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Table 4-1: ChIP-sequencing reads of S2 cells chipped with mouse α-Myc.  
After performing peak calling using MACS software, peaks were filtered with different false dis-
covery rate (FDR) values and used for subsequent analyses. Input and IgG control peaks were 










sites    
(FDR 0.1) 
Naïve α Myc 12.569.801 6.874.174 2.781.777 260 240 
Naïve IgG 14.848.998 9.475.215 1.630.732 27  
KD Myc α Myc 16.283.576 9.058.587 3.315.590 22  
KD Myc IgG 13.234.306 7.851.731 2.249.910 24  
Naïve Input 29.940.708 20.986.173 738.107   
KD Myc input 23.512.194 16.678.250 553.226   
4.1.2 Myc binds a core set of sites 
A list of 240 peaks resulted from the ChIPseq experiment after analyzing the data 
(3.1.14) that were specifically bound by Myc in naïve cells but not in the Myc depleted 
cells and which were not recognized by control IgGs (Table 4-1). An example of a spe-
cific binding site is shown in Figure 4-2 A for Fibrillarin. A distinct peak can be seen in 
naïve cells, which were chipped with the mouse α-Myc antibody. The summit of the 
peak is located at the E-box, marked with an asterisk. No peak is present in the nega-
tive controls as well as the input sample. To exclude that binding sites were not detect-
ed due to epitope masking of the monoclonal mouse α-Myc antibody, the ChIPseq was 
repeated with a polyclonal rabbit α-Myc antibody (kindly provided by G. Morata) and 
rabbit IgG control (Table 4-2). This ChIPseq experiments resulted in 98 specifically Myc 
bound peaks, of which most (75) overlapped with peaks from the first ChIPseq experi-
ment (Figure 4-2 B; Table 4-2). 
Table 4-2: ChIP-sequencing reads of S2 and KC 167 cells chipped with rabbit α-Myc and 










sites    
(FDR 0.1) 
Naïve α Myc S2 17,098,819 11,317,552 1,993,197 263 98 
Naïve IgG S2 11,543,400 6,867,642 2,370,948 31  
Naïve Input S2 13,314,075 9,796,752 633,339   
Naïve α Myc KC 27,884,589 19,565,700 1,646,483 308 21 
Naïve IgG KC 19,316,418 9,122,683 5,944,743 187  
Naïve Input KC 33,927,814 25,567,219 823,938   
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Figure 4-2: Myc binding sites in Drosophila cells3 
 
A. As an example of a binding site in S2 cells Myc binding to the Fibrillarin locus is shown. 
Strong binding is observed with mouse α-Myc antibodies in naïve S2 cells (1st lane), but not 
upon Myc depletion (2nd lane) or with control mouse IgG (3rd and 4th lane); the grey box marks 
the Myc binding peak as called by the software MACS, the asterisk shows a consensus E-box. 
Chromosomal coordinates (on chromosome 2R) are indicated below the traces, as are the ex-
tents and orientations of genes in this region. 
B. Venn-diagram of the number and overlap of binding sites resulting from three independent 
ChIPseq experiments in Drosophila S2 and Kc167 cell lines.  
C. ChIP-qPCR of control regions. Chromatin was isolated from 975 wing discs, precipitated with 
rabbit α-Myc or control IgG antibodies and assayed by qPCR for enrichment of the indicated 
loci. Error bars indicate SD of technical triplicates. 
D. ChIPseq profile of Fibrillarin as an example of a Myc binding site in wing imaginal discs. 
Weak binding is observed with rabbit α-Myc antibody as well as for control rabbit IgG and input 
control; the asterisk shows the consensus E-box. Chromosomal coordinates are indicated below 
the traces, as are the extents and orientations of genes in this region. 
 
The 263 peaks which were found in the two different ChIPseq experiments performed 
in S2 cells fit to the number of Myc binding sites found in DamID experiments per-
formed by Orian et al. (2003), where they identified 287 Myc binding sites in DamID 
experiments. On the other hand the number of binding sites is smaller than the nearly 
4000 sites reported by Yang et al. (2013) who performed their ChIPseq in Kc167 cells 
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and used a different antibody (Santa Cruz, rabbit α-Myc). To exclude major differences 
between the different cell lines, ChIPseq with chromatin from Kc167 cells was per-
formed, using the rabbit α-Myc antibody (G. Morata) and control IgGs (Table 4-2). 
Analysis of the data led to the identification of 279 Myc binding sites, of which 110 
overlapped with those found in S2 cells. As the background binding in the Kc167 cells 
was substantially higher than in the S2 cells, only 21 binding sites were statistically 
significant (FDR < 10%; of which 19 overlap peaks in S2 cells, Figure 4-2 B). Since the 
majority of binding sites overlapped or was non-specific, major differences between the 
cell lines were excluded.  
To get additional data about Myc binding in vivo, almost 1000 wing discs were isolated 
from wandering larvae and further processed for ChIPseq, using the rabbit α-Myc anti-
body or rabbit IgG control. The qPCR showed good enrichment over IgG for Nop5 
(0.3% ± 0.06% of input vs. 0.09% ± 0.08% of input) but not for the negative control 
Pka-C1 (0.09% ± 0.09% of input vs. 0.04% ± 0.02% of input; Figure 4-2 C). Preparation 
of the library worked well, resulting in similar DNA concentrations after PCR enrichment 
as obtained for S2- and KC-cells (data not shown). The sequencing of the DNA-library 
had only low reads (Table 4-3), but since 68% to 76% of all reads mapped to a single 
position in the Drosophila genome, the sequencing depth was probably sufficient. 
However, no binding site with a false discovery rate below 0.1 was called. Even the 
strong Myc target genes, e.g. fibrillarin showed unspecific binding in input and IgG con-
trol (Figure 4-2 D). Unfortunately it is not possible to distinguish whether this is due to a 
lower amount of Myc in wing discs compared to S2 or Kc167 cells or if technical differ-
ences in ChIP progression led to these results.  
 
Table 4-3: ChIP-sequencing reads of wing imaginal disc cells  
chipped with rabbit α-Myc. 
Sample Total reads Single 
alignment 
No     
alignment 
Naïve α Myc 5,893,418 4,267,658 598,248 
Naïve IgG 4,034,230 2,766,320 527,988 
Naïve Input 5,683,989 4,302,615 262,376 
4.1.3 Investigation of Myc binding sites identified by Yang et al. 
To exclude that several binding sites might have been missed due to epitope masking, 
ChIP experiments with the Santa Cruz (SC) antibody were performed with several Myc 
binding sites detected by Yang (3.1.15) (Figure 4-3 A). The ChIP signals at the positive 
controls Nop5 and Uhg1 (4.1.4) showed a strong enrichment compared to IgG (146 
fold and 176 fold) which was drastically reduced after Myc depletion (34.4 fold and 10 
fold). Also several of the Yang binding sites showed a strong enrichment over IgG (e.g. 
2679, 1421, and 1234). The enrichment over IgG in naïve and Myc depleted cells is 
stronger for the Santa Cruz antibody than for the mouse α-Myc antibody (compare 
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Nop5 in Figure 4-1 B and Figure 4-3 A). This might me due to a higher sensitivity of 
Santa Cruz antibody or a better ratio towards the rabbit IgG. Indeed, quantification 
(ImageJ2 software) of the western blot signals (Figure 4-3 C) reveals that the Santa 
Cruz antibody still detects 3% of the Myc signal after Myc-kd, whereas the mouse α-
Myc antibody only detects 1.5% of residual protein. However, Yang et al. did not in-
clude any control ChIPs with non-immune IgGs or from Myc depleted cells and there-
fore we checked for the enrichment over IgG after Myc knockdown. Most of the sites 
exhibited only poor or no reduction after Myc knockdown (1421, 505, 1503), whereas 
some (2679, 193, 429, 1234) even displayed increase. Furthermore we looked at the 
ChIPseq traces of the selected Yang peaks (Figure 4-3 B), obtained with the mouse α-
Myc antibody (4.1.1). In all the ChIPseq traces a clear peak can be seen for the α-Myc 
ChIP in naïve cells. However these peaks are also present in the unspecific IgG con-
trol, after Myc depletion as well as in the input sample, indicating that these regions 
might be enriched in the library. Since the specificity of the antibody was never shown 
before, western blot analysis was performed (3.3.4) with naïve and Myc-depleted cells 
and incubated either with the mouse α-Myc or the rabbit α-Myc (SC) antibody (Figure 
4-3 C). Both antibodies detect Myc on the western blot and, as expected the Myc 
knockdown is highly efficient. The commercial antibody, however, detects an additional 
band which is unaffected by the knockdown. Hence the non Myc specific ChIP signal 
might correspond to this background reactivity of the Santa Cruz antibody. 
Since a large fraction of binding sites, obtained by Yang et al., (2013) are non Myc 
specific, and we only identified 265 binding sites in three different ChIPseq setups, we 
consider these sites to be the core set of Myc target genes. 
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Figure 4-3: Analysis of Myc binding sites published by Yang et al.3 
 
A. ChIP-qPCR of Yang peaks. Chromatin was isolated from naïve S2 cells or from S2 cells de-
pleted of Myc, precipitated with rabbit α-Myc (SC) or control IgG antibodies and assayed by 
qPCR for enrichment of the indicated loci. Error bars indicate SD of technical triplicates. 
B. ChIPseq traces obtained with the mouse α-Myc antibody or with mouse control IgG. Myc 
binding is observed in all lanes. The grey boxes mark the Myc binding peak as called by the 
software MACS. Chromosomal coordinates (on chromosomes 3L and 3R) are indicated below 
the traces. 
C. The Western blot illustrates the efficiency of Myc depletion; the asterisk points to the Myc 
band at ca.107 kDa, the arrowhead to a band presumably arising from post-translational modifi-
cation of Myc. The Santa Cruz antibody detects an additional band slightly above this modifica-
tion of Myc which is unaffected by Myc depletion (arrow). The lower panel shows the loading 
control, blotted against α-Tubulin. 
4 Results 61 
4.1.4 Myc binds to Uhgs 
Amongst the Myc bound genes we found a group of targets which had not been de-
scribed before. Four out of seven U-snoRNA host genes (Uhgs) and a putative novel 
Uhg were found to be bound (Uhg1, 2, 4, 5; Figure 4-4) and carry an E-box motif. The 
Myc binding sites of Uhg1, 2 and 5 are centered on the consensus E-box whereas the 
Myc binding site for Uhg4 is located in close proximity.It is very likely that the 2R-
cluster is a novel Uhg locus, since it consists of three snoRNAs on chromosome 2R 
that are arranged in tandem and are flanked by a consensus E-box (Figure 4-4), which 
is strongly bound by Myc. However, a first trial to amplify the whole gene region failed 
(data not shown). It remains open if the selected oligonucleotides and the PCR condi-
tions were not optimal for the amplification or if the 2R-cluster is no novel Uhg.  
 
Figure 4-4: Myc binds U-snoRNA host genes3 
 
ChIPseq profiles of Uhg1, Uhg2, Uhg4, Uhg5 and Uhg7 plus a putative novel Uhg, the so called 
2R-cluster. Strong binding is observed with mouse α-Myc antibodies in naïve S2 cells (1st lane), 
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but not upon Myc depletion (2nd lane) or with control mouse IgG (3rd and 4th lane); the grey 
boxes mark the Myc binding peaks as called by the software MACS, the asterisk show consen-
sus E-boxes. Chromosomal coordinates are indicated below the traces, as are the extents and 
orientations of genes in this region. 
The binding of Myc to the E-box was confirmed by ChIP experiments including Nop5 as 
positive and Pka-C1 as negative control (Figure 4-5 A), using the rabbit α-Myc antibody 
(SC). The binding to the different Uhg genes is highly enriched over IgG in control cells 
but not after Myc depletion (Table 4-4, rabbit α-Myc (SC)). The negative control Pka-C1 
shows no difference in enrichment between naïve and Myc depleted cells (naïve: 10.4 
fold; kd: 6.4 fold). Uhg1 was used as a positive control in further experiments. The 
ChIP was also performed using the mouse α-Myc antibody, also showing a strong re-
duction of Myc binding to the Uhgs after Myc depletion (78%-94%; data not shown). 
The enrichment over IgG, however, is much weaker compared to the rabbit α-Myc an-
tibody (SC), probably corresponding to a higher background binding of the mouse IgGs 
(Table 4-4, mouse α-My). 
 
Table 4-4: Enrichment over IgG in control and Myc depleted cells 
The enrichment data of the rabbit α-Myc (SC) antibody refer to Figure 4-5 A. The qPCR data of 
the mouse α-Myc ChIP are not shown. 








Nop5 146 fold 34.4 fold Not done Not done 
Uhg1 176 fold 10 fold 5.2 fold 0.55 fold 
Uhg2 196.3 fold 11.9 fold 3.3 fold 0.47 fold 
Uhg4 35.9 fold 3.5 fold 2.6 fold 0.41 fold 
Uhg5 13.5 fold 10.5 fold 1.4 fold 0.45 fold 
2R-cluster 77.8 fold 10.4 fold 3.5 fold 0.5 fold 
Since Myc cannot homodimerize and bind to E-boxes on its own it is likely that all E-
box dependent Myc targets require the association with Max for their regulation 
(Steiger et al., 2008). To address the question whether the binding and regulation of 
snoRNAs by Myc requires Max, ChIP was performed 48 hours after Max knockdown 
using rabbit α-Myc antibody (SC). The presence of Max had to be tested indirectly via 
qRT-PCR, since no α-Max antibody was available that efficiently recognizes endoge-
nous Max protein and can be used for Western blot. The qRT-PCR was performed 24 
hours after Max knockdown since Max protein has a half-life of less than 10 hours 
(Steiger et al., 2008), and protein levels should reflect mRNA levels 12-24 hours after 
mRNA measurement. Rab6 and Snm158 were used as housekeeping genes and the 
values of the knockdown samples were normalized to the values of the naïve samples 
(Figure 4-5 B’). While the relative expression of the housekeeping genes is unaffected 
by Max depletion, Myc levels are slightly increased (114% ± 28%), testifying that the 
repressing effect of Max upon Myc is reduced. Max mRNA levels are strongly reduced 
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after 24 hours (6.1% ± 2.5%) suggesting that 24 hours later Max protein levels are also 




Figure 4-5: Binding of Myc to Uhgs is Max dependent3 
 
A./B. ChIP-qPCR of Uhg loci. Chromatin was isolated from naïve S2 cells or from S2 cells de-
pleted of either Myc (A.) or Max (B.), precipitated with rabbit α-Myc (SC) or control IgG antibod-
ies and assayed by qPCR for enrichment of the indicated loci. Fibrillarin (Fib), nop60B (B.) and 
Nop5 were used as positive, Pka-C1 (B.) as negative control. The error bars indicate SD of 
technical triplicates. B. Similar results were achieved with the mouse α-Myc antibody 
B’. qRT-PCR of Myc and Max after Max knockdown. Total mRNA was isolated from naïve S2 
cells or from S2 cells depleted of Max and transcribed into cDNA. Rab6 and snm158 were used 
as housekeeping genes and the values of the knockdown samples were normalized to the val-
ues of the naïve samples. Error bars indicate SD of technical triplicates. 
B./B’. Experiments are representative of biologically independent duplicates. 
 
After Max knockdown, Myc binding to the positive controls Fibrillarin and Nop5 is 
strongly reduced (Fib: 82.3%; Nop5: 71.1%; Figure 4-5 B). For Nop60B (54.4%), Uhg4 
(59.4%), Uhg5 (56.1%), and 2R-Cluster (59.3%) the binding is decreased by at least 
50%. The binding at Uhg1 and Uhg2 is also reduced but to a lesser extent (Uhg1: 
42.8%; Uhg2: 33.9%). Since loss of Max reduced the recruitment of Myc to these 
promoters the binding of Myc to the Uhgs presumably involves Myc-Max heterodimers. 
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4.1.5 Ribosome biogenesis and ribosome protein genes are the core Myc 
targets  
The ChIPseq experiments lead to the discovery that Uhgs are a novel class of Myc 
target genes and the question arose whether they are directly regulated by Myc. To 
determine, if this is the case, Maria Stauch (pers. com.) performed high-throughput 
RNA sequencing (RNAseq) to globally detect Myc dependent changes in expression 
levels. To obtain a greater amount of less abundant transcripts, RiboMinusTM technolo-
gy was used, which selectively depletes ribosomal RNA molecules, regardless of the 
presence of a 5’-cap structure or their polyadenylation status. M. Stauch performed 
RNAseq in biologically independent triplicates for naïve and Myc depleted S2 cells. 
Only genes were kept for final analysis, which had more than 10 reads combined in all 
six samples and had a predicted transcript size of more than 125 nt. A cutoff at 125 nt 
was chosen due to technical reasons. From the resulting 8019 genes, 281 genes were 
differentially expressed in naïve compared to Myc-depleted S2 cells (p ≤ 0.05). From 
these 281 genes, the majority was down regulated after Myc knockdown and only a 
few were up regulated (240 vs. 41) (Herter et al., 2015). A comparison of expression 
and binding data showed that 254 of the bound genes are also regulated by Myc in at 
least one experiment (0 ≤ p ≤ 1). After Myc knockdown, 139 of the Myc bound genes 
are down regulated by at least one third (fold change ≤ 0.65) whereas 59 genes are up 
regulated by at least one third (fold change ≥ 1.34). Since these 59 genes were not 
enriched for any process and showed a poor overlap between different data sets in 
contrast to the Myc-activated genes, they were not analyzed further. The other 56 
genes were altered by less than one third in response to Myc-depletion, implying that 
Myc most probably has no effect on their regulation, and were not further considered in 
the analysis. 
The 139 genes which are bound by Myc and require Myc for their full expression were 
considered as the core set of directly activated Myc genes. GO (Gene Ontology) term 
analysis (GOrilla tool) and manual analysis revealed that the majority of these genes 
(112; 81%) play a role in ribosome biogenesis and in translation (Table 4-5, Herter et 
al., 2015), including synthesis of ribosomal RNA by RNA polymerase I (Pol I) (van 
Riggelen, 2010). Due to the depletion of rRNAs with RiboMinusTM technology, no direct 
binding of Myc to rRNA loci is observed. Instead components or cofactors of Pol I (e.g. 
Rpl135, Rbp5; Table 4-5) are bound and regulated by Myc, which confirms that the 
regulation of rRNA synthesis by RNA Pol I is indeed indirect in Drosophila (Grewal et 
al., 2005).  
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Table 4-5: Directly Myc-activated genes, sorted by biological category3 
Function Number Genes 
RNA Pol I activity 7 Rpl135, Rpb5, CG18600, mod, vig, CG7911, 
CG42358 
snoRNP function 15 Fib, hoip, Nop5, Nop56, Nop60B, NHP2, 
CG11180, CG4038, CG7637, Nopp140, Uhg1, 
Uhg2, Uhg4, Uhg5, Uhg7 
40S subunit assembly, pro-
cessing, maturation 
18 Bka, l(3)07882, CG9253, CG9799, CG30349, 
U3-55K, l(2)k09022, l(2)34Fd, CG12050, 
CG5728, CG7338, bys, CG11660, l(1)G0004, 
CG2691, CG15027, Eap, mat89Ba 
60S subunit assembly, pro-
cessing, maturation 
17 Nnp-1, CG8801, CG13096, CG11583, CG1785, 
CG32409, CG8939, RpLP0-like, Dbp73D, 
CG8545, CG5114, CG9630, ns1, Surf6, vas, 
CG8414, CG10286 
processing of both subunits 1 Ip259 
40S ribosomal subunit 19 RpS5a, RpS27A, RpS14a, RpS15Aa, RpS13, 
RpS20, RpS28b, RpS23, RpS16, RpS30, 
RpS27, RpS8, RpS7, RpS25, RpS10b, RpS24, 
RpS26, RpS4 RpS2 
60S ribosomal subunit 21 RpL7, RpL13, RpL11, RpL22, RpL9, RpL29, 
RpL14, RpL3, RpL10, RpL23A, RpL17, RpL24, 
RpL21, RpL18, RpL10Ab, RpL34b, RpL6, RpL5, 
RpL41, RpL30, RpL24-like 
Mitochondrial ribosome 2 mRpS17, mRpS14 
Translation factors 6 Ef2b, Ef1beta, eEF1delta, CG7414, bic, eIF6 
tRNA processing, maturation 6 La, l(1)G0045, JhI-1, CG8097, CG1074, 
CG31381 
Total Ribi and translation 112  
Metabolism 5 r, Sam, CG5599, SpdS, CG11089 
Transcription, RNA pro-
cessing 
5 Nap1, Elp2, Elp1, Dis3, CG31759 
Mitochondrial function 4 Hsc70-5, CG2059, CG3085, Spargel 
Other, unknown 13 FK506-bp1, FK506-bp2, CG16833, msk, 
CG12909, CG6550, Ufd1-like, CG5535, 
CG8132, CG2003, CG42672, CG9286, CG9300 
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Via RNA polymerase II (Pol II), Myc controls several genes coding for components of 
small nucleolar ribonucleoproteins (snoRNPs), including Fibrillarin (Fib), hoi-polloi 
(hoip), Nop5 and various Uhgs, and therefore controls the post-transcriptional modifica-
tions in general. Furthermore, Myc targets control genes essential for the maturation of 
the 40S (18 genes) or the 60S subunit (17 genes) and Myc induces the expression of 
components of the small (19 genes) and the large (21 genes) ribosomal subunits, as 
well as for the mitochondrial ribosome (2 genes). Additionally, Myc induces the expres-
sion of translation factors (6 genes) and of genes involved in tRNA maturation (6 
genes).  
4.1.6 Myc binds promoter-proximal sequences 
Considering the ChIPseq experiments described above, performed in different cell lines 
and with different antibodies (4.1.2), a core set of 265 Myc binding sites could be identi-
fied. In total, these 265 binding sites affect potentially 279 genes since some of the Myc 
binding sites are located close to more than one transcriptional start site (TSS). This is 
due to the high gene density in Drosophila. The majority of binding sites are located 
within 100 bp from the nearest TSS (58%) and 80% of the binding sites map in less 
than 1000 bp from a TSS (Figure 4-6 A), suggesting that Myc preferentially binds to 
promoter proximal sequences. This preference gets even clearer when only binding 
sites are considered which cover a canonical E-box (red line, Figure 4-6 A). In this 
case, 77% of all binding sites map within 100 bp and 93% within 1000 bp from the Myc 
binding summit. 
To identify sequence motifs that are associated with Myc binding sites, the MEME-
ChIP algorithm within the MEME suite was used (Machanick and Bailey, 2011). For this 
purpose a region ± 100 bp around the summit of a Myc peak was analyzed. As ex-
pected, the most highly enriched motif (46.7% ≙ 79 peaks, E=2.3*10-60) amongst the 
169 Myc bound and activated genes (4.1.5) is the extended E-box sequence 
“[AA]CACGTG[CG]” (Hulf et al., 2005) (Figure 4-6 B). Another highly enriched motif 
(26.0% ≙ 44 peaks, E=3.0*10-19) is the DNA replication element (DRE) “ATCGATA[G]”  
(Figure 4-6 B’) which has been found to be associated with Myc target genes (Orian et 
al., 2003). A third motif was also found to be enriched in Myc bound and down 
regulated genes (33.1% ≙ 56 peaks, E=1.1*10-36), but its physiological binding partner 
is unknown (Figure 4-6 C). The E-box and the third motif were centrally enriched at the 
summit, suggesting that Myc directly binds to these motifs. Since the DRE motif is not 
enriched centrally around the summit of the Myc peak, it is likely that Myc binding at the 
DRE sites is indirect and mediated by binding partner. 
For the Myc bound and up regulated genes (85 genes) a single motif was enriched 
(30.6% ≙ 26 peaks, E=1.2*10-13), for which the physiological binding partner is un-
known, too (Figure 4-6 D). 
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Figure 4-6: Myc binding sites in Drosophila3 
 
A. Position of Myc binding peaks relative to the nearest transcription start site (TSS). Data are 
grouped in 100-nt bins for a distance of up to 1’000 nt from the TSS and in 1’000-nt bins for 
distances between 1’000 nt and 10’000 nt, and shown as percent of all 265 peaks. Grey bars 
show all Myc binding peaks, the purple line only the Myc binding peaks containing a canonical 
E-box. Horizontal lines above the graph illustrate windows of ± 100 nt and ± 1’000 nt around the 
TSS.  
B./B’./C. MEME analysis showing the most strongly enriched motifs in 169 Myc bound genes 
which were down regulated after Myc knockdown (RNAseq data M. Stauch: 4.1.4). For the 
analysis, 100 bp around the summit of the Myc peaks were used.  
D. MEME analysis showing the most strongly enriched motif in 85 Myc bound genes which were 
up regulated after Myc knockdown (RNAseq data M. Stauch: 4.1.4). For the analysis, 100 bp 
around the summit of the Myc peaks were used.  
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4.1.7 Myc regulates Uhgs and snoRNAs 
As already shown in 4.1.5, Myc depletion led to 240 significantly downregulated genes 
(p<0.05) (Herter et al. 2015) amongst which 36 did not code for proteins, but for 
snoRNAs. The Drosophila genome is predicted to encode 288 snoRNA with sizes from 
46 to 316nt (flybase.org4
To analyze the effect of Myc depletion on several box C/D snoRNAs, qRT-PCR was 
performed. The corresponding box C/D snoRNAs host genes, Uhg1, 2, 3, 4, 5, 7 and 
Uhg8 were also included (
 and Huang et al., 2005). All snoRNAs which passed the cutoff 
of 125nt and were detectably expressed in S2 cells (103) were strongly downregulated 
after Myc knockdown (Herter et al., 2015). Among these, most of the box H/ACA 
snoRNAs were found, whereas the majority of box C/D snoRNAs were not detected in 
the RNAseq experiments since they were smaller than the cuttoff used. The exonic 
Uhg transcripts, hosting 48 snoRNAs in total, were found to be downregulated after 
Myc knockdown in the RNAseq data sets, too (Herter et al., 2015). 
Figure 4-7 A). No snoRNA hosted in Uhg7 was analyzed 
because I was not able to design functioning qRT-PCR primers. All selected snoRNAs, 
as well as the Uhg genes, were strongly downregulated after Myc depletion (40%-49% 
and 20%-55% of control transcripts, respectively). Nop60B which was formally known 
as Uhg6 also shows a strong reduction (30% of control transcripts). Fibrillarin (10% of 
control transcripts), a well established direct transcriptional target of Myc was used as 
positive control. 
To determine if Myc is also able to increase the expression of the snoRNAs and the 
Uhg genes, Myc was overexpressed in an inducible cell line (S2pMT-Myc), stably 
transfected with a plasmid containing HA-Myc under the control of the Drosophila 
metallothionein (MT) promoter. The MT-promoter is inducible by addition of copper 
sulfate and allows transient expression of the protein of interest. Six hours after Myc 
induction, an increase on protein- (Figure 4-7 C) as well as on RNA-levels can be 
observed (75 fold; data not shown). Transient overexpression of Myc is sufficient to 
increase the expression of the snoRNAs and their host genes to supraphysiological 
levels (121%-272% of control transcripts) (Figure 4-7 B). Taken together, the qRT-PCR 
data confirm the results of the RNAseq experiments and show that also the short box 
C/D snoRNAs are controlled by Myc. 
                                                 
4 flybase.org; FB release 2014_6 
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Figure 4-7: Myc directly regulates snoRNAs3 
 
A./B. The averages of the three reference genes rab6, snm158 and α-Tubulin were used as 
housekeeping genes and were set to 100%. Error bars show standard deviations of biologically 
independent duplicates. Spliced transcripts from each Uhg host gene are grouped with selected 
snoRNA(s) hosted within the intron of the corresponding Uhg gene, except for Uhg7 where no 
functioning qRT-PCR primers could be designed for the intronic snoRNAs. A. qRT-PCR after 
Myc knockdown: RNA levels were assayed 24 hours after addition of Myc-dsRNA to S2 cells. B. 
qRT-PCR 6 hours after addition of 125 µM CuSO4 to S2pmt-Myc cells to induce Myc over-
expression. 
C. Western blot of Myc (upper panel) and α-tubulin (lower panel) in control cells and cells over-
expressing Myc 6 h after CuSo4 induction (125 µM). The samples for western blot originate from 
the same transfection as the samples in B. 
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To show that the regulation of the host genes reflects the regulation of the mature 
snoRNAs and to confirm the qRT-PCR analysis of snoRNAs smaller than 125 nt, 
Northern blot analysis was performed (3.1.17) with wildtype or Myc depleted S2 cells. 
The Myc knockdown was confirmed via western blot (Figure 4-8 C). For northern blot, 
either control or Myc depleted RNA was loaded on the acrylamide gel and hybridized 
with 100 µM of the indicated γ-P32-ATP labeled probes (Figure 4-8 A). The blots were 
exposed on a Storage Phosphor Screen (3.1.17) and the quantification of the Northern 
blot signals was performed using ImageJ2 software. The arrowheads point to the 
bands of the predicted sizes (113 nt, 75 nt and 85 nt respectively). After Myc knock-
down the expression of the mRNA is reduced by 23% (snoRNA: Me18S-A1576), 43% 
(snoRNA: Me28S-C2645a) and 38% (snoRNA: Me28S-G2703c) (Figure 4-8 A, B), 
which confirms that mature snoRNAs are affected and not just their immature precur-
sors and fits to the results obtained by qRT-PCR. On the Me28S-G2703c blot a slower 
migrating signal can be seen around 140 nt (asterisk). Its origin is not clear, however it 
possible that it is a differently spliced variant of the indicated snoRNA since the intensi-
ty of the signal is reduced to the same extent as the signal at the expected height. In 
total 10 snoRNAs were investigated of which one additional snoRNA showed a re-
duced signal after Myc knockdown (Or-CD2, data not shown). Four snoRNAs gave no 
(Me28S-A3407a, U14:30Ea) or a very weak signal (Psi28S-2949, Me28S-A2634c) and 
therefore quantification was not possible. Only one snoRNA (Or-CD11) gave a strong 
signal which was not obviously changed after Myc depletion upon visual inspection. 
However, quantification of the northern blot signal showed a reduction of 19.5% (data 
not shown). Since a lot of smear instead of a distinct band was present on the northern 
blot, it was difficult to make a clear statement about signal changes upon loss of Myc. 
Therefore this snoRNA was not further considered. Unfortunately it was not possible to 
use a RNA as loading control since no RNA being unaffected by Myc knockdown in the 
correct size range (50 nt to 180 nt) was detectable. Therefore the same RNA samples 
were analyzed by reverse transcription and quantitative RT-PCR for the reference 
genes snm158 and rab6, as well as for the indicated snoRNAs (Figure 4-8 B). The ex-
pression levels of the depicted snoRNAs fit to the results gained from the Northern blot 
analysis (81.6%, 68.6% and 54.6% relative expression).  
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Figure 4-8: Northern blot analysis3 
A. Northern blot for three different snoRNAs (snoRNA: Me18S-A1576, snoRNA: Me28S-
C2645a, snoRNA: Me28S-G2703c). Arrowheads point to bands of the predicted sizes, the iden-
tity of the cross-reactive slower migrating band in the Me28S-G2703c blot (asterisk) is unclear. 
The locations of molecular weight DNA markers are indicated. 
B. qRT-PCR results and quantification of the Northern blot bands. Rab6 and snm158 were used 
as housekeeping genes and were set to 100%.  
C. Western blot of Myc (upper panel) and α-tubulin (lower panel) in control and Myc knockdown 
cells. The samples for western blot originate from the same transfection as the samples in A 
and B. The experiments shown in panels A, B and C are representative of biologically inde-
pendent duplicates. 
4.1.8 Biological effects of Uhg genes 
In the previous chapters it has been shown, that snoRNAs are a novel class of Myc 
targets. This raises the question whether loss or overexpression of snoRNAs plays a 
role in vivo. To address this question, overexpression and loss of function studies had 
to be performed. The vast majority of snoRNAs are hosted in other, partially growth 
related genes. Therefore we focused on snoRNAs hosted in Uhg genes, since they are 
non-protein coding and their loss should not impair any other growth-relevant tran-
scripts. Anan Uhg1 mutant fly line was established, since it encodes 16 out of 51 
snoRNAs, the largest number of all Uhg genes (Herter et al., 2015).  
The Uhg1 null mutant, Uhg11, was established by imprecise excision of a P-element 
and carries a deletion from the first to the last exon (nucleotides chr2R:13’586’606 to 
13’590’803, Figure 4-9 A). As a consequence the coding regions for all snoRNAs are 
eliminated. The attempt to establish an Uhg5 null mutant failed, while other Uhgs did 
not contain appropriate or available P-elements to establish a mutant. In the following 
experiments, a wildtype revertant, Uhg1rev, was used as control. The genomic se-
quence of the Uhg1 mutant revealed that the neighboring coding regions of Uhg1 were 
not affected. To investigate whether their expression was affected, qRT-PCR was per-
formed, using total RNA, isolated from wandering larvae of mutant and control animals 
(Figure 4-9 B). Rab6, α-Tubulin and Snm158 were used as housekeeping genes and 
the expression of Uhg1 and of the neighboring genes, CG6424 (77% ± 25%), 
RdgBβ (114% ± 23%) and CR45146 (103% ± 18%), was normalized to their average. 
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While the expression of the three neighboring genes is not strongly affected by the loss 
of Uhg1, Uhg1 expression is strongly reduced to 10.9% ± 2.5%. Since Uhg11 is a null 
mutant, a weaker amplification product was expected. To investigate whether the am-
plification product derives from maternally deposited RNA or from an experimental 
background, the melting curve and the migration of the amplification product were ex-
amined (Figure 4-9 B’ and data not shown). The melting curve and the migration be-
havior of the amplified product from Uhg11 larvae differ from control, showing no clear 
peak for a specific temperature and a differently sized product. Thus the amplification 
product presumably corresponds to a non-specific product.  
  
Figure 4-9: Loss of Uhg1 does not affect its neighboring genes3 
 
A. Uhg1 locus with adjacent genes. Black arrows indicate direction of transcription, grey boxes 
correspond to exons, purple boxes to introns, respectively, and purple boxes show snoRNAs. 
The asterisk represents the single E-box. 
B. Expression of Uhg1 and the neighboring transcripts in Uhg11 mutant wandering larvae. Ex-
pression was normalized to the average of the 3 housekeeping genes rab6, α-Tubulin, and 
snm158. The graph shows the average and standard deviations of three biological replicates. 
B’. The Uhg1 amplification product from mutant larvae shows an aberrant melting curve. De-
picted are the melting curves of technical triplicates from Uhg1rev and Uhg11 samples. 
 
Yoshihama and colleagues (2013) have predicted the target sequences for several 
snoRNAs, including the snoRNAs hosted in Uhg1. These snoRNAs exclusively affect 
2’-O-ribose-methylation of 18S- and 28S-rRNA at five positions (18S:A28, 28S:A1666, 
28S:G3081, 28S:G3277 and 28S:A3407). This implies, that these positions should not 
be methylated upon loss of Uhg1. Therefore methylation mapping by primer extension 
(3.4.5) was performed to visualize the consequences of the loss of the snoRNAs on 2’-
O-ribose-methylation at the expected nucleotides. This method uses primer extension 
by reverse transcriptase at low dNTP concentrations (Maden 2001; Motorin et al., 
2007) and is based on the observation that reverse transcriptase pauses or slows 
down at nucleotides which are methylated at the 2’-O-ribose. With decreasing dNTP 
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concentration the pause should be longer and therefore a stronger signal should be 
detected. Because of the halt, the following methylated site should show a weaker 
signal. Thus it is necessary that beside the site of interest, at least one other site, 
methylated by an other box C/D snoRNA, not hosted in Uhg1 is visible on the gel. The 
sequencing gel only allows to display a sequencing product of up to 100 nt, with the 
best resolution at 20-60 nt after start of the reverse transcription. Therefore one or two 
methylated sites should flank the site of interest in this 40 nt window. Since no flanking 
sites are present for 18S:A28 inside the 40 nt window, it was not further analyzed. The 
methylation mapping (3.4.5) was performed using total RNA from larvae being mutant 
(Uhg11) or wildtype (Uhg1rev) for Uhg1.  
For 28S:A3407 the sequencing always stopped before base A3407 and no further 
bands could be detected. This is probably due to a long pause at C3403, which caused 
a lack of reverse transcriptase or of the available dNTPs (data not shown). For the 
other three positions the expected effect was detected (Figure 4-10 C). The band which 
can be seen in the Uhg1rev samples at the indicated position (reverse letters with 
asteriks) is strongly reduced (A1666) or not present at all (G3277, G3081) in the Uhg11 
samples. In comparison no difference between the samples can be seen for bands 
which are unaffected by loss of Uhg1 (e.g. C3113). With decreasing dNTP 
concentrations (10 mM to 1 mM) the band intensity increases for all three methylation 
sites. For 28S:G3081 the intensity at 0.5 mM (dNTPs) is weaker than at 1 mM. This 
was expected since a methylation site which is unaffected by the loss of Uhg1 pauses 
the reverse transcriptase at C3113 (methylated by 28S:G3113, hosted in CG13900). 
With the G3277 primers, almost no signal can be seen at 0.1 mM dNTPs. Since this is 
the case for the mutant and the control lane it is very likely that the dNTP concentration 
was already too low for this sequence context. The sites being methylated by other box 
C/D snoRNAs, not hosted in Uhg1 (A1688, G3341) which were expected to influence 
28S:A1666 and 28S:G3277 are not detectable or unchanged. At position A1688 this 
might be due to the long pause at C1698 which is not methylated or modulated in an 
other specific way at the corresponding nucleotide. Position G3341 is probably too far 
away to have an influence on the halt at G3277. The additional bands visible on the 
sequencing gel might be due to other modifications of the nucleotides or due to random 
stops of the transcriptase (Motorin et al., 2007). 
Summing up the data obtained from the methylation assay, it can be stated that loss of 
Uhg1 and therefore its snoRNAs indeed leads to loss of methylation at five specific 
ribose residues and might therefore affect ribosome assembly and activity. 
 
4 Results 74 
 
Figure 4-10: Loss of Uhg1 leads to decreased O'-ribose-methylation of 28S rRNA 
 
Methylation mapping by primer extension for three different positions, 28S-A1666, 28S-G3081 
and 28S-G3277 affected by the loss of Uhg1. For every reverse transcription reaction, 8 µg of 
total RNA (Uhg1rev or Uhg11) were used and either 10 mM, 1 mM or 0.5/0.1 mM dNTPs. The 
lines A, C, G and T refer to the sequencing ladder. Here 0.167 µg of total RNA, 0.4 mM dNTPs 
each and 0.5 mM of ddATP, ddCTP, ddGTP or ddTTP were used. The numbers indicate the 
corresponding nucleotide of Uhg1; the letters with the asterisk indicate the methylation site of 
interest. Due to the reverse transcription, the nucleotides appear in reverse order.   
4.1.9 Uhg genes affect growth in vivo and tumor formation 
As shown previously (4.1.8), the Uhg1 null mutant affects 2’-O-ribose-methylation at 
specific positions and thus could affect ribosomal assembly and/or activity. To 
investigate whether the ribosomal activity is suppressed, translation assays were 
performed with each 10 Uhg11 and Uhg1rev wandering larvae (3.4.6). Following a 30 µl 
incubation time, the content of incorporated 3H-Amino-acid-mix was measured to serve 
as a read out for newly synthesized protein. The animals do not differ in weight (data 
not shown) or protein content (cold protein Uhg11: 124% ± 50%; p=0.8) (Figure 4-11 
A). However, the amount of newly synthesized protein in mutant larvae (Figure 4-11 A, 
hot protein) was reduced by 22.1% ± 3.6% compared to control animals (p=0.00045). 
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This significantly lower protein synthesis rate of the Uhg1 mutant animals is 
accompanied by a delay in development. Adult flies eclose about 12 hours later than 
control animals and female Uhg11 flies show a strongly reduced fertility (Herter et al., 
2015). Together the developmental delay and the female specific sterility are often 
seen in mutations in pathways affecting growth, which have been observed before for 
hypomorphic mutations in Myc (Johnston et al., 1999). To investigate whether Myc’s 
function is dependent on the presence of Uhg1, Myc was overexpressed in either 
wildtype (Myc OE) or Uhg1 mutant (Myc OE/ Uhg11) animals using hs-Flp in combina-
tion with actin-Gal4/FRT. In this setup, the presence of a FLP-out cassette prevents the 
actin promoter from triggering Gal4 expression. Upon heat shock (1 h) the transcription 
of Gal4 in cells in which the FLP-out cassette has been excised takes place and sub-
sequently expression of Myc (Steiger et al., 2008). The different genotypes are listed in 
Table 2-3. For each genotype an equal number of female wandering larvae (varying 
between 4 and 11 for the 5 different assays) were processed as described above and 
in 3.4.6. Due to the developmental differences of the genotypes, Uhg1rev and Myc OE 
larvae were collected 70 hours after egg deposition, whereas the timespan between 
egg deposition and collection of the Uhg11 and Myc OE/ Uhg11 larvae was approxi-
mately 12 to 15 hours longer. Myc overexpression was induced by a single heat shock 
(37°C; 1 h), 54 h (Uhg1rev and Myc OE) and 69 h (Uhg11 and Myc OE/ Uhg11) after egg 
deposition, respectively. All animals were collected and sacrificed 16 h ± 2 h afterwards 
and protein synthesis assay was performed (see above). To allow a better comparison 
between the protein synthesis rates of the different genotypes, the ratio of newly syn-
thesized to total protein was calculated for both genotypes and normalized to the ratio 
measured for Uhg1rev. Overexpression of Myc leads to a massive increase in protein 
synthesis (217% ± 95%; p=0.26) in a wildtype background (Figure 4-11 B). This in-
crease is completely abolished in the absence of Uhg1 (Myc OE/ Uhg11: 51% ± 14%; 
p=0.05) and is even lower than in the mutant alone (Uhg11: 59% ± 17%; p=0.01). This 
can be due to the bad condition of the Myc OE/ Uhg11 larvae, which were recognizable 
thinner than larvae from the other genotypes (pers. observation; data not shown). Why 
the animals were in such a bad condition is not clear. However, we were able to show 
that loss of Uhg1 influences protein synthesis rates. 
Besides effects on wildtype cells and animal growth, the impact of Uhg genes on a Myc 
dependent tumor model was analyzed (Betschinger et al., 2006). Loss of the tumor 
suppressor brat in type II neuroblast stem cell lineages leads to tumor formation that 
depends upon Myc (Figure 4-11 C). The tumor size can be compared via co-
expression of firefly luciferase (Neumüller et al., 2013; 3.4.7). The type II neuroblasts 
are selectively addressed by a combination of the worniu-Gal4 (wor-Gal4) driver which 
is specifically expressed in all neuroblasts and the asense-Gal80 (ase-Gal80) which 
blocks expression in type I neuroblasts (Neumüller et al., 2011). These flies were 
crossed with flies either carrying an UAS-construct for overexpressing different Uhg 
transgenes (see below), knockdown of Myc, or Uhg11/ Uhg1rev flies. Adult males were 
collected 12 hours after eclosion and processed for luciferase measurement (3.4.7). 
Luciferase values were normalized to control animals (“yw”). While luciferase values in 
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wildtype type II neuroblasts are not influenced by depletion of Myc (96% ± 15%), lucif-
erase levels are highly impaired after brat knockdown (81% ± 19%, p=0.004; Figure 
4-11 C). Loss of Uhg1 (Uhg11) does not lead to a reduction in luciferase levels (106% ± 
53%) (Figure 4-11 C). It might be possible that the delay in larval development, which 
is caused by the loss of Uhg1, also slows down the tumor growth rate and therefore the 
NBII tumors develop later. In this case, a reduction in tumor growth rate would be 
masked by the loss of Uhg1. Therefore, overexpression of various Uhg transgenes was 
chosen as a different approach. To establish fly lines, the gene regions of the different 
Uhgs, spanning all snoRNA containing introns, were cloned into a pUAST-vector and 
inserted into embryos (M. Gallant and P. Gallant, pers. com.). The oligonucleotides 
used for cloning are listed in Table 2-1. Unfortunately, overexpression of Uhg1 does 
not show an effect on luciferase levels (data not shown). Since the functionality of the 
UAS-Uhg1 transgenes was never tested, it is possible that no effect was observed be-
cause no increase in snoRNA levels was achieved.  
On the other hand, overexpression of two independent Uhg4 (Uhg4/1: 123% ± 32%, 
p=0.027; Uhg4/2: 113% ± 28%, p=0.13) and Uhg5 transgenes (Uhg5/1: 129% ± 21%, 
p=0.000; Uhg5/2: 119% ± 26%, p=0.011) leads to an increase in luciferase levels 
(Figure 4-11 C). No effect is measurable in a wildtype background (Figure 4-11 C; 
black bars).  
The effects on loss of Uhg1 were also investigated in another Myc-dependent tumor 
model (4.2.3), where overexpression of RasV12 and Chinmo in the head capsules (ey-
FLP) (Doggett et al., 2010) leads to severe tumor formation. Also in this tumor model 
neither heterozygous (27% ± 14%) nor homozygous (33 % ± 13%) loss of Uhg1 leads 
to a decrease in tumor size compared to control (32% ± 9%) (Figure 4-11 D). It remains 
open whether an effect in this model could be achieved with depletion of other 
transgenes. However, we were able to show that overexpression of different Uhg 
genes can enhance tumor formation in at least one Myc dependent tumor model. 
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Figure 4-11: Uhg genes affect growth and tumor formation in vivo3 
 
A. Total protein amount (cold) and amino acid incorporation rates (hot) in wandering larvae. 
Ratios (Uhg11/Uhg1rev) and standard deviations are shown for 3 biological replicates each with 
10 larvae for each genotype. Difference to control is p<0.001 (**, Student’s 2-tailed t-test) 
B. Ratio of newly synthesized protein (hot) to absolute protein amount in female wandering lar-
vae, normalized to control (Uhg1rev). Ratios and standard errors (SEM) are shown for 4 biologi-
cal replicates each with 4-11 larvae for each genotype. Difference to control is p≤0.05 (*, Stu-
dent’s 2-tailed t-test) 
C. Luciferase assays from single adult males overexpressing the indicated Uhg-transgenes 
under brat-knockdown (brat-kd) conditions in type II neuroblast lineages. #1 and #2 correspond 
to independent transgenes. Number of individually assayed flies (originating from 2-10 separate 
experiments) are shown in parentheses Error bars indicate SD. In addition to the indicated UAS-
Uhg transgene, the flies carried “worniu-GAL4 asense-GAL80/+; UAS-brat-(inverted repeat) 
UAS-Luciferase/+”. Difference to control is p<0.05 (*) and p<0.005 (**), respectively (Student’s 
2-tailed t-test). 
D. Ratio of the size of fluorescent tissue to the size of whole larvae for the depicted genotypes. 
Ratios and standard deviations were normalized to control (RasV12 + Chinmo). Error bars indi-
cate SD of individually assayed flies shown in parentheses. 
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4.2 Myc and Chinmo interact in growth control 
4.2.1 Chinmo controls growth via cell number 
The zinc finger protein Chinmo was shown to interact with Myc in the process of tissue 
growth and development (Schwinkendorf, 2008) but their interaction was not fully char-
acterized yet. Three different chinmo alleles were characterized, either having a muta-
tion in the zinc finger domain (chinmo110) or lacking it completely (chinmo108, chinmo134; 
Figure 1-8).  
To investigate whether the growth defect was based on reduction of cell size or cell 
number, a FLP/FRT system was used which allows the generation of homozygous mu-
tant clones by site-specific mitotic recombination (Newsome et al., 2000). Expression of 
FLP recombinase under the control of the eyeless regulatory sequences (ey-FLP) re-
stricts the recombination events to the developing head capsule. The mitotic recombi-
nation occurs between two FRT sequences on homologous chromosome arms, of 
which one arm carries the FRT insertion and the mutation of interest and the other arm 
carries a white (w+) marker and a cell lethal (cl) mutation (prevents the survival of ho-
mozygous cells). 
The compound eyes of Drosophila are made out of 600-700 single ommatidia, which 
themselves consist of always 20 cells. Therefore, counting the number of ommatidia 
and measuring the area of the compound eye is sufficient to state whether a reduction 
in eye size is based on differences in cell number or cell size. The eye sections were 
taken by D. Schwinkendorf with the help of a scanning electron microscope (SEM) and 
the numbers of ommatidia of four to five eyes from different adult flies were counted. In 
both, heterozygous (yw eyFLP) and homozygous (yw eyFLP; FRT40 cl w+) head cap-
sules, ommatidial number is reduced for all three alleles compared to control (yw 
eyFLP: 724 ± 13; yw eyFLP; FRT40 cl w+: 711 ± 17) (Figure 4-12 A). In heterozygous 
animals, chinmo110 shows the strongest reduction in ommatidia number (513 ± 55) fol-
lowed by chinmo108 (574 ± 49) and chinmo134 (630 ± 35). The reduction of ommatidia is 
highly significant for all three alleles (p<0.001) compared to control animals (724 ± 13). 
In the homozygous Chinmo mutants (Chinmo-pinheads), the number of ommatidia is 
reduced even more. Here, chinmo108 (329 ± 16) and chinmo134 (353 ± 30) have less 
ommatidia than chinmo110 (391 ± 63), which fits to the observation (Sulzer, 2003; 
Schwinkendorf, 2008) that chinmo108 and chinmo134 have smaller heads than chinmo110 
animals. Also in the homozygous mutant animals the reduction of ommatidia is highly 
significant for the different alleles (p<0.0001) compared to control animals (712 ± 17). 
No difference in ommatidial size was observed (D. Schwinkendorf, unpublished data).  
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Figure 4-12: Chinmo alleles reduce ommatidial number 
 
A. Number of ommatidia of different animals carrying different chinmo alleles in a Myc wildtype 
background. Average and standard deviations are shown for 4 to 5 independent fly eyes, differ-
ence to control is p<0.001 (**) (Student’s 2-tailed t-test). The control chromosome is isogenic 
with the chinmo alleles, heterozygous animals have the genotype “y w tub>Myc>GAL4 ey-
FLP/Y; FRT-40 chinmoX /CyO, y+”, homozygous animals “y w tub>Myc>GAL4 ey-FLP; FRT-40 
chinmoX /FRT-40 cl w+”. 
B. Number of ommatidia of different chinmo alleles in a Myc mutant background. Average and 
standard deviations are shown for 4 to 5 independent fly eyes, difference to control is p< 0.01 
(*) or p<0.002 (**) (Student’s 2-tailed t-test). The control chromosome is isogenic with the 
chinmo alleles, Myc null mutants have the genotype “w dm4 tub>Myc>GAL4 ey-FLP/Y; FRT-40 
chinmoX/ CyO, y+”, the hypomorphic mutants “w dmP0 tub>Myc>GAL4 ey-FLP/Y; FRT-40 chin-
moX/ CyO, y+”. 
 
The effects of Chinmo mutation were also investigated in the Myc null mutant dm4 or 
the hypomorphic Myc mutant dmP0. The defects described above are dramatically ex-
acerbated when both Myc and Chinmo are completely eliminated, i.e. in Myc-null and 
Chinmo-homozygous mutant eyes. While both ey>dm4 mutants and Chinmo-pinheads 
allow normal survival and the development of quite normally patterned eyes, the double 
mutations are fully lethal and do generate at most rudimentary heads (Schwinkendorf, 
2008). Loss of Myc in a Chinmo-heterozygous background leads to a strong reduction 
in ommatidial size, which does not differ significantly between the chinmo alleles (D. 
Schwinkendorf, unpublished data). On the other hand, a partial loss of Myc (dmP0) has 
no influence of the number of ommatidia in a Chinmo-heterozygous background (com-
pare Figure 4-12 A “yw ey-FLP” and Figure 4-12 B “w dmP0 ey-FLP”). Interestingly the 
complete loss of Myc has an influence on the number of ommatidia in control animals 
(520 ± 82) as well as the chinmo-heterozygous alleles chinmo108 (439 ± 64) and 
chinmo134 (411 ± 103). Therefore loss of Myc not only affects cell size but also number, 
whereas Chinmo only affects cell number. 
4.2.2 Myc and Chinmo interact directly 
To be able to detect endogenous Chinmo and to perform immunoprecipitations inde-
pendently of a tag, a Chinmo antibody had to be produced. Therefore the central part 
of Chinmo (aa 132-516) was cloned into the pGEX-4T1 expression vector, neither in-
cluding the BTB/POZ (aa 32-128) nor the zinc finger domains (aa 517-540 and 545-
568). The plasmid was expanded in BL21 bacteria, which enables expression of the 
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GST fusion protein upon induction with Isopropyl-D-thiogalactopyranosid (IPTG). The 
resulting GST-Chinmo protein was purified (3.3.7) and sent to immunoGlobe® for anti-
body production. The resulting antiserum was depleted from α-GST antibodies with the 
help of GST protein only (immunoGlobe®) and finally resulted in the purified rabbit α-
Chinmo antibody (1.21 mg/ml). Both, the crude as well as the purified antibody specifi-
cally recognized Chinmo in Western blots (Figure 4-13 C, E; Figure 4-14 B) and Co-IPs 
(Figure 4-13 D, G). 
To get further insight into the interaction of Chinmo and Myc described on a genetic 
base, D. Schwinkendorf performed several experiments in S2 cells. She was able to 
show that Chinmo overexpression does not affect endogenous and transiently trans-
fected Myc levels. Apart from that, she was able to show that Chinmo can activate the 
transcription of a Myc-dependent luciferase reporter (CG5033; Schwinkendorf, 2008). 
Furthermore, qRT-PCR analysis showed that Chinmo overexpression leads to an in-
crease in some Myc target genes associated with ribosomal biosynthesis (i.e. fibrillarin, 
nnp1). Thus, Chinmo might be a co-activator of Myc, necessary for its biological func-
tions in vivo. This hypothesis raised the question whether Myc and Chinmo interact 
physically and if so, which domains are important for the interaction. Co-
immunoprecipitations (Co-IPs) between transiently transfected Myc and Chinmo 
showed that both proteins interact physically and that the binding site for Chinmo in 
Myc lies between amino acid 1-403, spanning all three Myc boxes but not the basic 
region or the helix-loop-helix/ leucine zipper (Schwinkendorf, 2008). To locate the bind-
ing site for Myc in Chinmo, two different Chinmo mutants were established by deletion 
mutagenesis. In a first step, the Zf- or the BTB/POZ-domain was removed. Chinmo-∆Zf 
lacks amino acids 517-604, spanning the two zinc fingers, and in Chinmo-∆BTB the 
BTB/POZ-domain (amino acids 32-128) are substituted by two amino acids (Thr32 + 
Arg33) (Figure 4-13 A) (Schwinkendorf, 2008). The sequence of the mutant plasmids 
was verified (Schwinkendorf, 2008). 
D. Schwinkendorf was able to co-immunoprecipitate Myc and Chinmo-∆Zf but not 
Chinmo-∆BtB. This might be due to two different possibilities: first, the BTB/POZ do-
main is important for the interaction and second, the Chinmo-∆BTB was unstable and 
could not be precipitated. To investigate these two options, S2 cell were transfected 
with different amounts (0.2 µg, 0.28 µg or 0.35 µg) of the AU1-Chinmo plasmids and 
lysed 48 hours afterwards. GFP (0.05 µg) was co-transfected to monitor the transfec-
tion efficiency. While AU1-Chinmo-wt (62 kDa) and AU1-Chinmo-∆Zf are clearly de-
tectable for all conditions, no bands can be seen for AU1-Chinmo-∆BTB (53 kDa, same 
height as AU1-Chinmo-∆Zf). The transfection worked well since clear GFP bands are 
detectable (Figure 4-13 B). Given that no signal for AU1-Chinmo-∆BTB was detected, it 
is conceivable that a deletion in the BTB/POZ domain decreases Chinmo stability, it is 
not soluble or that it is not expressed by the plasmid. 
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Figure 4-13: Myc and Chinmo interact physically; the BTB-POZ domain and the zinc fin-
ger domain are not important for this interaction 
 
A. Schematic diagram of wildtype and mutant Chinmo protein. Chinmo-∆BTB lacks the 
BTB/POZ domain and Chinmo-∆Zf lacks the complete C-terminus including the two zinc fingers. 
Numbers indicate coordinates of the corresponding deletions with the first and last deleted ami-
no acid. 
B. Western blot of AU1 tagged Chinmo variants. S2 cells were transfected with the indicated 
plasmids in different amounts (0.2 µg, 0.28 µg or 0.35 µg) and harvested 48 h later. The protein 
extracts were analysed by Western. GFP (0.05 µg) was co-transfected to monitor the transfec-
tion efficiency. 
C. Western blot of S2 cells, transfected with the indicated plasmids.  
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D. Western blot of co-IPs between Myc and Chinmo variants. S2 cells were transfected with the 
indicated plasmids and harvested 48 h after transfection. Chinmo-complexes were 
immunoprecipitated with the crude rabbit α-GST-Chinmo antibody and Western blotted with a α-
HA antibody. 
E. Western blot of naïve cells and cells depleted of Chinmo. 5*106 cells were either treated with 
dsRNA against Chinmo or left untreated and were harvested 120 h afterwards. Tubulin was 
used as loading control. 
F. Relative Luciferase levels after overexpression of the indicated plasmids. Lysates were taken 
48 h or 120 h (Chinmo-kd) after transfection. Error bars indicate SD of biological duplicates 
(Myc-kd, GFP-Chinmo-∆BTB and GFP-Chinmo-∆Zf) or triplicates. Relative reporter level (ctr) 
was set to 100%. 
G. Western blot of endogenous IP between Myc and Chinmo variant. Naïve S2 were 
immunoprecipitated with the rabbit α-Chinmo antibody or non-immune rabbit-IgG and Western 
blotted with mouse α-Myc or rabbit α-Chinmo antibody. 
 
To easily monitor the transfection efficiency and potentially stabilize Chinmo-∆BTB, the 
wildtype and the two mutant Chinmo constructs were cloned into a pUAST expression 
vector carrying GFP (2.3.2.2). All proteins were detectable in Western blot experiments 
(Figure 4-13 C). Therefore Co-IPs together with HA-Myc were performed using the 
crude rabbit α-GST-Chinmo antibody and immunoblotted with mouse α-Myc antibody. 
S2 Cells were transfected with either HA-Myc alone or in combination with one of the 
GFP-Chinmo constructs, harvested 48 hours later and processed for 
immunoprecipitation (3.3.6). Figure 4-13 D clearly shows that both mutants are still 
able to interact with Myc and therefore the BTB/POZ-domain is presumably not im-
portant for the physical interaction between Myc and Chinmo. The stronger signal for 
the mutants compared to the wildtype can be explained by the weaker intensity of 
Chinmo-wt in the input sample. Also a weak interaction of HA-Myc in the absence of 
any GFP-Chinmo construct can be seen, however the Co-IP is much stronger. To fur-
ther investigate the Myc binding site in Chinmo, six more Chinmo deletions were estab-
lished, lacking a different number of amino acids either at the C- or the N-terminus, 
which still need to be tested.  
Since the BTB/POZ-domain is presumably not the Chinmo-Myc interaction domain, the 
luciferase assay performed by D. Schwinkendorf was repeated to investigate whether 
Chinmo-∆BTB is also able to transactivate Myc target genes. S2 cells were transfected 
with either AU1-Chinmo-wt or the different GFP-Chinmo plasmids alone or in combina-
tion with HA-Myc and additionally with a Myc-dependent reporter plasmid (CG5033, 
2.3.2). Cells were harvested 48 hours after transfection. To examine whether the acti-
vation is dependent upon Chinmo, S2 cells were treated with dsRNA against Chinmo 
or transfected with HA-Myc as control. Depletion of Chinmo is shown in Figure 4-13 E. 
Consistent with previous observations, Myc overexpression increases the relative re-
porter level almost 3 fold compared to control (277% ± 61%) and Myc depletion re-
duces the level to 33% ± 13% (Figure 4-13 F). Depletion of Chinmo has no effect on 
luciferase levels (103% ± 14%), showing that Chinmo is not required for Myc-
dependent target gene activation. However, all Chinmo-plasmids are able to transacti-
vate the Myc-dependent reporter on their own by 131% to 138%, only GFP-Chinmo-
∆Zf shows a higher increase (173% ± 11%). This result is similar to experiments per-
formed by D. Schwinkendorf, although the effects in her experiments were slightly 
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higher (Schwinkendorf, 2008). Combined overexpression of Myc and Chinmo trans-
genes even enhances luciferase activity compared to overexpression of Chinmo alone 
(231% ± 16%). These experiments show that Chinmo is able to hyperactivate Myc tar-
gets. 
So far, physical interaction was only shown for Myc and Chinmo overexpression. En-
dogenous immunoprecipitations of Chinmo and Myc were performed using the rabbit α-
Chinmo antibody or rabbit IgG as non-immune control. Both, the rabbit α-Chinmo as 
well as the non-immune IgG co-precipitate endogenous Myc (Figure 4-13 G), but to 
different extents. The signal obtained for the Myc immunoprecipitation with the Chinmo 
antibody is much stronger than the signal of the IgG control. 
Since Myc and Chinmo presumably physically interact with each other and Chinmo is 
able to transactivate a Myc dependent reporter (Figure 4-13 D-G), we were interested if 
Chinmo and Myc share the same target genes. Therefore, ChIP experiments were per-
formed in naïve S2 cells with either rabbit α-Chinmo or mouse α-Myc antibody and the 
corresponding non-immune IgG control. While the binding of Myc to hoip and Nop5 
was quite weak compared to IgG (hoip: 1.5 fold; Nop5: 1.7 fold), the Chinmo IP showed 
a very strong enrichment over IgG (hoip: 42 fold; Nop5: 44.8 fold; Figure 4-14 A). A 
weak binding of Chinmo towards Pka-C1 (10.9 fold) is observed, which is not the case 
for Myc (0.4 fold). The weak binding of Myc might be due to experimental problems, for 
example an old batch of antibody. 
To investigate whether the Chinmo antibody specifically binds the Myc target genes 
hoip and Nop5, Chinmo was depleted in S2 cells for 72 hours (Figure 4-14 B). Quantifi-
cation of the western blot signals shows a depletion of Chinmo by at least 80%. How-
ever, the antibody displays strong background binding, which is not depleted upon 
knockdown of Chinmo. For ChIP experiments, cells were also harvested 72 hours after 
transfection with dsRNA against Chinmo. The binding is reduced by more than 30% for 
all three genes after Chinmo knockdown (Figure 4-14 C) but the enrichment over IgG is 
still very high (hoip: 72.5 fold, Nop5: 109.1 fold, Pka-C1: 32.3 fold). This might be due 
to the non-specific binding of the rabbit α-Chinmo antibody or by some residual Chinmo 
protein that is not completely depleted by RNAi. Due to the strong background binding 
of Chinmo, the antibody is not suitable for ChIPseq experiments. 
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Figure 4-14: Chinmo and Myc bind to the same target genes 
 
A./C. ChIP-qPCR of Myc control genes. Chromatin was isolated from naïve S2 cells or from S2 
cells depleted of Chinmo, precipitated with rabbit α-Chinmo, mouse α-Myc or control IgG anti-
bodies and assayed by qPCR for enrichment of the indicated loci. Hoip and Nop5 are known 
Myc target genes and used as positive, Pka-C1 as negative control. The error bars indicate SD 
of technical triplicates. Experiments were performed in biological duplicates. 
B. Western blot of naïve S2 cells or S2 cells depleted of Chinmo by addition of dsRNA against 
Chinmo. Cells were harvested 72 h after dsRNA treatment. Western blot was performed with 
rabbit α-Chinmo antibody. 
4.2.3 Tumor induction of Chinmo and RasV12 is Myc-dependent  
Chinmo has been linked to cancer by other groups previously to this thesis (Doggett et 
al., 2010). Since Myc and Chinmo interact in the regulation of growth we wanted to 
investigate whether this tumor formation is dependent upon Myc. Ectopic activation of 
oncogenic Ras in combination with loss of the cell polarity regulator and tumor sup-
pressor scribble (scrib) within the eye imaginal disc of Drosophila results in neoplastic 
tumors (Pagliarini and Xu, 2003). To study the global transcriptional changes of these 
tumors, the group of H. Richardson (Doggett et al., 2010) performed a comparative 
microarray approach. The BTB/Zf domain containing protein family was highly enriched 
in their analysis, including Chinmo (Doggett et al., 2010). They were able to show that 
overexpression of Chinmo together with RasV12 leads to tumor formation. Based on 
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these results, experiments were performed to investigate if ectopic activation of 
Chinmo and Ras indeed leads to tumors. The transgenes of interest were exclusively 
activated in cells of eye imaginal discs (ey-FLP), combining FRT/FLP-techniques with 
UAS/Gal4 (yw ey-FLP, GFP; 2.9). For differentiation purposes, GFP was co-expressed 
with the particular transgenes. A tumor was defined as fluorescent tissue that overgrew 
the eye-imaginal discs. For comparing the size of the different fluorescent tissues, the 
size of the whole larvae was measured and divided through the size of the fluorescent 
tissue and normalized to wildtype control (GFP). 
Overexpression of RasV12 (120% ± 24%), Myc (109% ± 24%) or Chinmo alone does not 
increase tumor size but overexpression of Chinmo even reduces tumorous tissue 
slightly (83.5% ± 9.2%). This effect seems to be independent from Chinmo, since loss 
of Chinmo has no effect in a RasV12 overexpressing system (119% ± 21%). However, 
the specificity of the Chinmo-kd transgenes was never tested before. The combination 
of Myc together with RasV12 (121% ± 34%) or Chinmo (151% ± 65%) has only mild ef-
fects on tumor growth measured as fluorescent tissue (Figure 4-15 A, B). Overexpres-
sion of RasV12 together with Chinmo on the other hand leads to a massive increase in 
tumor size (300% ± 159%, p=0.02; Figure 4-15 A, B).  
To investigate Myc’s role in this tumor model, flies carrying RasV12 and Chinmo were 
crossed to flies carrying the myc null allele dm4 or the hypomorphic allele dmP0, the 
“tub-FRT-Myc-FRT-GAL4 ey-FLP” transgene and GFP. Since the “tub-FRT-Myc-FRT-
GAL4 ey-FLP” transgene drives ubiquitous expression of Myc-wt cDNA, the lethality of 
the myc mutant is fully rescued (de la Cova et al., 2004; Bellosta et al., 2005). There-
fore Myc is slightly overexpressed in the whole animal except the head capsule. Ectop-
ic expression of RasV12 and Chinmo in a Myc mutant background leads to a strong de-
crease in tumor size, showing that the tumor formation indeed depends on Myc (Figure 
4-15 C). Partial loss (dmP0: 58.5% ± 2.8%, p=0.0026) as well as complete loss of Myc 
(dm4: 66% ± 13%, p=0.03) shows a strong reduction in tumor growth. Therefore we can 
conclude that the RasV12-Chinmo tumor model is indeed dependent upon Myc. 
  
4 Results 86 
 
 
Figure 4-15: Chinmo cooperates with RasV12 in the induction of tumors 
 
A. Larvae express GFP and the depicted UAS-constructs under the control of the tub-Gal4 ey-
FLP promoter. 
B. Ratio of the size of fluorescent tissue to the size of whole larvae for the depicted genotypes. 
Ratios and standard deviations were normalized to control (yw ey-FLP, GFP). Error bars indi-
cate SD of individually assayed flies shown in parentheses. Difference to control is p<0.05 (*, 
Student’s 2-tailed t-test). 
C. Ratio of the size of fluorescent tissue to the size of whole larvae for the depicted genotypes. 
Ratios and standard deviations were normalized to control (yw ey-FLP, DRasV12 + Chinmo). 
Error bars indicate SD of three individually assayed flies. Difference to control is p<0.05 (*) or 
p<0.005 (**) respectively (Student’s 2-tailed t-test). 
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5 Discussion 
5.1 Characterization of direct Myc target genes in Drosophila 
melanogaster 
5.1.1 Myc binds a core set of target genes in Drosophila 
The transcription factor Myc is known to be involved in various processes like cell 
growth, proliferation, cell cycle progression, cell adhesion and apoptosis (Dang et al., 
2006; Vita and Henriksson, 2006). New technologies such as microarray and next gen-
eration sequencing technology allowed getting an overview of the genes which are 
regulated and bound by Myc. While several publications focus on Myc target genes in 
vertebrates (Schuhmacher et al., 2001; Dang et al., 2006; Lin et al., 2012; Nie et al., 
2012), less is known about direct Myc targets in other organisms. To get a comprehen-
sive list of directly regulated genes in Drosophila, we performed ChIPseq and RNAseq 
(M. Stauch, pers. com.) analysis.  
To reduce the possibility that binding sites were missed due to epitope masking, 
ChIPseq analysis was performed with two different antibodies, a monoclonal mouse 
α−Myc and a polyclonal rabbit α−Myc antibody. In addition, two different cell lines, Dro-
sophila S2 cells and Kc167 cells, were used. Both cell lines are hematopoietic cells of 
embryonic origin, but it could be possible that they differ in their molecular characteris-
tics. However, the binding sites of S2 and Kc167 cells showed a big overlap (Figure 4-2 
B) excluding major differences between the cell lines.  
All three ChIPseq experiments together led to the identification of 265 statistically sig-
nificant Myc binding sites (FDR ≤ 10%; Figure 4-2 B). Due to the good overlap between 
the three ChIPseqs, it is very likely, that these 265 binding sites represent the core set 
of Myc binding sites in Drosophila. The number of binding sites identified in our exper-
iments nicely matches the number of binding sites identified in DamID experiments by 
Orian et al. (2003). For DamID experiments, a fusion protein consisting of E.coli DNA 
adenine methyltransferase (Dam) and the protein of interest is created. The fusion pro-
tein is expressed in cells and Dam will be targeted to the native binding sites of the 
protein used for fusion. Dam marks the sequences near a binding site by methylation of 
adenines in the sequence GATC, which can be detected by specific restriction en-
zymes. The methylated DNA is amplified and labelled for hybridization to microarrays 
(van Steensel, 2005). Orian et al. identified 287 Myc bound genes under slightly in-
creased Max levels, while they identified only 22 Myc bound genes when Max was not 
overexpressed. Therefore Max was probably rate limiting in their experiments. Taking 
into account that they identified the target genes under slightly increased Max and Myc-
Dam levels, it is possible that part of their targets are overexpression artefacts. Howev-
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er, the spotted microarray they have used covered only 6255 cDNAs, representing 
roughly half of Drosophila coding sequences, and they therefore probably missed sev-
eral target genes. Thus the sum of 287 Myc bound genes might very well reflect the 
real amount of Myc target genes. However, the number of binding sites identified is 
tremendously smaller compared to Yang et al. (2013). In their study, Yang et al. exam-
ined the distribution of Myc during interphase and mitosis in Kc167 cells. Myc associ-
ates preferentially with paused genes and a large fraction of Myc sites persisted during 
mitosis. In total 3995 binding sites were identified, with the biggest fraction present at 
promoter-proximal regions and the corresponding genes being involved in ribosomal 
RNA synthesis. The big discrepancy between the number of binding sites in our 
ChIPseq analysis and the Yang analysis could have three reasons. First of all, the cell 
lines S2 and Kc167 could differ in their molecular characteristics, what has been ex-
cluded (see above). Secondly, the commercial rabbit α-Myc antibody (SC) might detect 
other epitopes on Myc, have a higher affinity, or the way of experimental processing led 
to differences in sequencing results (e.g. buffers, cross-linker). Finally, since the speci-
ficity of the Santa Cruz antibody was never shown in any publication, some of the 
peaks might reflect non-specific binding of the antibody to chromatin. QRT-PCR analy-
sis of 17 randomly selected Yang peaks (3.1.15; 4.1.1) revealed that the peaks were 
not Myc specific, due to the fact that they showed positivity also in IgG control or were 
not decreased upon Myc KD. The unspecific binding might correspond to a background 
reactivity of the antibody which was detected in Western blot analysis, too (Figure 4-3 
C). ChIPseq traces of the selected Yang peaks from our own data, obtained with the 
mouse α-Myc antibody also showed a non-specific Myc signal (Figure 4-3 B). Since 
Yang et al. (2013) did not include control ChIPs with non-immune IgG or from Myc de-
pleted cells and since we were able to show that randomly chosen Yang peaks were 
not Myc specific (Figure 4-3 A, B), we consider the additional peaks found by Yang et 
al. to be Myc non-specific. 
In agreement with data published in mammalian cells (Zeller et al., 2006; Walz et al., 
2014), most binding sites map less than 1000 bp from a transcriptional start site also in 
flies, suggesting that Myc preferentially binds to promoter-proximal sequences. This 
preference is even enhanced when only binding sites are considered which cover an E-
box binding motif, the most enriched binding motif in our dataset (Figure 4-6 A, B). 
Several publications have shown that Myc preferentially binds E-boxes, in vertebrates 
as well as in flies (Amati et al., 1992; Solomon et al., 1993, Gallant et al., 1996). E-box 
presence in the promoter has also been described previously as indicative of Myc-
regulated genes (Hulf et al., 2005). Another highly enriched motif in our dataset, is the 
DNA replication element (DRE; Figure 4-6 B’), which has been recognized to be asso-
ciated with Myc target genes before (Orian et al., 2003). DRE sequences were reported 
to be present near genes involved in growth and cell proliferation (Hirose et al., 1993, 
2001). 
RNAseq was performed in naïve and Myc depleted S2 cells (M. Stauch, pers. com.), to 
get insight which of the Myc bound genes are also regulated. Some non-coding RNAs 
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(rRNAs, tRNAs, miRNAs) had been identified in vertebrates as Myc targets before 
(Grandori et al., 2005; Gomez-Roman et al., 2003). To investigate whether these and 
other non-protein coding transcripts mediate biological activities of Myc, non-
polyadenylated transcripts were included in our search for Myc targets. In total 240 
genes were found to be activated by Myc, while only 41 Myc repressed genes were 
identified to be differentially expressed in all three independent RNAseq experiments. 
Myc-activated polyadenylated transcripts overlap nicely with previously published data 
(Hulf et al., 2005; Grewal et al., 2005; Bonke et al., 2013), while the Myc repressed 
ones show only poor overlap (Herter et al., 2015). When expression and binding data 
were combined, 139 genes were identified to be directly activated by Myc, while 59 
genes were directly repressed. Summing up the ChIPseq and the RNAseq data, less 
than 300 genes are bound by Myc in Drosophila, and only 198 genes are regulated 
directly. This represents roughly 1% of all Drosophila genes and stands in sharp con-
trast to earlier published data, where Myc is assumed to regulate around 15% of all 
genes (Dang et al., 2006). Furthermore several other groups (Nie et al., 2012; Lin et 
al., 2012; Walz et al., 2014; Sabo et al., 2014) propose a much higher number of genes 
controlled by Myc in mammals. However, we only considered genes which were differ-
entially regulated with a fold change of at least one-third and a p-value below 0.05 for 
our analysis. Also other differences in data processing, e.g. the definition of the false 
discovery rate for the peak calling could explain this huge discrepancy. However, the 
organization of Drosophila is simpler than that of vertebrates (e.g. one instead of three 
Myc proteins) and Orian et al. (2003) found equal numbers of Myc target genes, in 
comparison to us. Thus it is highly probable that the 300 genes we found in our setup 
represent the core set of Myc target genes in Drosophila. 
Independent on the amount of directly regulated genes, genes involved in ribosome 
biogenesis, translation and RNA-processing are among Myc controlled genes in all 
cases. Dependent on its expression levels, Myc controls genes involved in cell adhe-
sion, apoptosis and angiogenesis, too (Lee et al., 2012; Walz et al. 2014). Taking into 
account the high number of genes controlled by Myc in mammals and the various pro-
cesses they play a role in, Myc may act as a general transcription factor in mammals. 
In Drosophila, on the other hand, Myc seems to act as a specific, process related tran-
scription factor, mainly involved in growth control. In this context, the question arises if 
growth control represents the primordial function of Myc, having evolved to a broader 
functional field in higher organisms. Also the presence of a single Myc protein in flies 
versus three Myc family members in vertebrates might be a reason for the fewer target 
genes and processes Myc is involved in. In addition, the regulation of some gene sets 
in mammals is dependent on Myc levels and promoter affinity (Walz et al. 2014; F. 
Lorenzin, pers. com.) and might be relevant only in tumorous tissues. 
5.1.2 snoRNAs are new Myc targets 
From the 240 genes, which were significantly downregulated after Myc depletion (fold 
change ≤0.66; p<0.05), 36 genes did not code for proteins but instead for snoRNAs. 
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Further analysis on the snoRNAs showed that all 103 snoRNAs that passed the 125 nt 
cutoff and were detectably expressed in S2 cells were, downregulated upon Myc deple-
tion (Herter et al., 2015). The Drosophila genome is predicted to encode 288 snoRNAs 
(Huang et al., 2005; Herter et al., 2015), which divide into two major classes, Box C/D 
(SNORA) and Box H/ACA (SNORD) snoRNAs (Kiss-László et al., 1998; Bachellerie et 
al., 1995). SnoRNAs are quite small, consisting of only 46 nt to 316 nt. While SNORAs 
guide methylation of 2’O-ribose of target genes, mainly rRNAs, mRNAs and tRNAs, 
SNORDs are essential for pseudouridylation of target RNAs (Kiss, 2001). Many 
snoRNAs are hosted in protein coding genes, which themselves are bound and regu-
lated by Myc. The biggest fraction of snoRNAs (229; 80%) is encoded in introns of 84 
protein-coding genes (Dieci et al., 2009), many of which are Myc targets, too (Table 
4-5). Examples of hosting genes are those encoding for components of snoRNPs (Fib, 
hoip, nop5), translation factors (Ef2b, eEF1delta, bic) or ribosomal protein genes 
(RpS5a, RpL7, RpL11). To investigate whether the dramatic impact of Myc on the 
snoRNAs is directly via their host genes, or instead, if the regulation is indirect, for ex-
ample via depletion of snoRNPs and a resulting destabilization of the corresponding 
snoRNAs (Lafontaine and Tollervey, 1999), Myc’s transcriptional effects on Uhg genes 
were studied. Almost 17% of all snoRNAs (48) are not encoded in introns of protein-
coding genes but in introns of non-protein-coding “U-snoRNA host genes” (Tycowski 
and Steitz, 2001; Huang et al., 2005). In Drosophila, 7 Uhgs exist (Uhg1; 2; 3; 4; 5; 7; 
8), which are dedicated to the synthesis of snoRNAs only. The gene formally known as 
Uhg6 is actually Nop60B. Our data reveal a putative novel Uhg gene (2R-cluster), 
since three snoRNAs were found to be arranged in tandem repeats on chromosome 
2R with a single E-box flanking them upstream. Since only seven other snoRNAs are 
independently transcribed, it is likely that these three snoRNAs belong to another Uhg 
gene. 
All but three of the Uhg-encoded snoRNAs are smaller than 125 nt and were therefore 
not detected in the RNAseq (Herter et al., 2015). qRT-PCR and Northern blot analysis 
revealed that Myc depletion leads to downregulation of the snoRNAs and their host 
genes (Figure 4-7 A), confirming the RNAseq results and that also mature snoRNAs 
are affected and not just the immature precursors (Figure 4-7 C). Furthermore, overex-
pression of Myc can also increase the expression of the snoRNAs to supraphysiolgical 
levels (Figure 4-7 B). Consequently Myc controls all examined snoRNAs independently 
of their stability by direct binding to the host genes. Myc binding was shown to the E-
boxes of Uhg1, 2, 4, 5 and the 2R-cluster (Figure 4-5 A, B). In addition, a peak was 
found close to the TSS of Uhg7. Since Uhg7 and Rpl23A overlap and the peak was 
closer to the TSS of Rpl23A, it was allocated to Rpl23A. However there is still the 
posiblility that Uhg7 is also bound by Myc. Binding of Myc to the Uhgs presumably 
involves Myc-Max heterodimers, since loss of Max reduced the recruitment of Myc to 
these promoters (Figure 4-5 C). This was expected, since Myc needs the association 
with Max to bind to E-boxes (Blackwell et al., 1990; Blackwell et al., 1993). However, 
loss of Max does not decrease the recruitment of Myc to the promoters to the same 
extent as loss of Myc. Therefore it is possible that the binding is partially independent 
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of Max or that the knockdown of Max was not complete. Considering that the knock-
down of Max was not verifiable due to the lack of a Max antibody, it is likely that still 
residual Max was present. To distinguish between the possibilities, ChIP should be 
performed at different time points after Max depletion, to investigate if the binding fur-
ther decreases. 
Myc not only regulates snoRNAs in Drosophila, but also in mammals. The human ge-
nome encodes 745 snoRNAs, of which 419 are encoded in 232 different host genes, 
including 15 non protein-coding “snoRNA host genes” (SNHG) (Li et al., 2010). Rea-
nalysis of data from human U2OS cells (Walz et al., 2014), showed a significant en-
richment of snoRNA host genes among the highly c-Myc bound genes (Herter et al., 
2015). These genes can also be activated by c-Myc, as shown in murine T-cell lym-
phomas (Müller et al., 2010; Herter et al., 2015). Like in Drosophila, vertebrate Myc has 
an impact on the SNHG loci, which are dedicated to the production of snoRNAs. Myc is 
recruited to the majority of SNHG promoters in human and murine cells, mostly to posi-
tions containing an E-box (E. Wolf, pers. com.; Herter et al., 2015). Also in 
neuroblastomas with high N-MYC expression, the upregulation of snoRNAs has been 
observed (Schramm et al., 2013). Therefore, the control of non-coding snoRNA host 
genes and of snoRNA levels in general, is an evolutionary conserved function of Myc 
proteins. 
5.1.3 snoRNAs play an important role in tumor formation  
To further investigate the role snoRNAs play in vivo, we focused on the snoRNAs en-
coded by the Uhg genes. All snoRNAs are quite small and their integration in snoRNPs 
complicates to target them directly via dsRNA or mutations. Targeting their host genes 
has the advantage that several snoRNAs can be studied at once. Furthermore, if 
snoRNAs can compensate for each other, depletion of several snoRNAs might show 
stronger phenotypes than loss of single snoRNAs. Several sites have been shown to 
be targeted by more than one snoRNA, and most of these snoRNAs are clustered with-
in the same host genes (e.g. Uhg1; Yoshihama et al., 2013). In this case, depletion of a 
single host gene leads to loss of modification at several sites at once. It is very likely 
that this increases the loss of function effect in comparison to loss of a single snoRNA 
or a single target site. Since most of the protein-coding host genes are Myc targets 
themselves and play important roles in processes involved in ribosome biogenesis and 
translation and therefore in growth-related processes, studying the role of the encoded 
snoRNAs is difficult. The Uhg genes, however, do not encode potentially growth-
relevant transcripts. Furthermore, they host 17% of all snoRNAs and Uhg1 alone en-
codes 16 different snoRNAs. An Uhg1 mutant fly line (Uhg11) was established (Herter 
et al., 2015) and used to study the effects, snoRNAs have on growth-related process-
es. As expected, Uhg1 mutant flies did not show methylation at three (28S:A1666, 
28S:G3081, 28S:G3277; Figure 4-10 C) out of five positions which are exclusively tar-
geted by snoRNAs encoded by Uhg1 (Yoshihama et al., 2013). Contrary to what had 
been described by Dong et al. (2012) and N. Watkins (pers. com.), the sites of interest 
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(A1666, G3277) were not influenced by the previous, Uhg1 unaffected methylation 
sites (Figure 4-10 C). While A1688 was not detectable at all, G3341 was not changed 
upon different dNTP concentrations. On the other hand, several other positions 
seemed to be influenced by decreasing dNTP concentrations (e.g. A1713), which are 
not be methylated. This fits to observations of Motorin et al. (2007), who states that 
regions exist, where the reverse transcriptase has the tendency to pause independent-
ly of mathylation (e.g. G3318, G3319). Furthermore, pauses observed at 2’-O-
methylated residues are sequence dependent and no pause may occur depending on 
the sequence context (Motorin et al., 2007). Loss of Uhg1 leads to loss of methylation 
at 5 specific ribose residues and could therefore affect ribosome assembly and activity. 
The Uhg1 mutant animals did not differ in size and weight (Herter et al., 2015) and also 
protein content was equal to control animals (Figure 4-11 A). However, in comparison 
to control flies, only one third of the females and half of the males survived to adulthood 
(M. Gallant, pers. com.). In addition, Uhg11 females showed a strongly reduced fertility 
which was not observed for male flies (M. Gallant, pers. com.). While total protein con-
tent of larvae did not differ between mutant and control animals, the synthesis rate of 
new proteins was significantly reduced in Uhg11 larvae (Figure 4-11 A). In agreement 
with slower protein synthesis, mutant animals had a delay in development and adult 
flies eclosed approximately 12 hours later than control animals (Herter et al., 2015). 
Female-specific sterility together with an increase in developmental timing are typical 
indications of mutations in pathways affecting growth (Johnston et al., 1999). Moreover, 
hypomorphic Myc mutations were shown to display the same defects (Johnston et al., 
1999). These observations could imply that loss of Myc downregulates expression of 
ribosomal genes and other genes involved in cellular growth, leading to defects in ribo-
some assembly and activity and so to female sterility and delay in development.  
To investigate whether Myc can still fulfill its functions in the absence of Uhg1, flies 
carrying a Myc transgene were crossed with either wildtype or Uhg1 mutant animals. 
Overexpression of Myc resulted in a massive increase in protein synthesis rate (Figure 
4-11 B), which fits to experiments performed in B lymphocytes in control and Eµ-myc 
mice (Iritani and Eisenman, 1999). B cells from Eµ-myc mice contained 2-fold higher 
protein levels than control animals, showing a correlation between Myc overexpression 
and increased protein synthesis. Overexpression of Myc in an Uhg1 mutant back-
ground however, did not enhance protein synthesis rate compared to Uhg11 larvae but 
was even slightly decreased (Figure 4-11 B). Thus Myc’s ability to increase protein 
synthesis is dependent on the presence of these snoRNAs and loss of methylation of 
only five residues leads to a massive impairment in ribosome activity that cannot be 
rescued by overexpression of other snoRNAs. Since Uhg11 animals still survive and 
develop quite normally, snoRNAs seem to complement each other at least partially. It 
is very interesting that the Uhg1 mutant animals only need half a day longer for devel-
opment than wildtype animals (10.5 days versus 10 days) but overexpression of Myc in 
Uhg11 animals does not show any increase in protein synthesis rates. Normally, over-
expression of Myc results in a 100% increase in cell size (Johnston et al., 1999), which 
might correspond to a 100% increase in protein synthesis rates (Figure 4-11 B). There-
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fore, it seems as if the Uhg11 animals already grow with maximum achievable protein 
synthesis rates, not being able to further increase the rates upon Myc overexpression. 
One reason for the decreased protein synthesis rate of Myc OE/ Uhg11 animals to-
wards Uhg11 animals might be their physical state. While animals of both genotypes 
started wandering the same time, the Myc OE/ Uhg11 animals were smaller (pers. ob-
servation). Therefore the inversion of the larvae (3.4.6) was more complicated. Given 
no big differences within the different experiments with the Myc OE/ Uhg11 animals 
(SEM < 14%), it is unlikely that the handling led to the observed differences in protein 
synthesis rates between Myc OE/ Uhg11 and Uhg11 animals. It remains open why the 
Myc OE/ Uhg11 larvae were smaller and if this might for example reflect a different 
composition of cell types, e.g. less polyploid tissue and therefore fewer cells which can 
react upon overexpression of Myc. It is also not clear whether smaller animals might 
have a slower protein synthesis rate due to viewer cell. The differences in protein syn-
thesis between different genotypes and between different trials could also originate 
from time dependent expression of the Uhgs. The interval between the heat shock and 
collection of the larvae was 16 h ± 2 h, but was given at different time points in the 
evening and therefore the light conditions in the incubator differed slightly. While our 
experiments show that reduction of Uhg1 leads to a decrease in protein synthesis 
rates, other groups were able to show that the expression levels of different Uhgs 
(Uhg1-5, Uhg8 and Nop60B) display a rhythmic and time dependent behavior in 
light/dark experiments performed in adult fly brains (Hughes et al., 2012; P. Menegazzi, 
pers. com.). Therefore it is possible that effects on protein synthesis are differentially 
strong at different time points throughout the day. It would be very interesting to inves-
tigate if protein synthesis rates change throughout the day in correlation with Uhg ex-
pression. Just recently it was shown that the circadian clock influences the translation 
of a subset of mRNAs involved in ribosome biogenesis (Jouffe et al., 2013). Further-
more it should be investigated whether Myc shows rhythmic expression, too, as it was 
shown for c-Myc (Fu et al., 2002). Interestingly, no other snoRNA host genes besides 
the Uhgs were found to display rhythmic expression (Hughes et al., 2012), arguing 
against rhythmic activity of Myc in Drosophila.  
Since loss of Uhg1 and therefore of only 16 different snoRNAs greatly affects growth, it 
is very likely that different snoRNAs can only partially substitute for each other. Thus, 
loss of snoRNAs can lead to severe effects in development and growth and presuma-
bly enhances tumor formation and other diseases. Loss of Uhg1, however, did not re-
duce tumor growth in a Myc dependent brain tumor system (Figure 4-11 C). It is possi-
ble that the delay in larval development and the prolonged time, needed for metamor-
phosis (Herter et al., 2015), which is caused by the loss of Uhg1, also slows down the 
tumor growth rate. In this context, the NBII tumors might develop later and a reduction 
in tumor growth rate would be masked by the loss of Uhg1. Also, loss of Uhg1 did not 
affect "RasV12 + Chinmo" tumors (Figure 4-11 D), while loss of Myc has a strong effect 
in this tumor model as well. Loss of Myc on the other hand does not only lead to reduc-
tion of distinct but all snoRNAs and therefore a much greater impairment. It is likely that 
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loss of several Uhgs at once might also lead to a reduction in tumor growth in both tu-
mor models.  
On the other hand, overexpression of Uhg4 or Uhg5 led to an increase in tumor growth. 
How this increase is achieved is not clear, however all processes in ribosome biogene-
sis are coordinated with each other to sustain rapid cell growth (Warner, 1999). Over-
expression of Uhg4 or Uhg5 might trigger a feedback loop, activating synthesis of 
rRNAs and ribosomal proteins and therefore ensure an efficient assembly of ribosomal 
particles. It should be tested, whether overexpression of Uhg4 and Uhg5 has an effect 
on protein synthesis rates, too. 
SnoRNAs not only play a role in tumor formation in Drosophila, but deregulation of 
several snoRNAs was observed in human cancers (Mannoor et al., 2012). The group 
of G. Jenster (Martens-Uzunova et al., 2012) performed deep sequencing in prostate 
cancer samples to investigate the composition of the entire small transcriptome and 
found a strong differential expression of snoRNAs between metastatic and non-
metastatic prostate cancer samples, linking snoRNA abundancy to poor prognosis. 
Furthermore the snoRNAs SNORD44, SNORD43, SNORD48 and RNU6B were found 
to be deregulated in breast cancer and head and neck squamous cell carcinomas, and 
the low expression levels of SNORD44 were associated with poor prognosis and corre-
lated with an aggressive pathology (Gee et al., 2011). The authors also mention that 
they noted generally lower levels of snoRNAs in association with aggressive tumors 
and poor prognosis and suggest that the loss of the snoRNAs and therefore a de-
crease in ribosome biogenesis leads to chromosomal instability, an indicator of cancer. 
Another set of specifically downregulated snoRNAs in tumor samples was described in 
acute leukemia (Valleron et al., 2012). In neuroblastomas with high N-MYC expression, 
on the other hand, several snoRNAs were found to be overexpressed (Schramm et al., 
2013), raising the possibility that snoRNAs contribute to N-MYC dependent tumor 
growth, similar to what we have described in Drosophila type II neuroblast tumors. Not 
only snoRNA sets have been found to be deregulated in human cancers, but also dis-
tinct snoRNAs have been shown to have an impact on cellular proliferation or transfor-
mation. A SNORD114-1 variant promotes cell growth through cell cycle modulation, 
where it is involved in the G0/G1 to S phase transition (Valleron et al., 2012). 
SNORA42 was shown to be overexpressed in lung tumors, where it enhances cell 
growth and colony formation and is inversely correlated with survival of patients (Mei et 
al., 2012). Our data together with published data in humans show evidence that 
snoRNAs play a role in tumor formation. Since it is possible that they contribute to Myc 
dependent tumor growth, the connection between snoRNAs and Myc should be studied 
further, to better understand the mechanism of their interaction, which might enable 
new therapeutic approaches in cancer therapies.  
5.1.4 Myc controls all levels of ribosome biogenesis 
It was shown before that Myc plays an important role in ribosome biogenesis (Grandori 
et al., 2005; Grewal et al., 2005; Arabi et al., 2005) and influences mRNA translation by 
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regulating the transcription of translation initiation factors, like elF4E and elF4A 
(Schmidt, 2004). Our data, however, reveal a new set of Myc target genes involved in 
ribosomal biogenesis, the snoRNAs. In higher eukaryotes, most snoRNAs are encoded 
in introns of other genes, many of which code for translation- or ribosome-related pro-
teins. In Drosophila, more than 50% of all host genes belong to these groups of pro-
teins, while in humans still more than a quarter does (Dieci et al., 2009). It is convincing 
that this arrangement helps to adapt snoRNA production to the cell’s biosynthetic 
needs. Not only snoRNAs are direct Myc targets, but also the partner proteins which 
are essential to form snoRNPs (small nucleolar ribonucleoprotein particles). These 
targets are, for example the box C/D snoRNP components Fibrillarin, Nop58/ Nop5, 
Nop56,15.5kDa/ hoi-polloi, with Fibrillarin being the methyltransferase responsible for 
methylation of the 2’O ribose of the target nucleotide (Kiss, 2001; Reichow et al., 
2007). Dyskerin/ Nop60B, GAR1, NHP2, NOP10/ CG7637 are the box H/ACA compo-
nents, with Dyskerin/ Nop60B being the pseudouridine synthase (Henras et al., 1998; 
Watkins et al., 1998). All of these components are included in our list of bound and 
regulated genes (Table 4-5). Furthermore, several other factors required for the correct 
assembly and functionality of the snoRNPs are established Myc targets. Nopp140, a 
nucleolar phosphoprotein, functions as a molecular link between the nucleolus and the 
coiled bodies (Isaac et al., 1998) and is associated with box C/D and box H/ACA 
snoRNPs (Bachellerie et al., 2002). Also the nucleoplasmic helicases Tip48/ reptin and 
Tip49/ pontin were shown to be required for the production of box C/D and box H/ACA 
snoRNAs as well as for the localization of snoRNP proteins (Bachellerie et al., 2002; 
King et al., 2001). Both proteins are no direct Myc targets, but show a close physical 
and genetic interaction with Myc (Bellosta et al., 2005). Also Modulo (mod), a Drosophi-
la homolog of nucleolin (Mikhaylova et al., 2006), which was shown to be directly con-
trolled by Myc (Perrin et al., 2003), was found in our dataset. By controlling all 
snoRNAs and the core proteins essential to form snoRNPs, Myc acts as a master regu-
lator of snoRNP production. Besides its role in snoRNP production, Myc controls sev-
eral other steps in ribosome biogenesis, such as induction of components of the small 
(e.g. RpS5a, RpS27a, RpS14a) and the large (e.g. RpL7, RpL13, RpL11, RpL22) ribo-
somal subunits and genes essential for their processing and maturation (Table 4-5). In 
agreement with earlier publications, stating that rRNA synthesis by RNA Pol I in Dro-
sophila is indirect (Grewal et al., 2005), no direct binding to rRNA loci was observed in 
our data. Instead some components or cofactors of Pol I were found to be directly acti-
vated by Myc, for example Rpl135, a Pol I subunit (Grewal et al., 2005). Due to the 
small transcript size of tRNAs, they were not included in the RNAseq analysis, but it 
has been shown that Myc increases the amount of tRNAs and other RNA polymerase 
III (Pol III) products (Gomez-Roman et al., 2003; Steiger et al., 2008). Since no signifi-
cant enrichment of Myc at the 306 annotated tRNA loci was observed (data not 
shown), it is likely that Myc does not contact DNA directly at these sites. In fact, Myc 
does neither need Max nor its DNA binding domain to activate Pol III (Steiger et al., 
2008) and 96% of all tRNAs (295 of 306) do not contain E-boxes. Therefore it is very 
likely that Myc does not contact these sites directly. Myc not only encodes proteins 
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involved in translation and ribosome biogenesis, but also proteins involved in metabo-
lism, RNA processing and transcription as well as in mitochondrial function (Table 4-5).  
Put in a nutshell, Myc not only stimulates transcription of ribosomal proteins and rRNA, 
but also regulates snoRNAs and therefore all components to build snoRNPs. By con-
trolling all these components, Myc can be considered as a master regulator of ribo-
some biogenesis (Figure 5-1). 
 
 
Figure 5-1: Myc acts as a master regulator for ribosome biogenesis3 
 
Myc has been shown previously to activate RNA Polymerases I and III and therefore the tran-
scription of rRNAs and tRNAs. The majority of direct Myc target genes code for ribosomal pro-
teins or control ribosome biogenesis (RiBi genes). SnoRNAs are a new class of Myc targets and 
are considered to be direct if their host genes are bound by Myc. 
 
Myc repressed genes were not significantly enriched for any process (GOrilla tool). In 
contrast to the Myc activated genes, they also showed only a poor overlap between 
different data sets. Among these targets, two genes were found which are involved in 
ecdysone response, Eip75 and Kr-h1 (Ecdyson-induced protein 75B; Krüppel homolog 
1) and two other ones which play a role in the JAK/STAT pathway, Socs36E and nej 
(Suppressor of cytokine signaling at 36E; nejire). Eip75 is the only Myc repressed tar-
get gene, which hosts a snoRNA (snoRNA:Me28S-A30). Other repressed genes are 
for example brk (brinker), a negative factor in Dpp signaling, Snx3 (Sorting nexin 3), a 
positive factor in Wnt signaling, Indy (I’m not dead yet), a citrate transmembrane trans-
porter and velo (Veloren), a SUMO protease (data not shown).  
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5.2 Analysis of Chinmo and Myc interaction 
5.2.1 Chinmo and Myc function in partial redundant pathways 
In 2003, A. Sulzer characterized a complementation group consisting of three different 
alleles, which had been found earlier in an ey-FLP-screen. This so called “pinhead”-
screen had been performed (Sulzer, 2003) to identify genes, which are involved in 
growth control. The complementation group included the CG31666 gene and was 
named chnöpfli because of the small heads resulting from the mutations. Later on, Zhu 
et al. (2006) identified CG31666 in a screen for genes, required for temporal identity of 
mushroom body neurons in Drosophila and named it chinmo (Chronologically inappro-
priate morphogenesis). The small heads observed for the different chinmo alleles were 
not caused by differences in ommatidial size (Sulzer, 2003). Instead, the number of 
ommatidia was significantly lower than in wildtype animals (Figure 4-12 A). The number 
was even more reduced in homozygous mutant eyes. Surprisingly, chinmo110 showed 
the strongest effect in the heterozygous background, while it showed the weakest in 
the homozygous background. The effect in heterozygous animals stands in contrast to 
what has been observed by A. Sulzer, who reported that chinmo110 is the weakest al-
lele. Both, chinmo108 and chinmo134 have a mutation leading to a stop, which produces 
a truncation after the BTB domain and do not contain the zinc fingers. In contrast, 
chinmo110 only carries a mutation in the first zinc finger, maintaining the most functions 
of the wildtype protein. It is possible that chinmo110 is unstable (5.2.2). Another possibil-
ity for the observation that chinmo110 shows a stronger effect in heterozygous animals 
than the more severe mutations, chinmo108 and chinmo134, might be that chinmo110 acts 
as a dominant negative allele.  
The homozygous mutant eyes displayed a stronger phenotype for all alleles, consisting 
of fewer ommatidia. However, the heads and eyes were still quite normally shaped. 
Since also mutations affecting the insulin signaling pathway, show a reduction of eye 
size, A. Sulzer tested if Chinmo acts through this pathway. Interaction studies with dif-
ferent components of the pathway, like PKB, PTEN and TSC1 indicated that Chinmo 
does not function in the insulin receptor pathway.  
Chinmo was not only found in the screen for growth defective mutants (Sulzer, 2003) 
but also in a screen looking for novel components of the “Myc pathway” 
(Schwinkendorf, 2008). The screen was based on the dominant genetic interaction 
between the hypomorphic Myc allele dmP0 and Myc’s transcriptional cofactor Pontin/ 
Tip49 (Bellosta et al., 2005). The eyes of all 3 chinmo alleles are clearly distorted in an 
ey>dmP0 background (Schwinkendorf, 2008), which is due to a reduction in cell number 
(Figure 4-12 B), while the control animals are unaffected. Again, chinmo110 showed the 
strongest effect. In Myc-null mutant eyes, the number of ommatidia was even more 
reduced, independent of the presence or absence of Chinmo. This shows that while 
Chinmo only affects cell number, Myc affects both, cell number and size. This effect is 
similar to mutations in the insulin receptor pathway, where mutations in chico and the 
insulin receptor gene also affect cell number and size (Böhni et al., 1999; Brogiolo et 
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al., 2001). Similar effects can be explained by the fact, that Myc acts downstream of 
InR (Parisi et al., 2011). The effects on eye and head size are even exacerbated if 
both, Myc and Chinmo are completely eliminated. Animals that are homozygous mu-
tant for chinmo or Myc in the eye-imaginal discs survive and show the formation of 
quite normally patterned eyes. The double mutants on the other hand, display almost 
no head structure anymore and are fully lethal (Schwinkendorf, 2008). Thus, Myc and 
Chinmo do not act in the same pathway in the control of eye development (Figure 5-2). 
Besides their function in eye development, Myc and Chinmo have been shown to ge-
netically interact in other processes, too. Overexpression of different Chinmo 
transgenes with different Gal4-drivers always resulted in the death of the animals. This 
is probably due to apoptosis which is induced upon overexpression of Chinmo 
(Schwinkendorf, 2008). Reduction of Myc activity, however, enhances the survival rate 
of these flies. On the other hand, Myc is dependent upon Chinmo to promote cell 
growth. Taken together, these data demonstrate that Myc and Chinmo fulfill partially 
redundant functions in growth and development (Figure 5-2).  
 
 
Figure 5-2: Model of genetic interactions between Myc and Chinmo 
 
In the absence of Myc, Chinmo’s ability to induce apoptosis is diminished, while Myc’s ability to 
induce cell growth is partially dependent on Chinmo. In the process of eye development, Myc 
and Chinmo have an equally important function. Red arrows show overexpression of the depict-
ed protein, whereas green arrows stand for endogenous expression.  
5.2.2 Chinmo and Myc interact physically 
The genetic data described above (5.2.1) suggest a close functional interaction be-
tween Myc and Chinmo. Therefore, the molecular basis of this interaction was investi-
gated. Overexpression experiments by D. Schwinkendorf showed that Chinmo has no 
stabilizing effect upon Myc and no regulatory effect either (Schwinkendorf, 2008). Vice 
versa, the RNAseq data obtained from M. Stauch revealed that Myc does not transcrip-
tionally regulate Chinmo (M. Stauch, pers. com.). On the other hand, Chinmo was 
shown to activate the transcription of a Myc-dependent luciferase reporter (CG5033) 
and to be important for the regulation of Myc target genes such as fibrillarin and nnp1 
(Schwinkendorf, 2008). These results led to the hypothesis that Chinmo might be a co-
activator for Myc, necessary for its biological functions in vivo. A direct physical interac-
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tion of Myc and Chinmo would support this hypothesis, and therefore Co-IPs with tran-
siently transfected transgenes (AU1-Chinmo and HA-Myc) were performed. D. 
Schwinkendorf was able to show that HA-Myc is only immunoprecipitated in the pres-
ence of AU1-Chinmo. She also restricted the Chinmo binding site in Myc to the first 403 
amino acids. To locate the Myc binding site within Chinmo, two mutants were estab-
lished lacking either the zinc finger domain (Chinmo-∆Zf) or the BTB/POZ domain 
(Chinmo-∆BTB) (Figure 4-13 A). Since ∆BTB was not detectable at all in Western blot 
experiments under different transfection conditions (Figure 4-13 B, it seems probable 
that the AU1-Chinmo-∆BTB construct is unstable or not soluble and therefore no inter-
action was observed. For monitoring transfection efficiency more easily and eventually 
stabilize Chinmo-∆BTB, all different Chinmo constructs were cloned behind GFP. And 
indeed, all GFP-Chinmo constructs were detectable in Western blot (Figure 4-13 C). A 
relative large fusion partner can change the N-terminal sequence of the protein and 
therefore lead to an increase in its yield and stability (Terpe, 2003). Another possibility 
why the GFP-Chinmo-∆BTB was detected could be that addition of the large GFP-tag 
increased the solubility of the construct (Esposito and Chatterjee, 2006; Young et al., 
2012). However, all GFP-Chinmo constructs were able to co-precipitate Myc (Figure 
4-13 D). The crude rabbit α-GST-Chinmo antibody also precipitates HA-Myc in the ab-
sence of any GFP-Chinmo construct, raising the possibility that HA-Myc was precipitat-
ed with the help of endogenous Chinmo.  
Luciferase assays showed that not only GFP-Chinmo-∆Zf but also GFP-Chinmo-∆BTB 
was able to transactivate the Myc dependent luciferase reporter (Figure 4-13 E), dis-
playing that the fusion proteins retain their function. In comparison to luciferase exper-
iments performed by D. Schwinkendorf, overexpression of any of the constructs was 
not sufficient to activate the reporter to the same extent as overexpression of Myc. Also 
co-expression of Chinmo and Myc did not lead to an increase in reporter activation in 
comparison to overexpression of Myc alone. It is possible that differences in the exper-
imental setup (e.g. different time points, amount of used plasmids/ reagents) led to the-
se differences. However, both setups were able to show that Chinmo is able to 
transactivate the Myc dependent luciferase reporter CG5033. 
Considering the strong effect chinmo110 shows in vivo, it is surprising that the interac-
tion between Myc and Chinmo is not impaired by the ∆Zf-construct nor is Chinmo’s 
ability to activate the Myc dependent luciferase reporter. Only one zinc finger is affect-
ed in the chinmo110 allele, leading to reduced eye size while loss of both zinc finger-
domains has no effect in a Myc dependent reporter assay. One explanation for the 
strong genetic effect could be that the amino acid alteration from histidine (CAT) to 
tyrosine (TAT) at the first histidine of the first zinc finger somehow destabilizes the 
whole protein. Western blot analysis of protein lysates, obtained from chinmo110 homo-
zygous heads, could reveal if Chinmo is stably expressed.  
The direct physical interaction of Chinmo and Myc, which was obtained under overex-
pressed conditions, was also observed for an endogenous Co-IP performed with the 
rabbit α-Chinmo antibody (Figure 4-14 A). The co-precipitated Myc signal in the en-
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dogenous Co-IP was rather weak but still indicates a physical interaction of the two 
proteins. The endogenous Co-IP was repeated once with exactly the same conditions, 
but failed. It remains open whether a higher amount of cells or changes in salt concen-
trations used for the IP could enhance the co-precipitation. It is also possible that the 
binding of Myc and Chinmo increases with enhanced expression levels, explaining the 
strong interaction upon overexpression versus the weak endogenous interaction. An-
other option could be that the complex is poorly soluble, which is overcome by addition 
of a tag (Terpe, 2003; Esposito and Chatterjee, 2006). Furthermore, the interaction of 
Myc and Chinmo might be indirect via other, still unknown factors. 
5.2.3 Chinmo directly activates Myc target genes 
To investigate whether Myc and Chinmo share common target genes, ChIP experi-
ments were performed, using hoi-polloi and Nop5 as Myc positive targets and Pka-C1 
as negative control (Figure 4-14 B). As expected, the ChIP performed with the mouse 
α-Myc antibody showed a higher enrichment over IgG for hoip and Nop5 than for Pka-
C1. The very weak binding might be due to experimental problems, for example an old 
batch of antibody. In addition, the enrichment over IgG was often quite low, probably 
due to an unspecific background binding of the mouse-IgG (see also Table 4-4, mouse 
α-Myc). In contrast to Myc’s poor binding behavior towards its target genes, Chinmo 
showed a strong enrichment over IgG for hoip and Nop5 and a weaker one for Pka-C1 
(Figure 4-14 B). Since nothing is known about Chinmo’s target genes it is possible that 
Pka-C1 is bound by Chinmo, too. The binding of Chinmo at hoip and Nop5 could either 
arise from a stable interaction of Chinmo and the respective gene, a high affinity of the 
antibody, or unspecific reactivity of the same. The specificity of the rabbit α-Chinmo 
antibody was never tested in ChIP before, because it is non-commercial and was pro-
duced by our own (immunoGlobe®; 4.2.2). To exclude unspecific binding of the anti-
body, ChIP was performed after Chinmo knockdown. The binding of all three genes 
was reduced after Chinmo depletion, but only by 30%-40% (Figure 4-14 C). It is possi-
ble that some binding persisted due to an incomplete knockdown of Chinmo (Figure 
4-14 C’). Elongation of the incubation time with dsRNA, however, did not increase the 
knockdown efficiency. No differences in knockdown efficiency had been observed be-
tween 72 h and 120 h (compare Figure 4-13 D’, Figure 4-14 C’). Besides the incom-
plete knockdown of Chinmo, it is very likely that the antibody features massive unspe-
cific binding as it has been shown in several Western blots (Figure 4-13 D’; Figure 4-14 
C’). Therefore the antibody should be purified further to reduce or even completely 
eliminate this background reactivity. Accordingly, Chinmo was cloned into a pMal-c5x 
vector (data not shown), which produces a maltose binding fusion protein upon induc-
tion in E.coli, and allows purification of the antibody via Amylose resins (Maina et al., 
1988; Park et al., 1998). The purification still has to be performed. Nonetheless, the 
reduced binding after Chinmo depletion shows that at least some binding of Chinmo 
towards the shown genes was specific. To get a comprehensive list of Chinmo bound 
genes, ChIPseq should be performed. Considering the high background binding, the 
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antibody should be purified before and suitable controls should be included, for exam-
ple knockdown control and non-immune IgGs. Chinmo not only binds to Myc target 
genes but has been shown to activate at least some of them, like fibrillarin, nnp-1 and 
CG12295 (Schwinkendorf, 2008). All of these genes are transcribed by RNA Pol II, 
contain an E-box and were shown to be Myc targets (Hulf et al., 2005; Herter et al., 
2015). It is still open if Chinmo needs the presence of Myc for this activation. To inves-
tigate whether the activation of nnp-1, fib and CG12295 is brought about by a physical 
recruitment of Chinmo, ChIP should be performed with these genes. 
 
 
Figure 5-3: Model of molecular interactions of Chinmo and Myc 
 
A. Myc and Chinmo bind each other directly at their target genes. 
B. Chinmo and Myc individually bind to the same promoter region.  
C. The interaction of Chinmo and Myc is achieved via a third, unknown protein (factor X). 
D. Myc and Chinmo form a complex at the promoter region of their target genes, involving other 
and presently unknown proteins 
 
The interaction of Chinmo and Myc is still not clear. Several possibilities of how they 
interact might be possible. One option would be that Myc and Chinmo directly interact 
with each other to activate common target genes (Figure 5-3 A). The existing data (ex-
ogenous and endogenous Co-IP) argue for this direct binding, yet it is possible that the 
interaction is mediated via third, still unknown factor (Figure 5-3 C). Independent of 
their binding, Myc and Chinmo could be recruited individually to the promoter region of 
the target gene for the correct expression (Figure 5-3 B). To investigate whether 
Chinmo and Myc are indeed concurrently bound to the same DNA sequences, Re-
ChIP experiments should be performed. A last option could be that Chinmo and Myc 
interact in a complex including other, unknown proteins (Figure 5-3 D). Taken together, 
the molecular data obtained indicate for partially redundant functions of Chinmo and 
Myc in growth and development, but are still not sufficient to explain their exact way of 
interaction.  
5.2.4 Myc is important for Chinmo’s role in tumor induction 
Already one century ago, C. Bridges and M. Stark suggested that Drosophila can de-
velop tumors, based on their discovery of melanotic tumor-like granules in mutant lar-
vae (Stark, 1917). Since then, several screens were performed to identify cancer relat-
ed genes in flies, of which many have a mammalian homolog (Potter et al., 2000). 
Studying the fly homologs of mammalian cancer genes has promoted the understand-
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ing of the genetic pathways in which they act, and their role in developmental process-
es. Using the two yeast derived UAS/Gal4- and FLP/FRT-systems, R. Pagliarini and T. 
Xu (2003) tested several candidates in Drosophila eye discs, to search for tumors 
showing a metastatic behavior. They found that cooperation between the overex-
pressed oncogene RasV12 and loss of genes affecting cell polarity, led to invasion, mi-
gration and secondary tumor formation (Pagliarini and Xu, 2003). While loss of scribble 
(scrib), lethal giant larvae (lgl) and discs large (dlg) caused metastatic behavior when 
combined with RasV12 expression, loss of large tumor suppressor (lats) only resulted in 
tumor formation. Mutations of the tumor suppressor lats were shown before to cause 
massive overproliferation phenotypes (Xu et al., 1995). In 2003, a study was published 
using the MARCM (mosaic analysis with repressible cell marker) system. In this study 
the authors showed that scribble mutant clones alone do not overgrow due to in-
creased cell death, while co-activation of oncogenic Ras or Notch leads to neoplastic 
tumors (Brumby and Richardson, 2003). These authors stated that the tumor progres-
sion is dependent on the JNK pathway (Jun N-terminal kinase) and performed a com-
parative microarray to study the JNK-dependent transcriptional changes of Ras- and 
Notch-driven scrib tumors (Doggett et al., 2010; Turkel et al., 2013). The BTB/Zf do-
main containing protein family was highly enriched in their analysis, including Abrupt, 
Chinmo, Fruitless and Broad. Based on their results, we investigated whether ectopic 
activation of Ras and Chinmo leads to tumor formation. Indeed, overexpression of 
Chinmo and Ras led to the formation of massive tumors, while their individual overex-
pression had no effect (Figure 4-15 A, B). Activation of Chinmo alone even reduced the 
size of fluorescent tissue, what can be due to the apoptotic effect of Chinmo overex-
pression (Schwinkendorf, 2008). Activation of Ras alone led to a very weak increase in 
size of fluorescent tissue, which was not influenced by co-activation of Myc or loss of 
Chinmo. Co-activation of Chinmo and Myc also led to a slight increase, but considering 
the small number of tested animals (2) this effect has to be confirmed in further exper-
iments. Some fluorescent tissue was observed outside the imaginal discs in “RasV12 + 
Chinmo” animals (data not shown), which might have been metastasis. However it is 
quite likely that this was due to a misexpression of the eye-Gal4 driver, since the same 
observations were made with flies overexpressing only Ras. Consistent with data from 
R. Pagliarini and T. Xu (2003), this misexpression occurred mostly in the gonads. Since 
Myc plays such an important role in tumor formation in vertebrates and we have shown 
that Myc and Chinmo interact genetically and molecularly with each other, we wanted 
to know whether the “RasV12 + Chinmo” tumors are dependent upon Myc. The tumor-
ous tissue was significantly smaller for Myc hypomorphic as well as null mutant eye 
discs, revealing that Myc is important for this tumor induction (Figure 4-15 C). Interest-
ingly the effect on the partial loss of Myc was bigger than for the complete loss. This 
difference might be negligible, considering the small sample size and the bigger fluctu-
ations in the dm4 animals. Therefore the experiment should be repeated with more in-
dividuals.   
Regarding Myc’s important role in the formation of “RasV12 + Chinmo” tumors, a future 
goal should be to investigate whether Myc is generally required for all types of tumors 
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or if Myc’s requirement is specific for the “RasV12 + Chinmo” tumors. Therefore, Ras- 
and Notch-driven scrib tumors should be examined as well as additional genes known 
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6 Appendix 
6.1 List of abbreviations 
Selections of abbreviations that can be found in this thesis are explained below. Fur-
thermore the abbreviations of the IUPAC (International union of pure und applied 
Chemistry) and of the SI-System (Système international d'unités) were used. 
6.1.1 Prefixes 
Table 6-1: abbreviations for prefixes and multiplication factors 
abbreviation prefix factor 
p Pico- 10-12 
n Nano- 10-9 
µ Micro- 10-6 
m Milli- 10-3 
c Centi- 10-2 
k Kilo- 103 
6.1.2 Units 
A    ampere 
Da    dalton 
g     gram 
h     hour 
J     joule 
l     liter 
m     meter 
min    minute 
M     mol/l 
OD    optical density 
s     second 
U     unit 
v/v    volume per volume 
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w/v    weight per volume 
°C     degree Celsius 
6.1.3 Proteins, protein domains and other biomolecules 
A     adenine 
aa     amino acid 
bp     basepair(s) 
bHLH   basic helix-loop-helix 
BTB    broad-complex, tramtrack and bric à brac 
C     cytosine 
cDNA    complementary DNA 
dATP    deoxyadenosine triphosphate 
dCTP    deoxycytidine triphosphate 
dGTP    deoxyguanosine triphosphate 
dTTP    deoxythymidine triphosphate 
DNA    deoxyribonucleic acid 
ddNTPs   dideoxyribonucleoside triphosphates 
dNTPs   deoxyribonucleoside triphosphates 
dsRNA  double stranded RNA 
FRT   flipase recombination target 
G     guanine  
GFP   green fluorescent protein 
GST    glutathione-S-transferase 
HRP    horseradish peroxidase 
nt     nucleotide(s) 
ORF   open reading frame 
POZ    pox virus and zinc finger 
RNA   ribonucleic acid 
rNTPs   ribonucleotide triphosphates 
LZ    leucine zipper 
T     thymine 
UAS   upstream activating sequence 
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UTR  untranslated region 
Zf    zinc finger 
6.1.4 Chemicals and solutions 
APS    ammoniumpersulfate 
ddH2O   bidestilled water 
DMSO   dimethylsulfoxide 
EDTA    ethylendiamintetraacetate 
FBS    fetal bovine serum 
PBS    phosphate-buffered saline 
SDS    sodium dodecyl sulfate 
TBE    Tris-borate-EDTA-buffer 
TBS    Tris-buffered saline 
TBS-T   Tris-buffered saline with tween-20 
TE    Tris-EDTA-buffer 
TEMED   N,N,N',N'-tetramethylethylendiamine 
Tris    Tris-(hydroxymethyl)-aminomethan 
6.1.5 Other abbreviations 
E. coli    Escherichia coli 
e.g.   for example 
hs    heat shock 
IP     immunoprecipitation 
PAGE    polyacrylamide-gelelectrophoresis 
PCR    polymerase chain reaction 
pers. com.  personal communication 
qPCR    quantitative PCR 
qRT-PCR  quantitative Reverse Transcriptase PCR 
rpm    rotations per minute 
RT    room temperature 
SC    Santa Cruz 
o./n.    overnight; 16-20 h 
wt    wildtype 
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